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KESAN POLIMORFISME GEN ANGIOTENSIN I-CONVERTING ENZYME 
(ACE) I/D DAN ALPHA-ACTININ-3 (ACTN3) R/X KE ATAS PRESTASI 
FIZIKAL DAN KESIHATAN MANUSIA DALAM POPULASI MALAYSIA  
 
ABSTRAK 
 
Perbezaan data set populasi dalam sorotan kajian semasa dengan laporan 
terhad di kalangan sampel Asia, di tambah pula dengan penemuan yang tidak 
konsisten di kalangan kumpulan etnik yang berbeza, serta kekurangan maklumat bagi 
penglibatan polimorfisme gen ACE I/D dan ACTN3 R/X dalam adaptasi latihan telah 
menghadkan keupayaan penyelidik untuk membuat kesimpulan yang bermakna yang 
berkaitan dengan kesan-kesan polimorfisme ini ke atas prestasi fizikal dan kesihatan 
manusia. Oleh itu, penyelidikan kedoktoran ini melaksanakan tiga siri kajian untuk 
mengkaji kesan polimorfisme gen ACE I/D dan ACTN3 R/X ke atas prestasi fizikal 
dan kesihatan manusia dalam populasi Malaysia. Dalam kajian pertama, sampel 
DNA telah diambil melalui sel bukal daripada 180 orang Asia dari Malaysia (70 
lelaki, 110 perempuan) berumur 20.4 ± 1.6 tahun, dan 180 orang Kaukasia dari 
Australia (62 lelaki, 118 perempuan) berumur 23.3 ± 3.6 tahun. Dalam kajian kedua, 
sampel DNA telah diambil daripada 180 atlet terlatih Malaysia (148 lelaki, 32 
perempuan) berumur 20.5 ± 1.9 tahun, 180 kawalan sedentari Malaysia, dan 33 atlet 
berkala Australia (semua lelaki) berumur 20.7 ± 4.0 tahun. Prestasi daya tahan dan 
muskular atlet Malaysia masing-masing telah dinilai dengan ujian 20 meter Yo-Yo 
berkala pemulihan tahap 2 dan ujian penguncupan sukarela maksimum. Dalam kajian 
yang ketiga, tiga puluh lelaki tidak terlatih normotensive, (ACE genotip: II = 10, ID 
= 10, dan DD = 10), menjalani latihan genggaman isometrik (IHG) (empat set 2 
xx 
 
minit pengecutan isometrik pada 30% daripada penguncupan sukarela maksimum , 
dengan selang 1 minit rehat) 3 hari setiap minggu selama 8 minggu. Hasil kajian 
pertama menunjukkan bahawa pengagihan polimorfisme gen ACE I/D berubah di 
kalangan kumpulan etnik yang berbeza, tetapi tidak kepada polimorfisme gen 
ACTN3 R/X. Hasil yang diperolehi kajian kedua menunjukkan bahawa: a) Kesan 
polimorfisme ini pada prestasi daya tahan dan kekuatan/kuasa tidak berbeza 
mengikut kesukubangsaan. b) Alel ACE D dan alel ACTN3 R memberikan kelebihan 
dalam aktiviti-aktiviti yang memerlukan kekuatan/kuasa, dan c) Alel ACE I dan alel 
ACTN3 R tidak mempengaruhi prestasi daya tahan. Hasil daripada kajian terakhir 
menunjukkan bahawa polimorfisme gen ACE I/D mempunyai pengaruh positif dalam 
penyesuaian kardiovaskular dan otot berikut latihan genggaman isometrik di 
kalangan lelaki normotensive. Secara keseluruhan, kajian ini mengesahkan lagi 
tanggapan bahawa prestasi kekuatan/kuasa dipengaruhi oleh alel ACE D dan alel 
ACTN3 R. Sebagai tambahan, kajian ini menyimpulkan bahawa polimorfisme gen 
ACE I/D memodulatkan tindak balas kepada latihan genggaman isometrik dalam 
lelaki normotensive. 
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THE EFFECTS OF ANGIOTENSIN I-CONVERTING ENZYME (ACE) I/D 
AND ALPHA-ACTININ-3 (ACTN3) R/X GENE POLYMORPHISMS ON 
HUMAN PHYSICAL PERFORMANCE AND HEALTH WITHIN 
MALAYSIAN POPULATION 
 
ABSTRACT 
 
A disparity population data set in the current literature with limited reports 
among Asian samples, coupled with the inconsistent findings among different ethnic 
groups, and lack of information for the involvement of angiotensin I-converting 
enzyme (ACE) I/D and alpha-actinin-3 (ACTN3) R/X gene polymorphisms in training 
adaptation have limited the ability of researchers to draw meaningful conclusions 
pertaining to the effects of these polymorphisms on human physical performance and 
health. Therefore, this doctoral research implemented three series of studies to 
examine the effects of ACE I/D and ACTN3 R/X gene polymorphisms on human 
physical performance and health within the Malaysian population. In the first study, 
DNA samples were retrieved via buccal cell from 180 Asians from Malaysia (70 
males, 110 females) aged 20.4 ± 1.6 years, and 180 Caucasians from Australia (62 
males, 118 females) aged 23.3 ± 3.6 years. In the second study, DNA samples were 
retrieved from 180 well-trained Malaysian athletes (148 males, 32 females) aged 
20.5 ± 1.9 years, 180 Malaysian sedentary controls, and 33 intermittent Australian 
athletes (all males) aged 20.7 ± 4.0 years. Endurance and muscular performances of 
Malaysian athletes were evaluated with 20 meters Yo-Yo intermittent recovery level 
2 and maximal voluntary contraction tests, respectively. In the third study, thirty 
normotensive, untrained males (ACE genotype: II = 10, ID = 10, and DD = 10), 
xxii 
 
undergone isometric handgrip training (four sets of 2 minutes isometric contractions 
at 30% of maximal voluntary contraction, with 1 minute resting interval) 3 days per 
week for 8 weeks. The result from the first study indicated that the distribution of 
ACE I/D gene polymorphism varied among different ethnic groups, but not to 
ACTN3 R/X gene polymorphism. The findings obtained from the second study 
demonstrated that: a) The effects of these polymorphisms on endurance and 
strength/power performances did not vary by ethnicity, b) The ACE D allele and 
ACTN3 R allele conferred an advantage in activities that require strength/power, and 
c) The ACE I allele and ACTN3 X allele did not influence endurance performance. 
Finding from the final study demonstrated that ACE I/D gene polymorphism had a 
positive influence in cardiovascular and muscular adaptations following isometric 
handgrip training among normotensive men. Overall, this research reaffirms the 
notion that strength/power performance is influenced by the ACE D allele and 
ACTN3 R allele. In addition, this research concludes that the ACE I/D gene 
polymorphism modulates response to isometric handgrip training in normotensive 
men.  
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Background and Scope of the Research 
 
Genetics play a key role in almost every aspect of human physical performance and 
health. The influence of the genetic factor on human physical performance and health 
has been extensively studied over the past several decades (Bouchard et al., 1997, 
MacArthur and North, 2005, Bouchard and Hoffman, 2011). The first strong evidence 
for genetic involvement in human physical performance came from a family study 
known as the HEalth, RIsk factors, exercise Training And Genetics (HERITAGE) 
Family Study (Bouchard et al., 1995). Since then, efforts have been made to identify 
candidate genes to human physical performance. Through the first annual version of 
human gene map for performance and health-related fitness, several genes or markers 
related to physical performance and health-related phenotypes have been identified 
(Rankinen et al., 2001, Rankinen et al., 2002, Rankinen et al., 2004, Wolfarth et al., 
2005, Rankinen et al., 2006, Bray et al., 2009). The most updated version of this yearly 
publication revealed that there are 239 genes  associated with human physical 
performance (Bray et al., 2009). 
 
 Two of the most extensively investigated genes associated with human 
physical performance are angiotensin I-converting enzyme (ACE) and alpha-actinin-3 
(ACTN3) genes (Ma et al., 2013). It has been suggested that possession of the I allele 
of the ACE I/D gene polymorphism may influence endurance performance as the 
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presence of I allele of the ACE I/D gene polymorphism has been reported to be more 
pronounced among endurance athletes, such as elite distance runners (Myerson et al., 
1999, Alvarez et al., 2000, Hruskovicova et al., 2006, Min et al., 2009), rowers 
(Gayagay et al., 1998, Ahmetov et al., 2008b), triathletes (Collins et al., 2004, Shenoy 
et al., 2010), and long-distance swimmers (Tsianos et al., 2004b). Also, individuals 
with I allele have also been reported to have a higher capacity of maximal oxygen 
consumption (VO2max) (Hagberg et al., 1998, Goh et al., 2009), higher percentage of 
slow twitch muscle fibres (Zhang et al., 2003), greater cardiac output (Hagberg et al., 
2002), and higher heat tolerance (Heled, 2004). Meanwhile, possession of the R allele 
of the ACTN3 R/X gene polymorphism may offer additive effects on strength/power 
performance as the RR genotype (two copies of R allele) was observed more frequently 
in strength/power-oriented athletes, such as Russian power athletes (Druzhevskaya et 
al., 2008), elite-level bodybuilders and power lifters (Roth et al., 2008), gymnasts 
(Massidda et al., 2009), Indian power athletes (Kothari et al., 2011), and Polish power 
athletes (Cieszczyk et al., 2011), when compared with endurance athletes and controls. 
Individuals with R allele have also been reported to have greater strength/power 
capacity (Clarkson et al., 2005a, Moran et al., 2006b, Vincent et al., 2007, Norman et 
al., 2009, Shang et al., 2012, Erskine et al., 2014). 
 
Hence, there is a growing body of evidence amplifying the significance of ACE 
I/D and ACTN3 R/X gene polymorphisms in human physical performance (Yang et al., 
2003, Cam et al., 2007, Voroshin and Astratenkova, 2008, Druzhevskaya et al., 2008, 
Goh et al., 2009, Kothari et al., 2011, Ma et al., 2013). On the contrary, some studies 
have failed to demonstrate the influences of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance (Sonna et al., 2001, Lucia et al., 2006, 
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Moran et al., 2006a, Amir et al., 2007, Ahmetov et al., 2008a, Döring et al., 2010). 
Therefore, it has remained uncertain if human physical performance is indeed 
influenced by ACE I/D and ACTN3 R/X gene polymorphisms. Moreover, it has been 
speculated that the inconsistencies observed in the present findings may be due to 
small sample size and ethnicity differences (Zilberman-Schapira et al., 2012). 
 
 The distributions of ACE I/D and ACTN3 R/X gene polymorphisms have been 
reported to vary across ethnic groups in general populations worldwide (Batzer et al., 
1994, Batzer et al., 1996, Mills et al., 2001, Clarkson et al., 2005a, Jayapalan et al., 
2008). As for ACE I/D gene polymorphism, the frequency of I allele in the Caucasian 
population ranged from 0.78 to 0.23. However, in the Asian population, this frequency 
ranged from about 0.76 to 0.42. The distribution of ACE I/D gene polymorphism 
among the three ethnic groups in Malaysia; Malay (I allele: 0.71, D allele: 0.29), 
Chinese (I allele: 0.63, D allele: 0.37), and Indian (I allele: 0.58, D allele: 0.42), were 
reported to be different to each other with I and D alleles found to be more prevalent 
among the Malays (0.71) and Indians (0.42), respectively (Jayapalan et al., 2008). On 
the other hand, as for ACTN3 R/X gene polymorphism, the frequency of R allele in the 
Caucasian population ranged from 0.61 to 0.50, while in the Asian population, the 
frequency of R allele varied from 0.53 to 0.39.  
 
The different pattern in the distributions of ACE I/D and ACTN3 R/X gene 
polymorphisms across different ethnicities were apparently consistent with the 
research findings on the effect of ACE I/D gene polymorphism in the susceptibility to 
certain diseases (Ishigami et al., 1995, Barley et al., 1996, Staessen et al., 1997, Kunz 
et al., 1998, Fujisawa et al., 1998, Sagnella et al., 1999, Ng et al., 2005). For instance, 
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a study by Ng et al. (2005) showed that the association between ACE  I/D gene 
polymorphism and diabetic nephropathy was more common in the Asian population 
than those from the Caucasian population. Based on the findings in the distributions 
of ACE I/D and ACTN3 R/X gene polymorphisms in general populations worldwide 
and the research findings on the effect of ACE I/D gene polymorphism in disease 
susceptibility, there is a possibility that the effects of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance may vary depending on the ethnic 
origin, which indicates that such findings previously reported for Caucasian population 
may not be relevant and could be different in Asian population. Nevertheless, whether 
the effects of ACE I/D and ACTN3 R/X  gene polymorphisms on human physical 
performance vary between different ethnic groups has remained unclear at present due 
to insufficient comparative analyses across ethnicities in the current literature 
(Zilberman-Schapira et al., 2012, Ma et al., 2013). A recent meta-analysis showed that 
the effects of the ACE I/D and the ACTN3 R/X gene polymorphisms on human physical 
performance have been mostly reported among Caucasian population and less reported 
in the Asian population (Ma et al., 2013).  
 
Therefore, more research in the Asian population is needed to understand 
ethnic differences of the ACE I/D gene polymorphism, especially where the 
preliminary data suggest individual variation in response to exercise training could be 
influenced by this variant (Hagberg et al., 1999, Folland et al., 2000, Williams et al., 
2000, Zhang et al., 2002, Giaccaglia et al., 2008). For instance, the ACE I/D gene 
polymorphism has been reported to influence adaptation to light weight lifting and 
walking training (Giaccaglia et al., 2008), isometric and dynamic leg training (Folland 
et al., 2000), as well as aerobic training (Hagberg et al., 1999, Williams et al., 2000, 
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Zhang et al., 2002). The results of these studies demonstrate that individuals with the 
same genotype of ACE I/D gene polymorphism exhibited similar adaptations to the 
training. While the deficient of the ACTN3 protein due to ACTN3 R/X gene 
polymorphism had been reported does not have any harmful health effects (North et 
al., 1999), the ACE I/D gene polymorphism had been reported to be associated with 
several disease such as hypertension (Barley et al., 1996, Sagnella et al., 1999). 
Moreover, several studies showed that blood pressure response to exercise training for 
health management also vary among individuals with different genotypes of ACE I/D 
gene polymorphism (Hagberg et al., 1999, Zhang et al., 2002, Kim, 2009). For 
instance, a study by Hagberg et al. (1999) found that after 9 months of endurance 
exercise training at 75 to 85 % of VO2max, I allele carriers had reduced systolic and 
diastolic blood pressure more than D allele carriers. Despite these findings, it has 
remained unknown if the ACE I/D gene polymorphism can also influence 
cardiovascular and muscular responses to isometric handgrip training that had been 
found to be superior to the dynamic resistance exercise training in controlling and 
preventing high blood pressure in a normotensive population.  
 
1.2 Statement of the Problems 
 
The current literature pertaining to the effects of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance has appeared to be inconsistent, 
which is speculated to be due to ethnicity factor. Furthermore, compelling evidence 
indicates that the influences of the ACE I/D and the ACTN3 R/X gene polymorphisms 
on human physical performance may vary across ethnicity. However, whether the 
effects of ACE I/D and ACTN3 R/X gene polymorphisms on human physical 
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performance vary across ethnicity have remained unclear due to the disparity 
discovered in the data set for population-based studies in the current literature. 
Moreover, despite available evidence supporting the effect of ACE I/D gene 
polymorphism on adaptation to certain training programs, there is no evidence at 
present that the ACE I/D gene polymorphism may influence adaptation to isometric 
handgrip training in controlling and preventing high blood pressure in normotensive 
individuals.  
 
Therefore, more comprehensive studies on ACE I/D and ACTN3 R/X gene 
polymorphisms across different ethnicities, particularly among the Asian population, 
are needed to determine if the effects of these variants vary across ethnicity. To the 
author’s knowledge, there are limited studies examining the effects of ACE I/D and 
ACTN3 R/X gene polymorphisms on human physical performance within multi-ethnic 
Malaysian population. Based on the report by Jayapalan et al. (2008) on the 
distribution of ACE I/D gene polymorphism among multi-ethnic Malaysian 
populations, there is a possibility that the effects of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance may vary between ethnic groups in 
Malaysia. Hence, such genetic information could be useful to identify potential elite 
athletes in Malaysia and to assist coaches in optimizing their athlete’s training 
program. Besides that, a training study that implements the isometric handgrip exercise 
is also warranted to examine the training responses among normotensive individuals 
with different genotypes of ACE I/D gene polymorphism that may identify individuals 
who will lower resting blood pressure the most with this training program for health 
management. 
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1.3 Aims of the Research 
 
The main objective of this research had been to examine the influences of ACE I/D 
and ACTN3 R/X gene polymorphisms on human physical performance, as well as 
health, within the Malaysian population. The specific objectives of this research are as 
the following: 
 
(i)   To investigate ethnic variation on ACE I/D and ACTN3 R/X gene polymorphisms 
by comparing the distribution of the data between Malaysian and Australian 
populations, as well as between four ethnic groups (Malay, Chinese, Indian, and 
Other Bumiputra) in Malaysia. 
 
(ii) To examine the effects of ACE I/D and ACTN3 R/X gene polymorphisms on 
athletic status and human physical performance in the Malaysian population and 
to determine if the effects of these polymorphisms on human physical 
performance differ by ethnicity. 
 
(iii) To examine the effect of ACE I/D gene polymorphism on cardiovascular and 
muscular adaptations following an 8-week isometric handgrip training on 
cardiovascular and muscular adaptations among normotensive men. 
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1.4 Significance of the Research 
 
The findings retrieved from the series of experiments in this doctoral research project 
provide better comprehension on the involvement of the genetic factor on human 
physical performance among different ethnic groups. Furthermore, this research 
provides more information concerning ACE I/D gene polymorphism and training 
adaptation. In fact, besides establishing the influences of ACE I/D and ACTN3 R/X 
gene polymorphisms on human physical performance within multi-ethnic Malaysian 
population, this study could be able to assist sports coaches in developing talent of 
athletes based on their genetic traits. In addition, the findings obtained from this 
doctoral research project also provide valuable information on training adaptation for 
health management and its association to genetic traits. 
 
1.5 Thesis Structure 
 
This thesis includes three separate studies relating to the influences of ACE I/D and 
ACTN3 R/X gene polymorphisms on human physical performance and training 
intervention for health. A detailed review of the topic is discussed in Chapter 2 of the 
literature review. Meanwhile, Chapter 3 gives an overview of the research plan and 
the objectives of each study undertaken in this research project. The first study that 
was designed to examine the distribution patterns of ACE I/D and ACTN3 R/X gene 
polymorphisms within the Malaysian population and its association with ethnicity are 
presented in Chapter 4. This is followed by the second study that investigated the 
effects of ACE I/D and ACTN3 R/X gene polymorphisms on human physical 
performance within the Malaysian population and determined if those effects differ by 
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ethnicity in Chapter 5. The final study, which is presented in Chapter 6, examined the 
influence of ACE I/D gene polymorphism on training adaptations for health. Lastly, 
the overall conclusion of this doctoral research project is presented in Chapter 7. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 The Human Genetics 
 
Genetics is a branch of science that studies heredity and how an organism inherits, as 
well as transfers characteristics from one generation to the next (Winter et al., 2002). 
Human genetics, then, emphasizes on the variation that occurs in human beings 
(Winter et al., 2002). The fundamental component in genetics is known as a gene, 
which is a region of deoxyribonucleic acid (DNA) that contains particular codes for 
making a specific protein that is required for building tissues for the formation of 
organs (Mulvihill et al., 2011).  
 
Generally, genes that control human physical traits occur in pairs called alleles, 
which are alternative forms of genes located on loci (positions) on the same 
chromosome (Pitman, 1993). For example, high or low, round or wrinkled, red or 
white. Each human inherits two alleles for each gene from the mother and the father 
(Walker, 2009). Alleles can exist in the form of dominant and recessive, and if a gene 
is composed of a pair of dominant alleles or only one dominant allele is present, the 
characteristic from the dominant allele will appear over the characteristic carried by 
the recessive allele (Pitman, 1993). However, the recessive allele is able to show its 
characteristic if paired with another recessive allele (Pitman, 1993). Thus, this natural 
selection creates a scenario, whereby different phenotype (characteristic) outcomes 
can result from one gene (Winter et al., 2002). Moreover, the differences in allele may 
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be significant to explain the variation in human physiology (e.g. muscle strength) 
(Mulvihill et al., 2011).  
 
2.2 Influence of Genetics in Sports Performance 
 
The ability of an individual to maximize personal potential is enormously complex. 
Undoubtedly, some factors, such as the volume of training, motivation, and 
environment, attribute to the success of an athlete (Baker and Davids, 2006). 
Nevertheless, if training is a crucial determinant for an athlete to increase the levels of 
body strength, agility, speed, and endurance, it does not seem to be a comprehensive 
factor of human physical performance as the genetic factor is more responsible for 
determining human innate potential (Baker and Davids, 2006). The genetic factor is 
likely to give a major impact towards physical trait, as a study among more than one 
million Swedish men reported that 81% of their body height was attributable to a 
genetic factor, while the left 19% were influenced by environment (Silventoinen et al., 
2008).  
 
The data obtained from twin studies are the best evidence to estimate precisely 
the contribution of genetic factors on physical performance and limit the 
environmental factor (Chatterjee and Das, 1995, Calvo et al., 2002, Maridaki, 2006, 
Alonso et al., 2014). For instance, a study by Chatterjee and Das (1995) among 30 
pairs of monozygotic and 20 pairs of dizygotic twins showed that vital capacity, 
vertical jump, and heart rate were influenced more by genetic factors than 
environmental factors. Meanwhile, a study among 32 Caucasian male twins, who had 
similar environmental backgrounds, showed that the heritability of anaerobic capacity 
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was estimated between 20 and 70%, as measured with jumping tasks and the Wingate 
test (Calvo et al., 2002). A similar result was also successfully replicated in a study 
among 15 pairs of preadolescents and 15 pairs of adolescent female twins, which then 
supported a strong influence of genetic factors on muscular strength and power 
performance (Maridaki, 2006). The aerobic performance was also reported to be under 
genetic control through a twin study conducted in northeast Brazil that observed the 
rate of heritability of aerobic power to be 77% (Alonso et al., 2014).  
 
Nonetheless, Bouchard and colleagues (1995) were the first to examine the 
association between the genetic factor and the human physical performance via the 
HERITAGE family study which involved 484 Whites from 99 families and 260 Blacks 
from 105 families that were exercise trained for 20 weeks and were tested for maximal 
oxygen consumption (VO2max) on a cycle ergometer twice before and twice after the 
training program. Results from the HERITAGE family study found that there was 2.5 
times more variance in changes in aerobic fitness between families than within families 
in responses to exercise interventions (Bouchard et al., 1995). Since then, this 
association has continued to be extensively investigated, as reported in the first 
(Rankinen et al., 2001, Rankinen et al., 2002, Rankinen et al., 2004, Wolfarth et al., 
2005, Rankinen et al., 2006, Bray et al., 2009) and the second annual versions of the 
human gene map for performance and health-related fitness (Rankinen et al., 2010, 
Hagberg et al., 2011, Roth et al., 2012, Pérusse et al., 2013, Loos et al., 2015). In the 
initial publication of the human gene map for performance and health-related fitness 
by Rankinen and colleagues (2001), several genes or markers identified had been 
related to physical performance phenotypes. Subsequently, the number of genes 
identified had begun to increase and the last article of this yearly publication revealed 
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that 239 genes were associated with physical performance, which included cardio-
respiratory endurance, elite endurance, athlete status, muscle strength, muscle 
performance traits, and exercise intolerance of variable degrees (Bray et al., 2009). 
From this large number of genes, two genes that have been extensively examined are 
the angiotensin I-converting enzyme (ACE) and the alpha-actinin-3 (ACTN3) genes 
(Ma et al., 2013). The ACE and ACTN3 genes were suggested as the strongest 
candidate genes with the highest number of positive findings related to endurance and 
strength/ power performances, respectively (Ma et al., 2013).  
 
2.3 The Angiotensin I-Converting Enzyme (ACE) Gene and Human 
Performance 
 
2.3.1 The ACE Gene  
 
In humans, the ACE gene is located on the long arm (q) of chromosome 17 (17q23.3), 
spans 21 kilo bases (kb) in length, and comprises of 26 exons and 25 introns, as 
illustrated in Figure 2.1 (Sayed-Tabatabaei et al., 2006). The ACE gene is responsible 
for producing ACE (Sayed-Tabatabaei et al., 2006), and it has been identified as a key 
component in the renin-angiotensin system (RAS); which is a hormone system that 
regulates blood pressure, water fluid balance, and tissue growth (Silverthorn, 2007). 
In addition, as illustrated in Figure 2.2, the main role of ACE in circulating RAS is to 
produce angiotensin II (ANG II), which is a potent vasopressor and aldosterone-
stimulating peptide from angiotensin I (ANG I) (Coates, 2003), and to degrade 
bradykinin, a potent vasodilator that lowers blood pressure (Coates, 2003). Other than 
that, the plasma ACE level has been shown to differ between individuals, but identical 
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between family members, which indicates that the interindividual variation in the 
plasma ACE level is determined by genetic factors (Cambien et al., 1988). Among 
several polymorphisms in the ACE gene, the ACE I/D gene polymorphism (rs4646994) 
was found to have a strong linkage with the level of plasma ACE as it accounted for 
47% of the total phenotypic variance of ACE activity (Rigat et al., 1990). 
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Figure 2.1 The genomic organization of the ACE gene on the long arm (q) of 
chromosome 17 on band 23.3. The ACE gene consists of 26 exons and 
25 introns. *Picture adapted from Mayne (2006). 
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Figure 2.2 The role of ACE in the circulating renin-angiotensin system (RAS). 
*Picture adapted from Athilingam et al. (2012). 
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2.3.2 The ACE I/D Gene Polymorphism 
 
As shown in Figure 2.3A, the ACE I/D gene polymorphism refers to the presence 
(Insertion “I”) or absence (Deletion “D”) of a-287 base pair (bp) alu repetitive 
sequence in intron 16 of I or D alleles on chromosome 17, respectively (Rigat et al., 
1992). The ACE level was reported lower in individuals with two copies of I allele 
(Rigat et al., 1990). This led to a decrease in the conversion of ANG I to ANG II, 
which resulted in less vasoconstriction in skeletal muscle, and thus, an increased 
delivery of oxygenated blood to the working muscles (Sayed-Tabatabaei et al., 2006). 
Conversely, individuals with two copies of D allele had been reported to have a higher 
level of ACE (Rigat et al., 1990), which resulted in higher level of ANG II and led to 
a greater vasoconstriction, as well as reduced oxygenated blood flow to the working 
muscle (Jones and Woods, 2003, Sayed-Tabatabaei et al., 2006). Given these opposing 
physiological characteristics, I and D alleles may confer advantageous for endurance 
and strength/power events, respectively. 
 
The ACE I/D gene polymorphism may result in three possible genotypes of II 
(with low ACE serum levels), ID (with intermediate ACE serum levels), and DD (with 
high ACE serum levels) (Rigat et al., 1990). Figure 2.3B shows a visual detection of 
ACE I/D genotypes with the presence of I and D alleles, which are presented by 490 
bp and 190 bp, respectively (Rigat et al., 1992). Moreover, the distribution of ACE I/D 
gene polymorphism has been widely studied across many populations with allele and 
genotype frequencies being reported to vary across different racial groups (Barley et 
al., 1994, Batzer et al., 1994, Batzer et al., 1996, Jayapalan et al., 2008). 
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Figure 2.3 A. The ACE I/D gene polymorphism is characterized by an insertion or 
deletion of a 287-bp alu sequence at intron 16. B. A visual detection of 
ACE I/D genotypes. Lane 1: Homozygous II genotype (490 bp), Lane 
2: Heterozygous ID genotype (490 bp and 190 bp), and Lane 3: 
Homozygous DD genotype (190 bp). *Pictures adapted from Mayne 
(2006). 
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2.3.3 The Distribution of ACE I/D Gene Polymorphism across Ethnicity 
 
The current literature has observed variation in the distribution of the ACE I/D gene 
polymorphism in different racial and ethnic groups. Among the racial groups, the 
highest frequency of I allele was reported in the Black (Australian Aboriginal) 
population (0.97) (Lester et al., 1999), while the D allele was reported highest among 
the Caucasian population (0.77) (Tiret et al., 1992). In addition, the distribution 
patterns of I and D alleles in the Black population were about 0.97 to 0.27 and 0.73 to 
0.03, respectively. In Black population, the Australian Aboriginal population was 
reported to have the highest frequency of I allele as compared to other ethnic groups 
of Black population (Lester et al., 1999). Other than that, the D allele was reported to 
be the most prevalent among Nigerians (Batzer et al., 1994) and Somalis (Bayoumi, 
2006). Meanwhile, the trend observed among Amerindians (Vargas-Alarcon et al., 
2003) was closely similar to those reported for Pima Indians (Foy et al., 1996), Coastal 
Papua New Guineans (Perna et al., 1992), Sothos (Rupert et al., 2003), Mulatto 
(Pereira et al., 2001), and Alaska Natives (Rupert et al., 2003).  
 
On the other hand, in the Caucasian populations, the frequencies of I and D 
alleles ranged from 0.78 to 0.23 and 0.77 to 0.22, respectively. Among the Caucasians, 
the highest frequencies of I and D alleles were noted for Mexican (Vargas-Alarcon et 
al., 2003) and European (Tiret et al., 1992) populations, respectively. Nonetheless, I 
allele was observed to be less prominent among European (Tiret et al., 1992) and 
Caucasian populations from the Middle East, such as Egyptians (Ulu et al., 2006) and 
Omanis (Wang and Staessen, 2000). Moreover, the occurrence of I allele among 
Mexicans (Vargas-Alarcon et al., 2003) was observed to have close similarities with 
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the studies conducted by (Cambien et al., 1992) in European population. Furthermore, 
the high frequency of D allele observed among Europeans (Tiret et al., 1992) was fairly 
similar with those reported for Egyptians (Ulu et al., 2006) and Omanis (Wang and 
Staessen, 2000). The distribution trend of ACE I/D gene polymorphism in Australian 
samples (Lester et al., 1999, Lea et al., 2005) was reportedly identical with studies 
among the Brazilian (Pereira et al., 2001) and European (Renner et al., 2002) 
populations. In addition, results retrieved from several studies conducted in the same 
ethnic group, such as Turkish, were markedly similar to each other (Erdoğan et al., 
2004, Cam et al., 2005, Sipahi et al., 2006, Berdeli and Cam, 2009). Nevertheless, 
varying results have been reported from studies in European populations. While 
Cambien et al. (1992) reported that the frequency of I allele was 0.73 in their cohort 
sample, I allele was found to be less frequent in other studies; 0.23 (Tiret et al., 1992), 
0.43 (Vassilikioti et al., 1996), and 0.51 (Batzer et al., 1996).   
 
Meanwhile, in the Asian population, the frequencies of I and D alleles ranged 
from 0.76 to 0.42 and 0.58 to 0.24, respectively. I allele was reported to be most 
prominent in the Javanese population (Sasongko et al., 2005), whilst the highest 
frequency of D allele was observed in the Kazakh sample (Aĭtkhozhina and 
Liudvikova, 2003). Besides, a study by Jayapalan et al. (2008) that looked into 
different ethnic groups in Malaysia observed higher frequencies of I and D alleles 
among Malays and Indians, respectively. Moreover, the frequency of I allele among 
the Malays in this study was markedly similar with Thai (Nitiyanant et al., 1997), 
Singaporean Chinese (Lee, 1994), and Javanese (Sasongko et al., 2005) populations, 
while the higher D allele frequency detected among Indians was closely identical to 
previous finding of other Indian groups in Asia (Saha et al., 1996, Movva et al., 2007). 
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Additionally, the trend observed in the Chinese population in Malaysia was noticeably 
close to those reported for Hong Kong Chinese (Young et al., 1995), Taiwanese 
(Chuang et al., 1997), and Japanese (Tamaki et al., 2002) populations. 
 
It is quite clear from these observations that ethnic variation has been 
demonstrated to be existed in the distribution of ACE I/D gene polymorphism. 
Nevertheless, to the best of author’s knowledge, there is no report available for the 
distribution of ACE I/D gene polymorphism in certain ethnic groups particularly those 
from Asian population such as indigenous people of East Malaysia (will be referred as  
‘Other Bumiputra’). Hence, further studies are warranted to obtain the prevalence data 
of ACE I/D gene polymorphism in different ethnic groups to observe ethnic specificity 
in the distribution of ACE I/D gene polymorphism. The list of studies pertaining to the 
distribution of ACE I/D gene polymorphism across different ethnic groups is 
summarized in Table 2.1.  
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Table 2.1 Distribution of ACE I/D gene polymorphism in different ethnic groups 
Racial group Ethnic group 
Allele frequency Sample size 
(n) 
References 
I D 
Asian 
 
 
 
 
Malaysian pooled 
Malaysian Malay 
Indian 
 
Malaysian Indian 
Chinese 
 
Hong Kong Chinese 
Malaysian Chinese 
Singaporean Chinese 
 
Taiwanese 
Japanese 
 
 
 
 
Thai 
Javanese 
Kazakh 
 
Korean 
0.65 
0.71 
0.55 
0.55 
0.58 
0.60 
0.59 
0.63 
0.63 
0.69 
0.70 
0.64 
0.67 
0.60 
0.69 
0.67 
0.67 
0.70 
0.76 
0.42 
 
0.61 
0.35 
0.29 
0.45 
0.45 
0.42 
0.40 
0.41 
0.37 
0.37 
0.31 
0.30 
0.36 
0.33 
0.40 
0.31 
0.33 
0.33 
0.30 
0.24 
0.58 
 
0.39 
637 
274 
460 
166 
213 
102 
147 
183 
150 
671 
189 
189 
1245 
2168 
90 
113 
46 
298 
136 
145 
 
13914 
Jayapalan et al. (2008) 
Jayapalan et al. (2008) 
Movva et al. (2007) 
Saha et al. (1996) 
Jayapalan et al. (2008) 
Huang et al. (2004) 
Saha et al. (1996) 
Young et al. (1995) 
Jayapalan et al. (2008) 
Koh et al. (2003) 
Lee (1994) 
Chuang et al. (1997) 
Matsubara et al. (2002) 
Tamaki et al. (2002) 
Lau et al. (2002) 
Kario et al. (1997) 
Yoshida et al. (1995) 
Nitiyanant et al. (1997) 
Sasongko et al. (2005) 
Aĭtkhozhina and Liudvikova 
(2003) 
Yoo (2005) 
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Table 2.1        Continued 
Racial group Ethnic group 
Allele frequency Sample size  
(n) 
References 
I D 
Caucasian 
 
 
 
European 
 
 
 
 
 
 
 
 
Brazilian 
 
Australian 
 
 
Breton   
French 
 
French Acadian 
Greek Cypriot  
Egyptian 
  
Emirate 
Omanis 
Syrian 
0.48 
0.48 
0.46 
0.41 
0.43 
0.51 
0.49 
0.73 
0.23 
0.42 
0.46 
0.46 
0.56 
0.46 
0.58 
0.47 
0.48 
0.48 
0.51 
0.33 
0.28 
0.39 
0.29 
0.40 
0.52 
0.52 
0.54 
0.59 
0.57 
0.49 
0.51 
0.27 
0.77 
0.58 
0.54 
0.54 
0.44 
0.54 
0.42 
0.53 
0.52 
0.52 
0.49 
0.67 
0.72 
0.61 
0.71 
0.60 
2413 
3001 
522 
357 
84 
57 
186 
733 
98 
65 
150 
244 
634 
100 
41 
346 
54 
53 
46 
188 
188 
164 
159 
127 
Stephens et al. (2005) 
Mattace-Raso et al. (2004) 
Renner et al. (2002) 
Ferrieres et al. (1999) 
Vassilikioti et al. (1996) 
Batzer et al. (1996) 
Barley et al. (1994) 
Cambien et al. (1992) 
Tiret et al. (1992) 
Sprovieri and Sens (2005) 
Pereira et al. (2001) 
Lea et al. (2005) 
van Bockxmeer et al. (2000) 
Lester et al. (1999) 
Batzer et al. (1994) 
Marre et al. (1997) 
Batzer et al. (1996) 
Batzer et al. (1996) 
Batzer et al. (1996) 
Salem (2008) 
Ulu et al. (2006) 
Bayoumi et al. (2006) 
Wang and Staessen (2000) 
Salem (2008) 
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Table 2.1       Continued 
Racial group Ethnic group 
Allele frequency Sample size  
(n) 
References 
I D 
 Sudanese 
Mexican 
Swiss 
Turkish Cypriot 
Turkish 
 
 
 
Iranian 
Greek 
Slovenian 
German 
 
Croatian 
Polish 
Italian 
 
 
Colombian 
Chilean 
0.36 
0.78 
0.37 
0.33 
0.40 
0.51 
0.41 
0.47 
0.60 
0.38 
0.49 
0.49 
0.51 
0.51 
0.57 
0.69 
0.52 
0.43 
0.54 
0.57 
0.64 
0.22 
0.63 
0.67 
0.60 
0.49 
0.59 
0.53 
0.40 
0.62 
0.51 
0.51 
0.49 
0.49 
0.43 
0.31 
0.48 
0.57 
0.46 
0.43 
70 
300 
43 
33 
1063 
38 
88 
103 
167 
352 
218 
719 
163 
172 
111 
31 
92 
684 
69 
117 
Bayoumi  et al. (2006) 
Vargas-Alarcon et al. (2003) 
Batzer et al. (1996) 
Batzer et al. (1994) 
Berdeli and Cam (2009) 
Sipahi et al. (2006) 
Cam et al. (2005) 
Erdoğan et al. (2004) 
Abdi Rad and Bagheri (2011) 
Eleni et al. (2008) 
Zorc-Pleskovic et al. (2005) 
Mondry et al. (2005) 
Hohenfellner et al. (2001) 
Barbalic et al. (2004) 
Zak et al. (2003) 
Massidda et al. (2012) 
Rigoli et al. (2004) 
Di Pasquale et al. (2004) 
Camelo et al. (2004) 
Jalil et al. (1999) 
Black 
 
Amerindian (Teenek and Nahuas) 
Pima Indian 
Australian Aboriginal 
Somalis 
0.61-0.78 
0.71 
0.97 
0.27 
0.22-0.39 
0.29 
0.03 
0.73 
68 
184 
53 
53 
Vargas-Alarcon et al. (2003) 
Foy et al. (1996) 
Lester et al. (1999) 
Bayoumi  et al. (2006) 
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Table 2.1        Continued  
Racial group Ethnic group 
Allele frequency Sample size  
(n) 
References 
I D 
 Greek Cypriot 
Greenland Native   
Nguni 
Nigerian 
 
Coastal Papua New Guinean 
(PNG) 
Highland Papua New Guinean 
(PNG) 
Sotho   
Alaska Native 
Kenyan 
Black (Brazil) 
Mulatto (Brazil) 
Jamaican 
Southwest African American 
Northeast African American 
Southeast African American 
0.39 
0.55 
0.40 
0.27 
0.37 
0.66 
0.74 
0.38 
0.48 
0.73 
0.74 
0.38 
0.57 
0.65 
0.41 
0.33 
0.44 
0.47 
0.61 
0.45 
0.60 
0.73 
0.63 
0.34 
0.26 
0.62 
0.52 
0.27 
0.26 
0.62 
0.43 
0.35 
0.59 
0.67 
0.56 
0.53 
48 
41 
43 
11 
80 
48 
68 
48 
73 
111 
51 
85 
92 
40 
311 
44 
72 
74 
Batzer et al. (1994) 
Batzer et al. (1996) 
Soodyall et al. (1996) 
Batzer et al. (1994) 
Barley et al. (1994) 
Perna et al. (1992) 
Perna et al. (1992) 
Soodyall et al. (1996) 
Foy et al. (1996) 
Rupert et al. (2003) 
Rupert et al. (2003) 
Scott et al. (2005) 
Pereira et al. (2001) 
Pereira et al. (2001) 
Scott et al. (2010) 
Scott et al. (2010) 
Scott et al. (2010) 
Scott et al. (2010) 
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2.3.4 I allele and Endurance Performance 
 
A study by Gayagay et al. (1998) among sixty-four Australian national rowers had 
been the first report to display the additive effect of possession of the I allele of the 
ACE gene on endurance performance as a relative excess of both I allele and II 
genotype, which was found in the rowers, when compared to the controls. A similar 
finding was reported by Montgomery et al. (1998) for thirty-three elite male high-
altitude mountaineers and 1,906 British males. Montgomery et al. (1998) also 
demonstrated that the UK army military recruits, who possessed II genotype, showed 
an 11-fold greater improvement in duration of exercise after a 10-week general 
physical training program when compared to those with DD genotype. Since then, 
ACE gene has attracted much attention worldwide as a candidate gene related to 
endurance performance (Bouchard and Hoffman, 2011). 
 
The presence of I allele of the ACE I/D gene polymorphism has been reported 
to be more pronounced among endurance athletes, such as elite distance runners 
(Myerson et al., 1999, Alvarez et al., 2000, Hruskovicova et al., 2006, Min et al., 2009), 
rowers (Gayagay et al., 1998, Ahmetov et al., 2008b), triathletes (Collins et al., 2004, 
Shenoy et al., 2010), and long-distance swimmers (Tsianos et al., 2004b). Besides, 
individuals with I allele have also been reported to have a higher capacity of maximal 
oxygen consumption (VO2max) (Hagberg et al., 1998, Goh et al., 2009), higher 
percentage of slow twitch muscle fibres (Zhang et al., 2003), greater cardiac output 
(Hagberg et al., 2002), and higher heat tolerance (Heled, 2004).  
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Apart from that, some studies have attempted to identify if possession of the I 
allele would enhance the effect of exercise training on training adaptation. In 
comparison with D allele carrier, the I allele carrier was shown to enhance mechanical 
efficiency in trained muscle following an 11-week program of aerobic training 
(Williams et al., 2000), increased aortic distensibility due to chronic prolonged training 
(Tanriverdi et al., 2005a), greater exercise adherence to 6-month exercise training at 
60% and 85% of maximal exercise capacity (Thompson et al., 2006), as well as higher 
improvement in 30 minutes’ (at 70% of heart rate reserve) running speed performance 
after a 6-week anaerobic and aerobic training program (Cam et al., 2007).  
 
While these findings are convincing, the effect of possession of the I allele on 
endurance performance has remained inconclusive at present as several studies failed 
to replicate the association between I allele and endurance athlete status (Taylor et al., 
1999, Rankinen et al., 2000c, Scott et al., 2005, Oh, 2007, Amir et al., 2007, Tobina et 
al., 2010, Gineviciene et al., 2011, Ash et al., 2011). In addition, some cross-sectional 
studies revealed that individuals with D allele have better endurance performance 
(Tobina et al., 2010) and VO2max values (Zhaoa et al., 2003) compared to those 
individuals with I allele. Moreover, individuals with the DD genotype had also been 
reported with a 14 to 38% greater increase in VO2max with training than those subjects 
with II genotype (Rankinen et al., 2000b).  
 
Reasons for these inconsistent findings are unknown, but ethnicity could be 
one of the factors associated with these findings based on the previous reports that the 
distribution of ACE I/D gene polymorphism varies across ethnic groups. Hence, to 
control this potential bias, population-specific research is warranted to confirm the 
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effect of possession of the I allele on endurance performance. Moreover, to date, there 
are limited studies have examined possession of the I allele on endurance performance 
among Asian population, such as Malaysian population, compared to Caucasian 
population (Ma et al., 2013). This limited data set raises the question of whether the 
effect of possession of the I allele on endurance performance that previously reported 
for Caucasians population would also appear in Asian population such as in Malaysian 
population. A summary of studies that investigated the effect of possession of the I 
allele on endurance performance is presented in Table 2.2.  
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Table 2.2 Studies that investigated the effect of possession of the I allele on endurance performance 
Reference Population Study group (sample size) p value Results 
Studies that reported the effect of possession of the I allele on endurance performance 
Shenoy et al. (2010) Asian (Indian) National level army triathletes (n=29) 
Controls (n=101) 
0.02 I allele frequency in triathletes (0.85), 
controls (0.52) 
Cieszcyzk et al. (2010) Caucasian (Polish 
and Lithuanian) 
Elite judo players (n=28) 
Controls (n=115) 
0.02 I allele frequency in judo players (0.61), 
controls (0.44) 
Goh et al. (2009) Asian 
(Singaporean) 
National rugby union players (n=17) 0.03 V02max was higher for the subjects with 
II genotype 
Min et al. (2009) Asian (Japanese) Runners:- 
 Short distance (n=107) 
 Middle distance (n=62) 
 Long distance (n=108) 
0.001 I allele frequency in runners:- 
 Short distance (0.44) 
 Middle distance (0.48) 
 Long distance (0.66) 
Ahmetov et al. (2008b) Caucasian 
(Russian) 
Rowers (n=230)  
Controls (n=855) 
< 0.05 I allele frequency in rowers (0.35), 
controls (0.29) 
Voroshin and 
Astratenkov (2008) 
Caucasian 
(Russian) 
Elite 400 m distance runners (n=33) < 0.01 II genotype favoured endurance 
performance and heart rate recovery 
Cam et al. (2007) Caucasian 
 
Non-elite athletes (n=55) 
 
< 0.05 Better improvement in aerobic 
endurance performance in II genotype 
carriers 
Mayne (2006) Caucasian Athletes:- 
 Endurance (n=27) 
 Strength/power (n=63) 
Controls (n=48) 
< 0.01 I allele frequency in endurance athletes 
(0.24), strength/power athletes (0.07), 
controls (0.13) 
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Table 2.2      Continued 
Reference Population Study group (sample size) p value Results 
Thompson et al. (2006) Caucasian A six-month program with the subjects 
(n=110) 
< 0.01 I allele might increase adherence to 
exercise training regimen 
Hruskovicová et al. 
(2006) 
Caucasian Marathon runners (n=104) 
 1st to 50th places (n=20) 
 51st to 100th places (n=28) 
 101st to 150th places (n=26) 
 151st to 200th places (n=30) 
Half-marathon runners (n=222) 
Inline skaters (n=18) 
Controls (n=252) 
< 0.01 I allele frequency in marathon runners;  
 1st to 50th places (0.65) 
 51st to 100th places (0.52) 
 101st to 150th places (0.56) 
 151st to 200th places (0.55),  
half-marathon runners (0.48), inline 
skaters (0.61), controls (0.47) 
Tanriverdi et al. (2005a) Caucasian 
(Turkey) 
 Endurance athletes (n=56) 
 Controls (n=46) 
< 0.05 Aortic distensibility was increased by 
prolonged training in endurance athletes  
with the II genotype 
Tanriverdi et al. (2005b) Caucasian 
(Turkey) 
 Endurance athletes (n=56) 
 Controls (n=46) 
< 0.0001 Regular isotonic  exercise improved 
endothelium-dependent vasodilatation, 
especially in those with the II genotype 
Collins et al. (2004) Caucasian Triathletes:- 
 Fastest finishers (n=100) 
 Slowest finishers (n=100) 
Controls (n=199) 
0.036 I allele frequency in triathletes:- 
 Fastest finishers (0.52) 
 Slowest finishers (0.48),  
controls (0.42) 
Tsianos et al. (2004a) Caucasian Climbers (n=195) 0.01 I allele frequency for those who reached 
the summit was 0.47 than 0.21 for those 
who did not reach the summit 
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Table 2.2      Continued 
Reference Population Study group (sample size) p value Results 
Tsianos et al. (2004b) Caucasian Swimmers:- 
 10 km distances (n=19) 
 25 km races (n=16) 
0.01 I allele frequency in swimmers:- 
 10 km distances (0.29) 
 25 km races (0.59) 
Kasikcioglu et al. (2004) Caucasian  Elite wrestlers (n=29) 
 Controls (n=51) 
< 0.001 I allele carriers had higher VO2max than 
D allele carriers  
Heled (2004) Caucasian Healthy male (n=58) < 0.05 I allele  increased heat tolerance 
Zhang et al. (2003) Asian (Japanese) Untrained healthy young (n=41) < 0.01 I allele carriers had higher percentage of 
slow twitch muscle fibres than D allele 
carriers 
Hagberg et al. (2002) Caucasian Postmenopausal 
 Sedentary (n=20) 
 Physically active (n=20) 
 Endurance athletes (n=22) 
< 0.05 I allele carriers had 25% greater cardiac 
output than D allele carriers 
 
Nazarov et al. (2001) Caucasian 
(Russian) 
Swimmers:- 
 Long distance (n=12) 
 Middle distance (n=24) 
 Short distance (n=16) 
Controls (n=449) 
0.042 I allele frequency in swimmers:- 
 Long distance (0.54) 
 Middle distance (0.65) 
 Short distance (0.31),  
controls (0.50) 
Williams et al. (2000) Caucasian Army recruits (n=116) < 0.025 I allele conferred an enhanced 
mechanical efficiency in trained muscle 
Alvarez et al. (2000) Caucasian (Spain) Cyclists (n=25) 
Long-distance runners (n=25) 
Handball players (n=15) 
Controls (n=400) 
0.0009 I allele frequency in cyclists (0.28), 
long-distance runners (0.25), handball 
players (0.20), controls (0.16) 
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Table 2.2      Continued 
Reference Population Study group (sample size) p value Results 
Myerson et al. (1999) Caucasian Runners:- 
 ≤ 200 m (n=20) 
 400-3000 m (n=37) 
 ≥ 5000 m (n=34) 
Controls (n=1906) 
0.009 I allele frequency in runners:- 
 ≤ 200 m (0.35) 
 400-3000 m (0.53) 
 ≥ 5000 m (0.62), 
controls (0.49) 
Hagberg et al. (1998) Caucasian Postmenopausal 
 Sedentary (n=19) 
 Physically active (n=19) 
Athletes (n=20) 
< 0.05 The II genotype group had a 6.3 ml·kg-
1·min-1 higher VO2max than the ID 
genotype group after accounting for the 
effect of habitual physical activity level 
Montgomery et al. 
(1998) 
Caucasian Elite male British mountaineers (n=25) 
Controls (n=1906) 
0.02 I allele frequency in mountaineers 
(0.70), controls (0.45) 
Montgomery et al. 
(1998) 
Caucasian Army recruits (n=66) 0.001 I allele improved endurance 
performance 
Gayagay et al. (1998) Caucasian 
(Australian) 
National rowers (n=64) 
Controls (n=114) 
 0.03 I allele frequency in rowers (0.57), 
controls (0.43) 
Studies that reported possession of the I allele did not influence endurance performance 
Ash et al. (2011) Caucasian 
(Ethiopian) 
Athletes (n=114) 
 Endurance runners (n=76) 
 Sprint and power event athletes 
(n=38) 
Controls:- 
 Ethiopian population (n=317) 
 Endurance athlete-matched (n=410) 
> 0.05 Elite endurance athlete status in 
Ethiopians was not influenced by ACE  
I/D gene polymorphism 
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Table 2.2      Continued     
Reference Population Study group (sample size) p value Results 
Holdys et al. (2011) Caucasian (Polish) Athletes (n=166) 
 Speed-strength (n=35) 
 Endurance-speed-strength (n=71) 
 Endurance (n=50) 
Controls (n=83) 
> 0.05 No difference in mean values for the 
VO2max between athletes with different 
genotypes 
Gineviciene et al. (2011) Caucasian 
(Lithuanian) 
Athletes:- 
 Endurance (n=64) 
 Speed/ power (n=47) 
 Mix (n=33) 
 Team sports (n=49) 
Controls (n=250) 
0.025 II genotype carriers had greater grip 
strength and vertical jump than ID and 
DD genotype carriers 
 
 
 
Tobina et al. (2010) Asian (Japanese) Elite long distance (over 5000 m) 
runners (n=37)  
Control (n=335) 
> 0.05  The frequency of the II genotype in 
athletes was not significantly higher 
compared to non-athletes 
 Endurance performance was better in 
DD and ID genotype individuals than 
in II genotype individuals 
Oh (2007) Asian (Korean) Elite mixed athletes (n=139) 
Controls (n=163) 
> 0.05 The excess of I allele in long distance 
runners was not significant 
Amir et al. (2007) Caucasian (Israeli) Athletes:- 
 Endurance (n=79) 
 Power (n=42) 
Controls (n=247) 
< 0.05 D allele and DD genotype seemed to be 
higher in Israeli elite marathon runners 
than in sprinters 
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Table 2.2      Continued 
    
Reference Population Study group (sample size) p value Results 
Scott et al. (2005) Kenyan Athletes:- 
 International endurance (n=70) 
 National endurance (n=221) 
Controls (n=85) 
0.39 Elite Kenyans’ endurance athlete status 
was not influenced by ACE I/D gene 
polymorphism 
Zhaoa et al. (2003) Asian 
(Singaporean) 
Students with prior exercise/ 
military training (n=67) 
< 0.05 Subjects with the DD genotype had 
significantly higher level of VO2max 
than other genotypes 
Nazarov et al. (2001) Caucasian Swimmers:- 
 Long distance (n=12) 
 Middle distance (n=24) 
 Short distance (n=16) 
Controls (n=449) 
0.656 No difference was found in frequencies 
between elite long distance swimmers 
and controls 
Nazarov et al. (2001) Caucasian Track and field athletes:- 
 Long distance (n=10) 
 Middle distance (n=7) 
 Short distance (n=14) 
Controls (n=449) 
0.687 No difference was found in frequencies 
between elite long distance track, field 
athletes, and controls 
Sonna et al. (2001) Caucasian Army recruits (n=147) > 0.05 II genotype did not have a strong effect 
on aerobic power or endurance in 
healthy young American adults  
Rankinen et al. (2000b) Caucasian and 
Black 
Sedentary:- 
 Caucasian (n=476) 
 Black (n=248) 
0.042 Individuals with the DD genotype had 
14 to 38% of greater increase in 
VO2max with training than II genotype 
carriers 
35 
 
     
 
Table 2.2      Continued 
    
Reference Population Study group (sample size) p value Results 
Rankinen et al. (2000c) Caucasian Endurance athletes (n=192) 
Controls (n=189) 
> 0.05 ACE I/D gene polymorphism was not 
associated with the higher 
cardiorespiratory endurance 
performance level 
Taylor et al. (1999) Caucasian 
(Australian) 
National athletes aerobic 
sports(n=120) 
Controls (n=685) 
> 0.05 II genotype did not confer elite athletic 
ability 
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2.3.5 D allele and Strength or Power Performance 
 
As the elevation level of the ACE activity in individuals with D allele of the ACE  I/D 
gene polymorphism increased the production of ANG II (a potent growth factor in 
cardiac and vascular tissues) in the skeletal muscle renin-angiotensin system, which is 
the potential mechanism where muscle cell growth and hypertrophy may be activated 
(Geisterfer et al., 1998, Kai et al., 1998), this allele has been thought to influence 
strength or power performance (Jones and Woods, 2003, Sayed-Tabatabaei et al., 
2006). Therefore, several studies have attempted to examine the effect of possession 
of the D allele on strength or power performance. The D allele carriers were reported 
to possess the greatest muscle strength (Hopkinson et al., 2004, Williams et al., 2005, 
Costa et al., 2009b). In several case-control studies, the frequency of D allele was 
found to be higher among those athletes involved in strength or power-oriented events 
(Woods et al., 2001, Nazarov et al., 2001, Paulauskas et al., 2009, Costa et al., 2009a, 
Kikuchi et al., 2012, Wang et al., 2013, Eidera et al., 2013).  
 
Montgomery et al. (1997) reported that the left ventricular mass was increased 
by 18% in male Caucasian military recruits after a 10-week physical training period, 
with the highest left ventricular growth observed in subjects with the DD genotype 
compared to other subjects with II and ID genotypes. Possession of the D allele may 
have protective effects to muscle damage as the subjects with DD genotype had 
recorded the lowest blood creatine kinase values in response to eccentric contractions 
than the other genotype carriers (Yamin et al., 2007). Meanwhile, in a study carried 
out by Folland et al. (2000), young adult men with D allele had been reported to have 
greater strength gains after following a 9-week strength training program compared to 
37 
 
those with I allele. Similarly, greater gain in strength was observed in older individuals 
with DD genotype after 18 months of walking and light weight training (Giaccaglia et 
al., 2008).  
 
Nevertheless, the inconsistent findings in other studies have caused the effect 
of possession of the D allele on strength performance to remain inconclusive (Thomis 
et al., 2004, Kasikcioglu et al., 2004, Moran et al., 2006a, Charbonneau, 2007, Eynon 
et al., 2009a, Rodríguez-Romo et al., 2010, Scott et al., 2010, Gineviciene et al., 2011, 
Wang et al., 2013). Reasons for these inconsistent findings are unknown, but it could 
be due to ethnicity factor, and limited reports from Asian population such as from 
Malaysian population (Ma et al., 2013) as previously explained for the effect of 
possession of the I allele on endurance performance. Therefore, future research 
involving Asian population, particularly Malaysian population is warranted to confirm 
the effect of possession of the D allele on strength/power performance. The list of 
studies that investigated the effect of possession of the D allele on strength/power 
performance is summarized in Table 2.3. 
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Table 2.3 Studies that investigated the effect of possession of the D allele on strength/power performance 
Reference Population Study group (sample size) p value Results 
Studies that reported the effect of possession of the D allele on strength/power performance 
Eidera et al. (2013) Caucasian (Polish) Polish power athletes (n=100)   
Controls (n=354) 
0.014 D allele frequency in power athletes 
(0.63), controls (0.53) 
Wang et al. (2013) Caucasian 
(European, 
Commonwealth, 
Russian, and 
American cohorts) 
Swimmers;- 
 Short middle distance (SMD) (≤ 400 
m) (n=125) 
 Long distance (LD) (> 400 m) (n=68) 
Controls (n=1694) 
0.003 
0.005 
D allele was overrepresented in short-
and-middle-distance swimmers 
Ahmetov et al. (2013) Caucasian Healthy physically active pupils 
(n=457) 
0.037 High results for standing long-jump test 
in boys with D allele 
Kikuchi et al. (2012) Asian (Japanese) International wrestlers (n=52) 
National wrestlers (n=83) 
Controls (n=333) 
0.000 
0.002 
D allele frequency in international 
wrestlers (0.59), national wrestlers 
(0.44), controls (0.26) 
Costa et al. (2009a)  Portuguese Swimmers:- 
 Elite short distance (n=25) 
 Elite middle distance (n=14) 
 Average short distance (n=23) 
 Average middle distance (n=9) 
Controls (n=100) 
< 0.05 D allele frequency in swimmers:- 
 Elite short distance (0.78) 
 Elite middle distance (0.54) 
 Average short distance (0.61) 
 Average middle distance (0.72) 
controls (0.62) 
Costa et al. (2009b) Portuguese Swimmer:- 
 Short distance (n=22) 
 Middle distance (n=13) 
Triathletes (n=23) 
< 0.05 Higher right grip strength in D allele 
carriers compared to those with I allele  
carriers 
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Table 2.3 Continued 
Reference Population Study group (sample size) p value Results 
Paulauskas et al. (2009) Caucasian 
(Lithuanian) 
Wrestlers (n=16) 
Controls (n=116) 
< 0.05 D allele frequency in wrestlers (0.66), 
controls (0.55) 
Giaccaglia et al. (2008) Caucasian Older sedentary men and women 
(n=213) 
0.04 DD genotype  individuals showed 
greater gains in knee extensor strength 
compared to II genotype individuals 
Yamin et al. (2007) Caucasian (Israeli) Healthy physical education students 
(n=70) 
0.02 II genotype imposed an increased risk of 
developing muscle damage, whereas the 
DD genotype may have protective 
effects 
Charbonneau (2007) Caucasian and 
African American 
Older sedentary adults 
 
0.02 Caucasian males who carried at least 
one D allele exhibited more 
hypertrophy than II genotype carriers 
Cerit et al. (2006) Caucasian Non-elite Turkish army recruits 
(n=186) 
0.001 DD genotype seemed to have an 
advantage in development in short-
duration aerobic performance 
Williams et al. (2005) Caucasian Untrained men (n=81) 0.026 DD genotype carriers had greater 
muscle strength than other genotype 
carriers 
Cam et al. (2005) Caucasian 
(Turkish) 
Running performance:-  
 Superior (n=30) 
 Mediocre (n=29) 
 Poor (n=29) 
0.019 Better performance in short duration 
aerobic endurance was influenced by 
the D allele  
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Table 2.3 Continued     
Reference Population Study group (sample size) p value Results 
Kasikcioglu et al. (2004) Caucasian Elite wrestlers (n=29) 
Controls (n=51) 
 
< 0.001 Left ventricular mass was  found to be 
higher in DD genotype carriers (126.2 ± 
2.9 g/m2) than II (85.5 ± 4.0 g/m2) or ID 
(110.1 ± 2.3 g/m2) genotype carriers 
Hopkinson et al. (2004) Caucasian Chronic Obstructive Pulmonary 
Disease Patients (n=103) 
Controls (n=101) 
0.04 The D allele was associated with greater 
isometric quadriceps strength 
Hernández et al. (2003) Caucasian Endurance athletes (n=61) 0.031 The extent of exercise-induced left 
ventricular hypertrophy in endurance 
athletes was influenced by the D allele 
Graf et al. (2001) Caucasian Endurance trained elite athletes (n=83) 0.039 The highest ANG II plasma resting 
concentration was found in athletes with 
DD genotype 
Myerson et al. (2001) Caucasian British Army homozygous for the DD 
(n=79) and II (n=62) genotypes  
0.0009 Left ventricular growth was greater in 
the DD  genotype carriers than other 
genotype carriers 
Nazarov et al. (2001) Caucasian 
(Russian) 
Swimmers long distance (n=12) 
Swimmers middle distance (n=24) 
Swimmers short distance (n=16) 
Controls (n=449) 
0.001 D allele frequency in swimmers:-long 
distance (0.46), middle distance (n=35), 
short distance (n=69),  
controls (0.50) 
Woods et al. (2001) Caucasian Swimmers (n=56) 
Military recruits (n=1248) 
0.005 D allele frequency in swimmers (0.59), 
military recruits (0.41) 
Folland et al. (2000) Caucasian 33 healthy males < 0.05 The ID and DD genotypes carriers had 
greater strength gains than the II 
genotype  carriers 
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Table 2.3 Continued     
Reference Population Study group (sample size) p value Results 
Montgomery et al. 
(1997) 
Caucasian Military recruits (n=460) < 0.01 Left ventricular growth rose 
significantly only among the DD 
genotype carriers 
Studies that reported possession of the D allele did not influence strength/power performance 
Wang et al. (2013) Asian (Japanese 
and Taiwanese) 
Swimmers SMD (≥ 100 m) (n=166) 
Swimmers LD (200-400 m) (n=160) 
Controls (n=1252) 
< 0.05 The I allele was overrepresented in the 
short-distance swimmer group 
Gineviciene et al. (2011) Caucasian 
(Lithuanian) 
Elite athletes (n=193) 
Controls (n=250) 
< 0.05 Speed and power in Lithuanian athletes 
were determined by I allele 
Rodríguez-Romo et al. 
(2010) 
Caucasian 
(European) 
Non-athletic young adults (n=281) > 0.05 ACE I/D gene polymorphism did not 
seem to exert a major influence on 
muscle ‘explosive’ power 
Scott et al. (2010) Jamaican and 
Caucasian (US) 
Jamaican sprinters (n=116) 
US sprinters (n=114) 
Jamaican controls (n=311) 
US  controls (n=191) 
0.37 No excess in DD genotype in elite sprint 
athletes relative to controls 
Eynon et al. (2009a) Caucasian (Israeli) Sprinters (n=81) 
Controls (n=240) 
0.00007 D allele frequency in sprinters (0.49), 
controls (0.66) 
Charbonneau (2007) Caucasian and 
African American 
Older sedentary adults (n=243) 
 
> 0.05 Skeletal muscle strength was not 
influenced by the D allele 
Moran et al. (2006a) Caucasian 
(Greeks) 
Teenagers (n=1027) < 0.05 Strength phenotypes were influenced by 
the I allele 
Thomis et al. (2004) Caucasian Twins, who participated in the Leuven 
Twin & Training Study (n=57) 
> 0.05 No evidence for the effect of D allele on 
skeletal muscle  
Kasikcioglu et al. (2004) Caucasian Elite wrestlers (n=29)  
Controls (n=51) 
> 0.05 The frequency in athletes did not differ 
significantly from controls 
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2.4 The Alpha-Actinin-3 (ACTN3) Gene and Human Performance 
 
2.4.1 The ACTN3 Gene 
 
As illustrated in Figure 2.4, the ACTN3 gene is located on the long arm of chromosome 
11 (11q13.1) and it spans approximately 16,407 kb of genomic DNA, which embraces 
21 exons and 20 introns. The ACTN3 gene codes the ACTN3 protein, which is a 
member of the alpha-actinin-binding proteins (North et al., 1999). In humans, the 
alpha-actinin-binding proteins play an important role for structuring and for 
performing regulatory functions in cytoskeleton organization, as well as muscle 
contraction (Mills et al., 2001). In fact, four specific genes are responsible for the 
expression of different types of alpha-actinin-binding proteins; ACTN1 and ACTN4 
genes code for non-muscle proteins (Kaplan et al., 2000), whereas ACTN2 and ACTN3 
gene codes for myofibrillar proteins that are localized at the boundaries of sarcomeres 
in the contractile apparatus of muscle Z disk (Mills et al., 2001).  
 
As portrayed in Figure 2.5, the Z line, which is composed of ACTN2 and 
ACTN3 proteins, acts to stabilize and to integrate the muscle contractile apparatus by 
cross-linking actin filaments and other structural components (Mills et al., 2001). The 
ACTN2 protein is expressed in all skeletal muscle fibres, while the ACTN3 protein is 
expressed only in the fast-twitch skeletal muscle fibre (Mills et al., 2001).  
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Figure 2.4 The genomic organization of the ACTN3 gene on the long arm (q) of 
chromosome 11 on band 13.1. The ACTN3 gene consists of 21 exons 
and 20 introns. *Picture adapted from Mayne (2006). 
Exons (Coding region) 
1 8 
 
 1                                     8          12    16    21 
Exons (Coding region) 
Introns (Non-coding region) 
ACTN3 gene 
5’ 3’ 
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Figure 2.5 Skeletal muscle is composed of long cylindrical cells called muscle 
fibres. Each muscle fibre is composed of long tubes called myofibrils, 
which in turn, consist of filaments (actin and myosin). During muscle 
contraction, when these filaments are sliding past each other, the actin 
filament is anchored by the Z line, which is encompassed mainly by 
ACTN2 and ACTN3 proteins, for stabilization. *Picture adapted from 
Starr and Mcmillan (2015). 
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Due to the location of the ACTN3 protein, this protein is likely to give static 
and stable function in maintaining the ordered myofibrillar array with greater 
coordination to generate high muscle power and velocity during movements (Mills et 
al., 2001). The expression of ACTN3 protein was reported to depend on ACTN3 R/X 
gene polymorphism (North et al., 1999). 
 
2.4.2 The ACTN3 R/X Gene Polymorphism 
 
As shown in Figure 2.6A, the ACTN3 R/X gene polymorphism (rs1815739) is 
identified as a nonsense mutation, which specifically occurred in codon 577 of exon 
16, where the translation (C to T) at nucleotide position 1,747 alters the production of 
arginine codon (R) to a premature stop codon (X) (North et al., 1999). The wild-type 
and the null mutations for ACTN3 R/X gene polymorphism are characterized by R and 
X alleles, respectively (North et al., 1999). The R allele codes for functioning ACTN3 
gene that results in the production of ACTN3 protein, whilst incomplete sequence in 
the X allele, preventing the production of that protein (North et al., 1999). MacArthur 
et al. (2007) suggested that the loss of ACTN3 protein leads to alterations in skeletal 
muscle metabolism towards more efficient aerobic metabolism. Given these different 
physiological functions, possession of the R and X alleles may grant beneficial effects 
for strength/power and endurance activities, respectively. Figure 2.6B displays the 
identification of the ACTN3 R/X genotype through gel visualization, where the PCR 
product is fragmented by enzyme DdeI and the presence of R allele is characterized by 
205 bp and 86 bp, whereas for X allele are 108 bp, 97 bp, and 86 bp (North et al., 
1999). 
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(A) 
   
 Homozygous wild-type 
(RR) 
 
Heterozygote 
(RX) 
Homozygous null 
mutation 
(XX) 
 
Figure 2.6 A. DNA sequence and restriction endonuclease analysis of ACTN3 gene 
exon 16 demonstrating the three possible ACTN3 R/X genotypes at 
position 577. Double peaks mean heterozygote. *Picture adapted from 
North et al. (1999). B. A visual detection of ACTN3 R/X genotypes. 
Lane 1: 50 bp DNA marker, lane 2: Homozygous RR (205 bp, and 86 
bp), lane 3: heterozygous RX (205 bp, 108 bp, 97 bp, and 86 bp), and 
lane 4: homozygous XX (108 bp, 97 bp, and 86 bp). *Picture adapted 
from Mayne (2006). 
 
 
(B) 
50 bp ladder    RR         RX         XX 
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More than one billion people worldwide have reported an absence of ACTN3 
protein (North et al., 1999). Moreover, it has been suggested that under certain 
environmental conditions, this gene variation could evolve to accommodate the energy 
expenditure requirements of people (North, 2008). Nevertheless, the distribution of 
ACTN3 R/X gene polymorphism is different across several populations. 
 
2.4.3 The Distribution of ACTN3 R/X Gene Polymorphism across Ethnicity 
 
There is evidence that the distribution of the ACTN3 R/X gene polymorphism varies 
between ethnic groups. The highest frequencies of R and X alleles were observed in 
the Black population. The prevalence of R and X alleles in the Black population ranged 
from 0.92 to 0.42 and 0.58 to 0.08, respectively. Among the different ethnic groups in 
the Black population, the lowest rate of ACTN3 deficiency was reported in the 
Nigerian group (Yang et al., 2007). The trend observed in Nigerians was similar to the 
findings obtained for Kenyans (Yang et al., 2007) and African Bantu (Mills et al., 
2001). Meanwhile, the trend reported in Jamaican (Scott et al., 2010) and Highland 
Papua New Guinean (Mills et al., 2001) populations was remarkably comparable with 
the Northeast and the Southeast African Americans (Scott et al., 2010) and Ethiopians 
(Yang et al., 2007), respectively.  
 
On the other hand, the distribution of R and X alleles in the Caucasian 
populations ranged from 0.61 to 0.50 and 0.50 to 0.39, respectively. Among the 
Caucasians, the highest frequency of R allele was noted for the Russian population 
(Druzhevskaya et al., 2008). Other than that, the distribution patterns of R and X alleles 
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in the Australian population (Yang et al., 2003) had been similar to the pattern 
discovered in the Iranian population (Fattahi and Najmabadi, 2012).  
 
Meanwhile, in the Asian populations, the frequencies of R and X alleles vary 
from 0.53 to 0.39 and 0.61 to 0.47, respectively. The lowest prevalence of R allele was 
observed among Indians (Kothari et al., 2011). Besides, the distribution patterns of R 
and X alleles in Javanese population (Mills et al., 2001) were closely similar to those 
of Japanese population (Yang et al., 2007).  
 
Although these data suggest variation in the distribution of the ACTN3 R/X 
gene polymorphism across different populations, the data lacks a comprehensive 
understanding for ethnic variation in the distribution of the ACTN3 R/X gene 
polymorphism as most of the findings involved the Black and the Caucasian 
populations with limited evidence within Asian populations. Therefore, more studies 
involving Asian populations are required to bridge the gap in the current literature. A 
list of population-based studies conducted across different ethnic groups is 
summarized in Table 2.4.  
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Table 2.4 Distribution of ACTN3 R/X gene polymorphism in different ethnic groups 
Racial group Ethnic group 
Allele frequency Sample size 
(n) 
References 
R X 
Asian 
 
 
 
 
Asian pooled 
 
Javanese 
Indian 
 
Japanese 
0.53 
0.50 
0.46 
0.39 
0.52 
0.47 
0.47 
0.50 
0.54 
0.61 
0.48 
0.53 
55 
28 
48 
150 
125 
97 
Clarkson et al. (2005a) 
Mills et al. (2001) 
Mills et al. (2001) 
Kothari et al. (2011) 
Goel and Mittal (2007) 
Yang et al. (2007) 
Caucasian Caucasian Pooled 
European 
Iranian 
Australian 
Spanish 
Italian 
 
Polish 
Israeli 
Russian  
0.50 
0.58 
0.56 
0.56 
0.52 
0.58 
0.57 
0.60 
0.51 
0.61 
0.50 
0.42 
0.44 
0.44 
0.48 
0.42 
0.43 
0.40 
0.49 
0.39 
469 
107 
210 
436 
123 
31 
53 
254 
240 
1197 
Clarkson et al. (2005a) 
Mills et al. (2001) 
Fattahi and Najmabadi (2012) 
Yang et al. (2003) 
Lucia et al. (2006) 
Massidda et al. (2012) 
Massidda et al. (2009) 
Cieszczyk et al. (2011) 
Eynon et al. (2009b) 
Druzhevskaya et al. (2008) 
Black Aboriginal Australian 
African American 
 
Southwest African American 
Northeast African American 
Southeast African American 
0.71 
0.62 
0.73 
0.76 
0.83 
0.82 
0.29 
0.38 
0.27 
0.24 
0.17 
0.18 
87 
28 
45 
44 
72 
74 
Mills et al. (2001) 
Clarkson et al. (2005a) 
Mills et al. (2001) 
Scott et al. (2010) 
Scott et al. (2010) 
Scott et al. (2010) 
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Table 2.4 Continued 
Racial group Ethnic group 
Allele frequency Sample size 
(n) 
References 
R X 
 
African Bantu 
South African Bantu 
Native American 
Highland Papua New Guinean 
Hispanic 
 
Jamaican 
Ethiopian 
Kenyan 
Nigerian 
0.90 
0.89 
0.57 
0.64 
0.42 
0.59 
0.86 
0.66 
0.91 
0.92 
0.10 
0.11 
0.43 
0.36 
0.58 
0.41 
0.14 
0.34 
0.09 
0.08 
78 
88 
7 
39 
25 
32 
311 
105 
158 
60 
Mills et al. (2001) 
Mills et al. (2001) 
Mills et al. (2001) 
Mills et al. (2001) 
Clarkson et al. (2005a) 
Mills et al. (2001) 
Scott et al. (2010) 
Yang et al. (2007) 
Yang et al. (2007) 
Yang et al. (2007) 
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2.4.4 R allele and Strength or Power Performance 
 
A study by Yang et al. (2003) had been the first to link the ACTN3 gene to human 
physical performance. This study suggested that the R allele of ACTN3 R/X gene 
polymorphism could enhance sprint ability, as at least one copy of R allele was found 
in all male Olympian power and female elite sprint athletes (Yang et al., 2003). 
Moreover, Niemi and Majamaa (2005) reported similar findings with a higher 
frequency of the R allele in Finnish sprinters and a lower frequency of R allele in 
endurance athletes. They also reported that none of the top Finnish sprinters were 
predisposed for two copies of X allele (Niemi and Majamaa, 2005). Similar findings 
were also reported by Eynon et al. (2009b) with the frequency of R allele significantly 
higher in sprinters than endurance athletes and controls of Israeli population. 
Furthermore, the RR genotype (two copies of R allele) was observed more frequently 
in strength/power-oriented athletes, such as Russian power athletes (Druzhevskaya et 
al., 2008), elite-level bodybuilders and power lifters (Roth et al., 2008), gymnasts 
(Massidda et al., 2009), Indian power athletes (Kothari et al., 2011), and Polish power 
athletes (Cieszczyk et al., 2011), when compared with endurance athletes and controls.  
 
 Besides the positive finding on the effect of possession of the R allele on 
strength/power athletic status, individuals with R allele have also been reported to have 
greater strength/power capacity (Clarkson et al., 2005a, Moran et al., 2006b, Vincent 
et al., 2007, Norman et al., 2009, Shang et al., 2012, Erskine et al., 2014). Possession 
of the R allele was also found to influence training adaptation (Clarkson et al., 2005b, 
Delmonico et al., 2007, Ichinoseki-Sekine et al., 2010, Gentil et al., 2011). After a 2-
month home-based resistance training program, R allele carrier demonstrated greater 
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improvement in muscle strength than those with X allele (Ichinoseki-Sekine et al., 
2010). Likewise, absolute peak power value change with strength training was found 
to be higher in the RR group than in the XX group (Delmonico et al., 2007). Possession 
of the functional R allele had also been reported to be associated with susceptible 
muscle damage (Clarkson et al., 2005b) and muscle thickness (Gentil et al., 2011) in 
response to training. 
 
Contrary to the positive findings, several studies failed to identify the effect of 
possession of the R allele on strength/power performance (Clarkson et al., 2005a, 
Lucia et al., 2006, Santiago et al., 2010, McCauley et al., 2010, Scott et al., 2010, 
Djarova et al., 2011, Gineviciene et al., 2011, Wang et al., 2013, Ahmetov et al., 2013). 
For example, possession of the R allele had been reported to have no influence on knee 
extensor isometric strength (McCauley et al., 2010) and ventilatory thresholds (Lucia 
et al., 2006). In another study, individuals with XX genotype exhibited a greater 
absolute and relative one-repetition maximum (1-RM) gain after following resistance 
training (Clarkson et al., 2005a), as well as better grip strength and vertical jump 
(Gineviciene et al., 2011), compared to RR carriers. As previously explained in the 
effects of ACE I/D gene polymorphism on physical performance, these inconsistent 
findings could be due to ethnicity factor, and limited reports from Asian population 
(Ma et al., 2013). Hence, future study among Asian population, particularly Malaysian 
population is warranted to confirm the effect of possession of the R allele on 
strength/power performance. The list of studies that investigated the effect of 
possession of the R allele on strength/power performance is summarized in Table 2.5.  
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Table 2.5 Studies that investigated the effect of possession of the R allele on strength/power performance 
Reference Population Study group (sample size) p value Results 
Studies that reported the effect of possession of the R allele on strength/power performance 
Erskine et al. (2014) Caucasian Untrained healthy male (n=51) < 0.05 R allele carriers had greater quadriceps 
femoris muscle volume, maximum 
isoinertial strength (1-RM), and 
maximum power than X allele carriers 
Shang et al. (2012) Asian (Chinese) Young male soldiers (n=452) 0.021 R allele carriers displayed significantly 
higher handgrip strength than 
individuals with X allele 
Kothari et al. (2011) Asian (Indian) Power athletes (n=72) 
Endurance athletes (n=83) 
Controls (n=150) 
< 0.01 R allele frequency in power athletes 
(0.71), endurance athletes (0.31), 
controls (0.39) 
Cieszczyk et al. (2011) Caucasian (Polish) Power athletes (n=158) 
Controls (n=254) 
0.008 R allele frequency in power athletes 
(0.69), controls (0.60) 
Pimenta et al. (2011) Caucasian 
(Brazilian) 
Soccer professional athletes (n=37) < 0.05 R allele carriers were less susceptible to 
eccentric damage 
Gentil et al. (2011) Caucasian 
(Brazilian) 
Men (n=141) < 0.05 Only carriers of R allele showed an 
increase in muscle thickness in 
response to training 
Djarova et al. (2011) Zulu South 
African 
Cricketers (n=14) 
Controls (n=17) 
 
< 0.05 A high R allele frequency was found 
among cricketers with lower uric acid 
and lactic acid levels 
Ichinoseki-Sekine et al. 
(2010) 
Asian (Japanese) Untrained elderly women (n=35) < 0.05 Sit-ups and one-leg standing with open 
eyes were improved in the R allele 
group, but not in the X allele group 
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Table 2.5 Continued 
Reference Population Study group (sample size) p value Results 
Norman et al. (2009) Caucasian Moderate to well-trained men and 
women (n=120) 
 
< 0.05 Repeated exercise bouts prompted an 
increase in peak torque in the RR 
genotype group 
Massidda et al. (2009) Caucasian (Italian) Elite gymnasts (n=35) 
Controls (n=53) 
< 0.04 R allele frequency in gymnasts (0.73), 
controls (0.57) 
Eynon et al. (2009b) Caucasian (Israeli) Sprinters (n=74) 
Endurance runners (n=81) 
Controls (n=240) 
< 0.05 R allele frequency in sprinters (0.69), 
endurance runners (0.43), controls 
(0.51) 
Roth et al. (2008) Caucasian and 
Black 
Strength athletes Caucasian (n=52) 
Strength athletes Black (n=23) 
Controls Caucasian (n=668) 
Controls Black (n=208) 
< 0.05 The R allele was overrepresented in elite 
strength (bodybuilder and power lifter) 
athletes 
 
Druzhevskaya et al. 
(2008) 
Caucasian 
(Russian) 
Strength/sprint athletes (n=486) 
Controls (n=1197) 
< 0.05 R allele frequency in strength/sprint 
(0.67), controls (0.61) 
Vincent et al. (2007) Caucasian 
 
Healthy young males (n=90) 0.03 R allele carriers showed significantly 
higher relative dynamic quadriceps 
torques at 300°/s, compared to XX 
genotype carriers 
Delmonico et al. (2007) Caucasian Older men (n=71) 
Older women (n=86) 
< 0.05  In men, absolute peak power (PP) 
changed with strength training (ST) in 
the RR genotype group, which was 
higher than in other groups  
 In women, relative PP changed with 
ST in the RR genotype group, which 
was higher than in other groups  
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Table 2.5 Continued     
Reference Population Study group (sample size) p value Results 
Mayne (2006) Caucasian Strength/power athletes (n=44) 
Endurance athletes (n=27) 
Controls (n=48) 
< 0.01 R allele frequency in strength/power 
athletes (0.61), endurance athletes 
(0.56), controls (0.37) 
Moran et al. (2006b) Caucasian (Greek) Adolescent (n=922) 0.003 Subjects with RR and RX genotypes had 
faster 40 m sprint time than XX 
genotype subjects 
Niemi and Majamaa 
(2005) 
Caucasian 
(Finnish) 
Top endurance athletes (n=20) 
Endurance athletes (n=40)   
Top sprinters (n=23) 
Sprinters (n=68) 
Controls (n=1060) 
0.03 The frequencies of XX and RR 
genotypes were higher and lower 
among Finnish endurance athletes, 
respectively, and none of the top 
Finnish sprinters had XX genotype 
Clarkson et al. (2005b)  Caucasian  
 African-
American 
 Hispanic  
 Asian 
 Other  
Sedentary:- 
 Caucasians (n=115) 
 African-Americans (n=4) 
 Hispanics (n=6) 
 Asians (n=20) 
 Other (n=11) 
0.03 Subjects with XX genotype had the 
lowest muscle strength and the lowest 
resting creatine kinase activity than 
other genotype carriers 
Clarkson et al. (2005a)  Caucasian  
  
Women (n=286) 
 
< 0.05 XX genotype carriers had lower 
baseline strength than RX genotype 
carriers 
Yang et al. (2003) Caucasian 
(Australian) 
Sprinters (n=107) 
Endurance athletes (n=194) 
Controls (n=436) 
0.001 R allele frequency in sprinters (0.72), 
endurance athletes (0.54), controls 
(0.56) 
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Table 2.5 Continued     
Reference Population Study group (sample size) p value Results 
Studies that reported possession of the R allele did not influence strength/power performance 
Wang et al. (2013) Caucasian and 
Asian 
Caucasian swimmers;- 
 Short middle distance (SMD) (≥ 400 
m) (n=125) 
 Long distance (LD) (≥ 400 m) 
(n=68) 
Caucasian Controls (n=1694) 
Asian swimmers;- 
 SMD (≥ 100 m) (n=166) 
 LD (200-400 m) (n=160) 
Asian Controls (n=1252) 
> 0.05 Swimmer status in either Caucasians or 
East Asians was not influenced by R 
allele  
Ahmetov et al. (2013) Caucasian 
(Russian) 
Middle school-age children (n=457) < 0.05 High strength/power performance was 
not influenced by R allele 
Djarova et al. (2011) Zulu South 
African 
Cricket players (n=14) 
Controls (n=17) 
> 0.05 No significant difference was identified 
between two studied groups  
Gineviciene et al. (2011) Caucasian 
(Lithuanian) 
Power athletes (n=51) 
Endurance athletes (n=77) 
Mixed athletes (n=65) 
Controls (n=250) 
> 0.05 There was no significant difference in 
allele and genotype frequencies 
between the sports groups 
Gineviciene et al. (2011) Caucasian 
(Lithuanian) 
Power athletes (n=51) 
Endurance athletes (n=77) 
Mixed athletes (n=65) 
Controls (n=250) 
< 0.05 The grip strength and the vertical jump 
were better among athletes with XX 
genotype compared to athletes with RR 
genotype 
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Table 2.5 Continued     
Reference Population Study group (sample size) p value Results 
Scott et al. (2010) Jamaican and US 
African American 
Sprinter:- 
 Jamaican (n=116) 
 US (n=114)  
Controls:- 
 Jamaican (n=311) 
 US (n=191) 
0. 67 Elite sprint athlete was not influenced 
by R allele 
McCauley et al. (2010) Caucasian  Older males aged 60-70 years old 
(n=100) 
> 0.05 R allele did not affect the absolute and 
the relative high velocity strength 
Santiago et al. (2010) Caucasian 
(Spanish) 
Healthy young adults (n=284) > 0.05 R allele did not seem to influence the 
ability to produce peak (explosive) 
power  
Lucia et al. (2006) Caucasian 
(European) 
Endurance runners (n=52) 
Cyclists (n=50) 
Controls (n=123) 
> 0.05  No significant difference existed 
between the genotype groups 
 No difference was found in indices of 
endurance performance (VO2peak or 
ventilator thresholds) between athlete 
carriers of each ACTN3 R/X genotype 
Clarkson et al. (2005a) Caucasian and 
Asian 
 
Caucasian women (n=286) 
Asian women (n=23) 
< 0.05 Women with XX genotype displayed the 
greatest 1-RM response to training 
compared with those women with RR 
genotype after resistance training 
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2.4.5 X allele and Endurance Performance 
 
A study using an ACTN3 knockout mouse model demonstrated that the lack of 
ACTN3 protein in an X allele carrier has resulted in alterations of skeletal muscle 
metabolism, explicit to aerobic metabolism, nicotinamide adenine dinucleotide 
(NADH), and succinate dehydrogenase (SDH) (MacArthur et al., 2007). The activity 
of the enzyme citrate synthase (CS), which is commonly found in slow- twitch fibre 
and also a marker for mitochondrial oxidative capacity, was found to be 22% 
significantly higher in mice with null mutation (XX) compared to wild-type mice (RR) 
(MacArthur et al., 2007). Moreover, the higher activity of beta hydroxyacyl-CoA 
dehydrogenase (bHAD) and medium-chain acyl-CoA dehydrogenase (MCAD), which 
are two mitochondrial enzymes involved in fatty acid oxidation in mice with 
deficiency of ACTN3 protein, suggested an increased reliance on aerobic instead of 
anaerobic metabolism (North, 2008).  
 
Meanwhile, in another study involving an ACTN3 knockout mouse model, 
muscles with deficit in ACTN3 protein showed an increment in the twitch half 
relaxation time (MacArthur et al., 2008), which would significantly prolong the time 
taken for muscles to relax, and consequently, become detrimental to activities that 
require a repeated rapid contraction, such as sprinting and weight lifting, but providing 
another possible explanation that possession of the X allele may confer an advantage 
for endurance performance (Allen et al., 2008). The X allele appears to enhance 
endurance performance due to the higher frequency of the XX genotype in endurance 
athletes compared to controls, although this result is only reflected in female athletes 
(Yang et al., 2003). In addition, the frequency of X allele was also markedly over-
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represented in Israeli endurance athletes (Eynon et al., 2009b) and Chinese female 
endurance athletes (Shang et al., 2010) compared to strength/power athletes and 
controls. Thus, the X allele has been suggested to give beneficial effects on endurance 
performance due to the higher VO2max in the X allele carrier than those with R allele 
(Lucia et al., 2007). 
 
Nonetheless, despite these positive findings, some studies have shown that X 
allele failed to influence endurance performance (Moran et al., 2006b, San Juan et al., 
2006, Ahmetov et al., 2008a, Gomez-Gallego et al., 2009, Döring et al., 2010, Kothari 
et al., 2011). As previously explained in the effects of possession of the R allele on 
strength/power performance, these conflicting findings could be due to ethnicity 
factor, and limited reports from Asian population (Ma et al., 2013). Therefore, to 
further investigate the role of X allele on endurance performance, future research must 
involves Asian population, especially Malaysian population. The list of studies that 
investigated the effect of possession of the X allele on endurance performance is 
summarized in Table 2.6. 
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Table 2.6 Studies that investigated the effect of possession of the X allele on endurance performance 
Reference Population Study group (sample size) p value Results 
Studies that reported the effect of possession of the X allele on endurance performance 
Ahmetov et al. (2011) Caucasian 
(Russian) 
Sub elite Russian speed skaters (n=34) 
Controls (n=60) 
< 0.05 XX genotype carriers exhibited a higher 
proportion of slow twitch fibres  
Ahmetov et al. (2011) Caucasian 
(Russian) 
Speed skaters:- 
 Sprinters (n=39) 
 Middle distance (n=53) 
 Endurance-oriented (n=23) 
Controls (n=1301) 
0.046 The frequency of XX genotype was 
significantly higher in endurance-
oriented speed skaters than other skaters 
Shang et al. (2010) Asian (Chinese) Endurance athletes:- 
 Male (n=132) 
 Female (n=118) 
Controls:- 
 Male (n=298) 
 Female (n=152) 
0.02 
 
 X allele frequency in female endurance 
athletes (0.51), controls (0.41) 
 No significant difference was 
observed in male endurance athletes 
vs. controls 
Eynon et al. (2009b) Caucasian 
(Israeli) 
Endurance runners (n=81) 
Sprinters (n=74) 
Controls (n=240) 
< 0.05 X allele frequency in endurance runners 
(0.47), sprinters (0.30), controls (0.45) 
Lucia et al. (2007) Caucasian 
(European) 
Adult McArdle’s disease patients 
(n=40) 
Sedentary controls (n=40) 
< 0.05 Carriers of the X allele had a higher 
VO2max at the ventilation threshold 
(VT) than those with R allele 
Yang et al. (2003) Caucasian 
(Australian) 
Female Sprinters (n=35) 
Female Endurance athletes (n=72) 
Female Controls (n=292) 
< 0.001 X allele frequency in sprinters (0.29), 
endurance athletes (0.47), controls 
(0.56) 
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Table 2.6 Continued 
Reference Population Study group (sample size) p value Results 
Studies that reported possession of the X allele did not influence endurance performance 
Kothari et al. (2011) Asian (Indian) Athletes:- 
Endurance (n=83) 
Power (n=72) 
Controls (n=150) 
0.07 The X allele or the XX genotype was 
present at higher frequency in 
endurance athletes, but displayed 
insignificant association  
Döring et al. (2010) Caucasian 
(North America, 
Finland and 
Germany) 
Male elite endurance athletes (n=316) 
Controls (n=304) 
> 0.01 The prevalence of the XX genotype was 
similar in endurance athletes and 
controls 
Gomez-Gallego et al. 
(2009) 
Caucasian 
(Spanish) 
 Elite professional road cyclists 
(n=46) 
 Healthy men (n=46) 
< 0.05 Endurance phenotype trait was 
influenced by R allele 
Ahmetov et al. (2008a) Caucasian 
(Russian) 
Rowers (n=54) 
 
0.016 Male rowers with RR genotype showed 
better results in long-distance rowing 
than carriers of RX or XX genotypes 
Ahmetov et al. (2008a) Caucasian 
(Russian) 
Endurance-oriented athletes (n=456) 
Controls (n=1211) 
< 0.05 X allele was underrepresented in 
Russian endurance athletes 
Moran et al. (2006b) Caucasian 
(Greeks) 
Adolescent (n=922) > 0.05 Endurance phenotype was not 
influenced by X allele 
San Juan et al. (2006) Caucasian 
(Spanish) 
Healthy, non-athletic elderly women 
(age 61–80 years) (n=23) 
> 0.05 Complete deficiency of ACTN3 did not 
affect aerobic capacity 
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2.5 Exercise and Blood Pressure 
 
At present, hypertension has become one of the significant risk factors for chronic 
diseases, such as heart attack and stroke (Chobanian et al., 2003). Moreover, the 
National Health and Morbidity Survey 2011 reported that 32.7% of adults aged 18 
years old and above in Malaysia suffered from hypertension (Survey, 2011). Thus, it 
has been suggested that high blood pressure can be controlled and prevented with 
lifestyle modifications, such as dieting and exercising (Pescatello et al., 2004). In 
general, exercise helps to strengthen the heart where the heart will pump more blood 
with less effort, thus decreasing the force on arteries, which in turn lowers blood 
pressure (Dicker, 2010). Nevertheless, the optimal exercise training program in 
preventing and controlling high blood pressure has remained unclear as the magnitude 
of the exercise training effect may vary across different training prescriptions 
(Williams et al., 2007).  
 
2.5.1 Endurance Exercise Training and Blood Pressure 
 
Endurance exercise, which involves large muscle groups in dynamic activities such as 
walking and swimming, has shown to lower resting blood pressure in both 
hypertensive and normotensive individuals (Pescatello and Kulikowich, 2001, 
Cornelissen and Fagard, 2005b, Baynard et al., 2008, Goldberg et al., 2012). In fact, a 
recent meta-analysis study reported that endurance exercise training at a moderate to 
high intensity less than 210 minutes per week for less than 24 weeks reduced the 
resting systolic and diastolic blood pressure by 3.5 and 2.5 mmHg, respectively, with 
the largest reduction in blood pressure more pronounced in hypertensive than in 
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normotensive individuals (Cornelissen and Smart, 2013). Meanwhile, several studies 
have demonstrated that a similar magnitude of blood pressure reduction was observed 
for up to 22 hours after cessation of a single set of moderate-intensity endurance 
exercise training (Brownley et al., 1996, MacDonald et al., 2001, Cornelissen and 
Fagard, 2005b). It also showed that moderate-intensity endurance exercise training 
increases exercise capacity (Tsai et al., 2004) and decreases heart rate during exercise 
by 11.3 mmHg in hypertensive patients (Wilmore et al., 2001). Taken together, these 
findings suggest that endurance exercise training does not only help lower resting 
blood pressure, but also improves fitness and lowers the risk of cardiovascular injury 
during exercise among hypertensive individuals. 
 
Although endurance exercise training promotes beneficial effects on blood 
pressure regulation, approximately 50% of adults among those engaged in aerobic 
exercise program discontinued within 3 to 6 months (Owen et al., 2010). Dropout from 
this exercise program had been reported due to several factors, such as lack of time 
and medical condition (e.g. obesity or arthritis) (Owen et al., 2010). 
 
2.5.2 Resistance Exercise Training and Blood Pressure 
 
Resistance exercise training (strength training) refers to any type of training using 
resistance (e.g. dumbbells and elastic band) against the force of muscular contraction 
(Preedy, 2012). Resistance training, such as weightlifting, is generally designed to 
build muscle and increase strength (Kraemer et al., 2002). Since a study by 
MacDougall et al. (1985) demonstrated that systolic and diastolic blood pressure could 
reach values of 320 mmHg and 250 mmHg, respectively, during the double leg-press 
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in normotensive individuals, the resistance training has not previously been 
recommended for hypertensive patients.  
 
Nevertheless, subsequent studies have demonstrated that resistance training 
can lower resting blood pressure (Wiley et al., 1992, Wood et al., 2001, Vincent et al., 
2003). Furthermore, several meta-analysis studies have consistently reported that both 
resting systolic and diastolic blood pressure could be reduced by 3 to 4 mmHg 
following resistance exercise training (Kelley and Kelley, 2000, Cornelissen and 
Fagard, 2005a, Fagard, 2006). Interestingly, no incident of high blood pressure was 
observed after the resistance exercise training (Kelley and Kelley, 2000). Nonetheless, 
contrary to the findings obtained from endurance exercise training, the magnitude of 
blood pressure reduction following resistance exercise training had been similar in 
hypertensive and normotensive individuals (Cornelissen and Fagard, 2005a, Fagard, 
2006). Taken together, these findings demonstrated that resistance exercise training 
could be incorporated into an exercise program for blood pressure management. 
 
Based on the modes of resistance exercise training, the recent meta-analysis 
study reported that the reduction in resting systolic blood pressure was larger after 
isometric resistance training (-10.9 mmHg) compared to dynamic resistance training 
(-1.8 mmHg) (Cornelissen and Smart, 2013). Besides, a similar pattern of reduction 
was also observed for resting diastolic blood pressure (Cornelissen and Smart, 2013). 
Generally, dynamic resistance exercise involves movement at the joints, whereas 
isometric resistance exercise does not require any movement of the affected joint and 
the muscle length will remain unchanged (Hoffman, 2002). Thus, from the findings on 
resting blood pressure and the exercise characteristics, the isometric resistance 
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exercise training had been found to be superior to the dynamic resistance exercise 
training in controlling and preventing high blood pressure. 
 
2.5.3 Isometric Resistance Exercise Training and Blood Pressure 
 
Over several years, numerous studies have investigated the role of isometric resistance 
exercise training in reducing blood pressure (Wiley et al., 1992, Ray and Carrasco, 
2000, Howden et al., 2002, Taylor et al., 2003, Peters et al., 2006, McGowan et al., 
2007, Millar et al., 2008, Millar et al., 2013). In fact, a current meta-analysis study 
reported that the reduction in resting blood pressure had been largest after isometric 
resistance exercise training (systolic: −10.9 mmHg, diastolic: −6.2 mmHg) compared 
to endurance (systolic: −3.5 mmHg, diastolic: −3.7 mmHg) and dynamic resistance 
exercise training (systolic: −1.8 mmHg, diastolic: −2.5 mmHg) (Cornelissen and 
Smart, 2013). 
 
Although the optimal protocol of the isometric resistance exercise training has 
not been established at present, the most common protocol of this exercise training is 
composed of four sets of 2 minutes’ handgrip (McGowan et al., 2007, Millar et al., 
2008) or leg contractions (Howden et al., 2002) at 30 to 50 % of maximal voluntary 
contraction (MVC) (Wiley et al., 1992, Ray and Carrasco, 2000) with 1 to 4 minutes 
of rest period between each contraction (Wiley et al., 1992, McGowan et al., 2007) 
that are conducted three to five times per week for 4 to 10 weeks (Devereux et al., 
2010, Badrov et al., 2013). Relative to exercise trained-muscle, hand grip isometric 
exercise training (Wiley et al., 1992, Badrov et al., 2013) has been found to reduce 
resting blood pressure more than leg isometric exercise training (Baross et al., 2012). 
66 
 
In addition, with regard to exercise intensity, the isometric handgrip exercise training 
that was performed at 30% of MVC (Taylor et al., 2003) elicited greater reduction in 
resting blood pressure compared to a similar exercise at 50% of MVC (Peters et al., 
2006). On the other hand, as for training frequency, Badrov et al. (2013) reported that 
the effect of the isometric exercise training in lowering blood pressure had been 
independent of the volume of training as both groups trained 3 and 5 times per week 
produced a similar magnitude of reduction in blood pressure. Interestingly, the effect 
of this exercise training on blood pressure could be seen after 4 to 5 weeks of training 
with long duration of training, such as 8 to 10 weeks, which had shown to elicit larger 
reductions in blood pressure (Millar et al., 2007).  
 
It has also been demonstrated that the effect of the isometric exercise training 
is more pronounced in those with hypertension than individuals with normal blood 
pressur. In addition, several studies have shown that no harmful effect was detected 
when performing the isometric exercise as no overload was discovered in 
cardiovascular changes and the hemodynamic parameters were observed immediately 
after the end of the first session of this exercise training (Li et al., 2000, Auerbach et 
al., 2000, Araujo et al., 2011, Olher et al., 2013). When compared to aerobic exercise 
training, the isometric exercise training has the potential to ensure long-term adherence 
as it is easy to perform, does not require higher intensity training, and less exercise 
time (Millar et al., 2014). Therefore, based on all the findings obtained from previous 
research, the isometric exercise training could be a very effective training for 
hypertensive and normotensive individuals to control and prevent high blood pressure, 
respectively.  
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At present, the mechanism by which isometric exercise training elicits 
reduction in blood pressure has remained unclear (Millar et al., 2014). Wiles et al. 
(2010) suggested that the rise in blood pressure during isometric exercise will stimulate 
the baroreceptors, which are sensory afferent nerve endings located in the carotid sinus 
and the aortic arch. When the blood pressure is elevated, the baroreceptors are 
stretched and result in a reflex-mediated increase in parasympathetic nerve activity, as 
well as a decrease in sympathetic nerve activity (Wiles et al., 2010). Consequently, it 
causes a decline in the heart rate, while the diameter of blood vessels increases and 
further leads to a drop in the blood pressure (Wiles et al., 2010). Moreover, other 
studies have suggested that the reduction in blood pressure after isometric exercise 
training is related to the repeated power of hydrogen (pH) changes due to muscle 
fatigue and lactate production that act as a metaboreceptor stimulus (Devereux, 2010); 
augmentation in vasodilator substances, for instance, nitric oxide (NO) (Lopez et al., 
2009); and reduction in peripheral vascular adaptations (Gregory, 2012).  
 
On the other hand, data retrieved from HEalth, RIsk factors, exercise Training 
And Genetics (HERITAGE) Family Study suggest that reduction in blood pressure 
after exercise may be influenced by genetic factors (Wilmore et al., 2001). With that, 
several candidate genes for the reduction in blood pressure after exercise had been 
proposed and among these, the ACE gene was initially believed to influence blood 
pressure response to exercise due to its role in the RAS (Hagberg et al., 2000, Marteau 
et al., 2005, Dhanachandra Singh et al., 2014).   
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2.5.4 ACE I/D Gene Polymorphism, Isometric Exercise Training, and Blood 
Pressure 
 
The variation that occurs in the ACE gene, which is known as ACE I/D gene 
polymorphism, had been proposed to influence blood pressure regulation (Rigat et al., 
1990). Moreover, Rigat et al. (1990) reported that the ACE concentration in the RAS 
was lowest and highest among individuals with I and D alleles of the ACE I/D gene 
polymorphism, respectively. Therefore, individuals with two copies of I allele might 
have lower resting blood pressure compared to those with two copies of D allele as the 
lower level of ACE decreased the production of ANG II, a potent vasodepressor and 
aldosterone stimulating peptide, besides activating bradykinin, a potent vasodilator 
that leads to a drop in blood pressure (Coates, 2003). Hence, given that the ACE I/D 
gene polymorphism has an important role in blood pressure regulation, blood pressure 
response to exercise training may vary among individuals with different genotypes of 
ACE I/D gene polymorphism. 
 
 Besides, a few studies have attempted to investigate the influence of the ACE  
I/D gene polymorphism on blood pressure in response to endurance exercise training 
(Montgomery et al., 1997, Hagberg et al., 1999, Rankinen et al., 2000a, Zhang et al., 
2002, Dengel et al., 2002, Kim, 2009). Furthermore, Hagberg et al. (1999) reported 
that after 9 months of endurance exercise training at 75 to 85 % of VO2max, 
individuals with I allele had reduced systolic and diastolic blood pressure more than 
individuals with D allele (systolic: -10 vs. -5 mmHg; diastolic: -10 vs. -1 mmHg). 
Meanwhile, in a study that involved 64 Japanese with mild to moderate essential 
hypertension subjects, who were engaged in 10 weeks of exercise therapy on a bicycle 
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ergometer, the systolic blood pressure, the diastolic blood pressure, and the mean value 
for arterial pressure significantly decreased in individuals with II and ID genotypes, 
but not in those individuals with DD genotype (Zhang et al., 2002). In contrast, a study 
by Kim (2009) found that adult women with DD genotype had a greater reduction in 
DBP than those with II and ID genotypes following 12 weeks of combined aerobic and 
resistance exercise training. Despite the positive finding on the influence of the ACE 
I/D gene polymorphism in blood pressure, studies by Rankinen et al. (2000a), 
Montgomery et al. (1997), and Dengel et al. (2002) found that the ACE I/D gene 
polymorphism did not influence blood pressure in response to 20 weeks of endurance 
exercise training. Nonetheless, negative finding was also found for dynamic resistance 
exercise training, where the blood pressure response to a three-month program of 
dynamic resistance exercise training at 60%, 70%, and 80% of 1-RM, respectively, for 
each month did not differ for hypertensive women with different ACE I/D genotypes 
(Mota et al., 2013). The reasons for the discrepancy between these studies are unclear, 
but might be due to the differences in exercise protocol. For instance, a study by Kim 
(2009) involved mixed aerobic and resistance exercise training compared with only 
aerobic training (endurance training) in study by Hagberg et al. (1999).  
 
Despite conflicting findings of the above-mentioned studies, the positive 
finding obtained for the effects of ACE I/D gene polymorphism on endurance training 
adaptation raises the possibility that the ACE I/D gene polymorphism might also 
influence blood pressure response to isometric exercise training. Besides, based on the 
latest article review on isometric exercise training-induced reductions in resting blood 
pressure, the role of genetic factors, specifically the ACE I/D gene polymorphism in 
eliciting hypotension effect following the isometric exercise training, has not been 
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reported yet (Lawrence et al., 2014). Therefore, future research is warranted to 
examine the effects of ACE I/D gene polymorphism on blood pressure response to 
isometric exercise training.  
 
2.6 Research Gaps in the Field  
 
The effects of ACE I/D and ACTN3 R/X gene polymorphisms on human physical 
performance and health remain inconclusive due to inconsistent findings in the current 
literature (Ma et al., 2013). These inconsistent findings were thought to be related to 
some potential limitations including insufficient sample size, ethnicity, and disparity 
data in the current literature (Zilberman-Schapira et al., 2012, Ma et al., 2013).  
 
The number of participants has been reported as one of the potential limitation 
in this field (Zilberman-Schapira et al., 2012). In order to make a concrete conclusion, 
studies in this field are warranted to have a very large population samples (i.e. more 
than a few hundred) (Guilherme et al., 2014). This is difficult to overcome because 
each polymorphism exhibits different frequencies in different populations, indicate 
that the sample size necessary to detect the effects of particular gene polymorphism 
can vary according the tested population (Guilherme et al., 2014).  
 
Ethnicity has also been suggested to contribute to inconsistent findings due to 
lack confirmation in different ethnic population (Zilberman-Schapira et al., 2012). For 
instance, with regard to ACE I/D gene polymorphism, while studies involving 
Caucasian population reported that possession of the I allele of ACE I/D gene 
polymorphism influences endurance performance (Hagberg et al., 1999, Kasikcioglu 
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et al., 2004, Cam et al., 2007), some studies with Asian samples demonstrated that 
possession of the ACE I allele did not appear to influence endurance performance 
(Zhaoa et al., 2003, Tobina et al., 2010). Based on these findings and previous reports 
that the distribution of ACE I/D and ACTN3 R/X gene polymorphisms vary between 
different ethnic groups (Barley et al., 1994, Batzer et al., 1994, Batzer et al., 1996, 
Jayapalan et al., 2008), there is a possibility that the effects of ACE I/D and ACTN3 
R/X gene polymorphisms on physical performance could also vary by ethnicity. Thus, 
to understand the potential effect of ethnicity factor on ACE I/D and ACTN3 R/X gene 
polymorphisms, population stratification according to the ethnic background is, 
therefore, an important issue to consider in this field.  
 
In addition, to the best of author’s knowledge, there are limited studies 
comparing the effects of ACE I/D and ACTN3 R/X gene polymorphisms on physical 
performance in Asian population, particularly Malaysian population, to Caucasian 
population for a comprehensive description concerning the ethnic variation on these 
polymorphisms. One of the first report on the association between ACTN3 R/X gene 
polymorphism and physical performance was based on a study by Yang et al. (2003) 
involving Australian Caucasian athletes. In that study, Yang and colleagues observed 
that elite athletes of endurance sports are predominantly with X allele while the R allele 
was found to be over-represented in strength/power athletes (Yang et al., 2003). Based 
on the study of Yang et al. (2003), it would also be interesting to compare the effects 
of ACE I/D and ACTN3 R/X gene polymorphisms on physical performance in 
Malaysian population to Australian population to determine if similar association exist 
among Malaysian population as what reported among Australian Caucasian 
population. 
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The disproportion in the current literature was also noted as most related 
articles had been based on Caucasian populations, while there are fewer reports for the 
Asian population (Ma et al., 2013). Therefore, more studies in other populations, 
particularly among the Asian population, are required to verify the findings observed 
in the Caucasian samples.  
 
In addition, although isometric handgrip training has been reported to be more 
efficient in lowering resting blood pressure compared to other different modes of 
exercise training (Cornelissen and Smart, 2013), the mechanism by which isometric 
handgrip training induced reduction in resting blood pressure has remained unknown. 
Given that the ACE I/D gene polymorphism influenced blood pressure response to 
endurance training (Hagberg et al., 1999, Zhang et al., 2002, Kim, 2009), there is a 
possibility that the ACE I/D gene polymorphism might also influence blood pressure 
response to isometric exercise training. Therefore, future studies are warranted to 
investigate the effect of the ACE I/D gene polymorphism on blood pressure adaptation 
to isometric exercise training. Thus, in future it may be possible to predict who 
will likely benefit most from the isometric exercise training for blood pressure 
management. 
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CHAPTER 3 
 
RESEARCH OVERVIEW 
 
3.1 Introduction 
 
Two of the most extensively investigated genes associated with human physical 
performance are angiotensin I-converting enzyme (ACE) and alpha-actinin-3 (ACTN3) 
genes (Ma et al., 2013). Therefore, the main idea of this thesis had been to provide the 
evidence gathered from three studies in support of the roles of specific genetic factors 
represented by angiotensin I-converting enzyme (ACE) I/D and alpha-actinin-3 
(ACTN3) R/X gene polymorphisms on human physical performance and health within 
the Malaysian population.  
 
 A population-based study was carried out in the first study to determine if the 
distributions of ACE I/D and ACTN3 R/X gene polymorphisms were differed by 
ethnicity as a standard reference before establishing the effects of these 
polymorphisms on physical performance within the Malaysian population. Therefore, 
180 Asians (99 Malays (55%), 45 Chinese (24.7%), 23 Other Bumiputras (12.9%), 
and 13 Indians (7.4%)) from Malaysia (70 males, 110 females) aged 20.4 ± 1.6 years, 
and 180 Caucasians from Australia (62 males, 118 females) aged 23.3 ± 3.6 years, who 
were sedentary healthy individuals were selected as participants in the first study. A 
sample of DNA was retrieved via buccal cell from each participant and the ACE I/D 
and ACTN3 R/X genotypes were then identified through Polymerase Chain Reaction.  
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 The effects of ACE I/D and ACTN3 R/X gene polymorphisms on human 
physical performance and their association with ethnicity within the Malaysian 
population were examined in the second study. One hundred eighty well-trained 
Malaysian athletes (148 males, 32 females) aged 20.5 ± 1.9 years, and 180 Malaysian 
sedentary controls from the first study, involved in the second study. A sample of DNA 
was retrieved via buccal cell from each participant and the ACE I/D and ACTN3 R/X 
genotypes were then identified through Polymerase Chain Reaction. The endurance 
performance and muscular strength of Malaysian athletes were evaluated with twenty 
meters Yo-Yo intermittent recovery level 2 and maximal voluntary contraction tests, 
respectively. Within the cohort of Malaysian athletes, 34 participants (25 males, 9 
females) aged 19.8 ± 1.9 years were classified as endurance athletes, 41 participants 
(25 males, 16 females) aged 19.7 ± 1.8 years as strength/power athletes, and 105 
participants (99 males, 6 females) aged 21.0 ± 1.8 years as intermittent athlete. In 
addition, given that a strong association between ACTN3 R/X gene polymorphism and 
physical performance was previously observed in Australian population (Yang et al., 
2003), therefore, 33 intermittent athletes (all males) aged 20.7 ± 4.0 years, who were 
of Caucasian origin, had been recruited from the Australian population for well-
matched comparison-group study to Malaysian population, represents by 33 Malay 
intermittent athletes (all males) aged 20.8 ± 1.7 years from the intermittent group of 
Malaysian athletes. 
 
 In the final study, an experimental study was conducted to determine the 
influence of ACE I/D gene polymorphism on training adaptation for health among 
normotensive men in Malaysia. Thirty normotensive, untrained males (ACE genotype: 
II=10, ID=10, and DD=10), undergone the most common protocol of isometric 
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handgrip (IHG) training (four sets of 2 minutes isometric contractions at 30% of 
maximal voluntary contraction, with 1 minute resting interval) 3 days per week for 8 
weeks. Cardiovascular and muscular variables were measured on three consecutive 
days prior to commencing training and after 8 weeks of training, as well as after the 
initial training session. The criteria of the third study that only men were involved was 
based on the understanding that regulation of blood pressure in women is affected by 
the menstrual cycle. Thus, it would be difficult to isolate the influence of genetic 
makeup on physiological adaptation of isometric handgrip training in this study if 
women were involved without considering their individual menstrual cycle variation.   
  
 The flow chart of the overall research process is illustrated in Figure 3.1. The 
comprehensive methodologies used in each study are described in detail in the 
following chapters. The study protocols on Malaysian and Australian samples were 
approved by the Human Research Ethics Committee in Universiti Sains Malaysia 
(Appendix A) and the Human Research Ethics Committee in University of Sydney, 
respectively (Appendix B). 
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Figure 3.1       The general research process 
The Influence of ACE I/D Gene 
Polymorphism on Cardiovascular and 
Muscular Adaptations to 8 Weeks of 
Isometric Handgrip Training in a 
Normotensive Population in Malaysia 
The Effects of ACE I/D and ACTN3 R/X Gene Polymorphisms on Human 
Physical Performance in the Multi-Ethnic Malaysian Population 
Multi-Ethnic Malaysian 
Athletes (n=180) 
 148 males, 32 females 
 aged 20.5 ± 1.9 years 
 
Physical Tests 
Yo-Yo intermittent recovery level 2 and 
maximal voluntary contraction tests 
 
Malay 
Intermittent 
Athletes  
(n=33) 
Caucasian 
Intermittent 
Athletes 
(n=33) 
Endurance 
Athletes 
(n=34) 
 25 males, 
9 females 
 aged 19.8 
± 1.9 
years 
Strength/ 
Power 
Athletes 
(n=41)  
 25 males, 
16 females 
 aged 19.7 
± 1.8 
years  
Intermittent 
Athletes 
(n=105) 
 99 males, 6 
females  
 aged 21.0 ± 
1.8 years 
Australian 
General 
Population 
(n=180) 
 All Caucasians 
 62 males, 118 
females 
 aged 23.3 ± 3.6 
years 
Malaysian 
General 
Population 
(n=180) 
 Malay (n=99), 
Chinese 
(n=45), Indian 
(n=13), Other 
Bumiputra 
(n=23)  
 70 males, 110 
females 
 aged 20.4 ± 1.6 
years 
Distributions of ACE I/D and ACTN3 
R/X Gene Polymorphisms in Malaysian 
and Australian Populations, and Their 
Association with Ethnicity 
Study 1 Study 2 Study 3 
Participants:  
30 healthy, normotensive, untrained 
Malay males, aged 30.3 ± 5.1 years  
ACE I/D genotype group:  
II (n=10), ID (n=10), DD (n=10) 
Training: 
Unilateral, alternate isometric 
handgrip training, four sets of 2 
minutes isometric contractions at 
30% of maximum voluntary 
contraction with 1 minute resting 
interval, 3 days per week for 8 weeks 
8 Weeks of Isometric Handgrip 
Training 
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3.2 Research Objectives and Hypotheses 
 
3.2.1 Study 1: Distributions of ACE I/D and ACTN3 R/X Gene Polymorphisms in 
Malaysian and Australian Populations, and Their Association with Ethnicity 
 
The objective of this study was to establish the distribution patterns of ACE I/D and 
ACTN3 R/X gene polymorphisms in the Malaysian population. This study also determined 
whether the distributions of ACE I/D and ACTN3 R/X gene polymorphisms differ among 
ethnic groups.  
 
3.2.2 Study 2: The Effects of ACE I/D and ACTN3 R/X Gene Polymorphisms on 
Human Physical Performance in the Multi-Ethnic Malaysian Population 
 
The main focus of this study was to examine the effects of ACE I/D and ACTN3 R/X gene 
polymorphisms on athletic status and human physical performance in the Malaysian 
population. This study also determined if the effects of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance differ by ethnicity. The ACE level was 
reported lower in individuals with two copies of I allele (Rigat et al., 1990) and led to a 
decrease in the conversion of ANG I to ANG II, which resulted in increased delivery of 
oxygenated blood to the working muscles (Sayed-Tabatabaei et al., 2006). Meanwhile, 
MacArthur et al. (2007) suggested that the loss of ACTN3 protein via the X allele leads to 
alterations in skeletal muscle metabolism towards more efficient aerobic metabolism. 
Therefore, possession of the I allele of ACE I/D and the X allele of ACTN3 R/X gene 
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polymorphisms were hypothesized to affect endurance performance. Meanwhile, based 
on the findings that the elevation level of the ACE activity in individuals with D allele of 
the ACE  I/D gene polymorphism increased the production of ANG II (a potent growth 
factor in cardiac and vascular tissues) in the skeletal muscle renin-angiotensin system, 
which is the potential mechanism where muscle cell growth and hypertrophy may be 
activated (Geisterfer et al., 1998, Kai et al., 1998), and the R allele codes for functioning 
ACTN3 gene that results in the production of ACTN3 protein (North et al., 1999), 
possession of the D allele of ACE I/D and the R allele of ACTN3 R/X gene polymorphisms 
were hypothesized to affect strength/power performance. The effects of ACE I/D and 
ACTN3 R/X gene polymorphisms on human physical performance were hypothesized to 
vary between ethnic groups. 
 
3.2.3 Study 3: The Influence of ACE I/D Gene Polymorphism on Cardiovascular 
and Muscular Adaptations to 8 Weeks of Isometric Handgrip Training in a 
Normotensive Population in Malaysia 
 
This study was designed to examine the effect of ACE I/D gene polymorphism on 
cardiovascular and muscular adaptations to an 8-week isometric handgrip training among 
normotensive men with different ACE I/D genotypes. It was hypothesized that 
cardiovascular and muscular adaptations to an 8-week isometric handgrip training would 
vary between the ACE I/D genotype groups. 
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CHAPTER 4 
 
DISTRIBUTIONS OF ACE I/D AND ACTN3 R/X GENE POLYMORPHISMS IN 
MALAYSIAN AND AUSTRALIAN POPULATIONS, AND THEIR 
ASSOCIATION WITH ETHNICITY 
 
4.1 Introduction 
 
Performance in sports has been suggested to be influenced by genetic factors (Guilherme 
et al., 2014). Among the candidate genes studied, the most studied genes related to sports 
performance have been the angiotensin I-converting enzyme (ACE) and alpha-actinin-3 
(ACTN3) genes (Ma et al., 2013). The ACE I/D gene polymorphism in the ACE  gene has 
been thought to confer a greater advantage in endurance activity due to its role in 
determining the level of ACE circulation in tissues (Rigat et al., 1990); a main component 
in the renin-angiotensin system (RAS) (Sayed-Tabatabaei et al., 2006). Meanwhile, the 
ACTN3 R/X gene polymorphism in the ACTN3 gene has been thought to present an 
advantage to activities that require short bursts of intense strength and power because it 
codes for ACTN3 protein (North et al., 1999); a protein found only in the fast-twitch 
skeletal muscle fibre.  
 
Moreover, research findings on the effects of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance have remained inconsistent (Hagberg et 
al., 1999, Zhaoa et al., 2003, Kasikcioglu et al., 2004, Niemi and Majamaa, 2005, Cam et 
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al., 2007, Druzhevskaya et al., 2008, Eynon et al., 2009b, Tobina et al., 2010, Kothari et 
al., 2011, Gineviciene et al., 2011). Most studies involving the Caucasian population 
reported that possession of the I allele of ACE I/D gene polymorphism influences 
endurance performance (Hagberg et al., 1999, Kasikcioglu et al., 2004, Cam et al., 2007). 
Conversely, some studies in the Asian population revealed that possession of the ACE I 
allele did not appear to influence endurance performance, as the endurance performance 
was significantly higher in those with ACE D allele than those with ACE I allele (Zhaoa 
et al., 2003, Tobina et al., 2010). With regard to ACTN3 R/X gene polymorphism, studies 
involving Indian (Kothari et al., 2011), Finnish (Niemi and Majamaa, 2005), Israeli 
(Eynon et al., 2009b), and Russian (Druzhevskaya et al., 2008) athletes demonstrated that 
possession of the ACTN3 R allele may confer an advantage for strength/power 
performance. In contrast, Gineviciene et al. (2011) reported that possession of the ACTN3 
R allele failed to confer any advantage to strength/power performance among Lithuanian 
athletes. 
 
These contradictory results reported across different ethnicities were apparently 
consistent with the research findings on the effect of ACE I/D gene polymorphisms on the 
susceptibility to certain diseases (Ishigami et al., 1995, Barley et al., 1996, Staessen et al., 
1997, Kunz et al., 1998, Fujisawa et al., 1998, Sagnella et al., 1999, Ng et al., 2005). A 
previous meta-analysis study carried out by Kunz et al. (1998) demonstrated that ACE I/D 
gene polymorphism contributed to the susceptibility to diabetic nephropathy with a 
significant association among Asian patients, but not in Caucasian patients. In contrast, a 
meta-analysis study by Fujisawa et al. (1998) reported that the ACE I/D gene 
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polymorphism was associated with diabetic nephropathy in both Asian and Caucasian 
populations. Subsequently, in 2005, a study by Ng et al. (2005) in a large population-based 
sample clearly demonstrated that the association between ACE  I/D gene polymorphism 
and diabetic nephropathy was more marked among type 2 diabetic patients in the Asian 
population than those from the Caucasian population. Ethnic difference in ACE I/D gene 
polymorphism was also observed in the susceptibility to hypertension. In a study that 
involved the Japanese population, ACE I/D gene polymorphism was not found to be 
associated with hypertension (Ishigami et al., 1995). In addition, studies concerning 
Caucasian samples also failed to identify any significant association between ACE I/D 
gene polymorphism and hypertension (Staessen et al., 1997, Sagnella et al., 1999). On the 
other hand, several studies reported that within the black population, there was a positive 
relationship between ACE I/D gene polymorphism and hypertension (Barley et al., 1996, 
Sagnella et al., 1999). 
 
The reason for the existence of ethnic variation in the effects of these 
polymorphisms on physical performance and the susceptibility to certain diseases has 
remained unknown. The ethnic variation in the distributions of ACE I/D and ACTN3 R/X 
gene polymorphisms globally maybe partly responsible for these differences  as well 
(Zilberman-Schapira et al., 2012). Moreover, studies showed that I allele frequency of the 
ACE I/D gene polymorphism was more frequent in the healthy Australian Aboriginal 
population (Lester et al., 1999) and least in European (Tiret et al., 1992). In healthy 
Caucasian populations, the I allele frequency ranged between 0.78 and 0.23, whereas the 
D allele frequency varied between 0.77 and 0.22. However, in healthy Asian populations, 
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the I and the D allele frequencies ranged from 0.76 to 0.42 and 0.58 to 0.24, respectively. 
On top of that, a study by Jayapalan et al. (2008) among different ethnic groups in 
Malaysia also found a significant difference in the distribution of ACE I/D gene 
polymorphism between ethnic groups in Malaysia, with the I allele tending to be more 
frequent in the Malay group, while a higher frequency of D allele was observed for the 
Indian group. As for the ACTN3 R/X gene polymorphism, the highest R allele frequency 
was found in Nigerian (Yang et al., 2007) and the lowest in Indian populations (Kothari 
et al., 2011). In a healthy Caucasian population, the frequencies of R and X alleles ranged 
from 0.61 to 0.50 and 0.50 to 0.39, respectively. Meanwhile, the R and X alleles 
frequencies in the healthy Asian population ranged from 0.53 to 0.39 and 0.61 to 0.47, 
respectively.   
 
To date, the distribution patterns of ACE I/D and ACTN3 R/X gene polymorphisms 
in the Malaysian population have not been well documented. The distribution of ACE I/D 
gene polymorphism in Malaysia was reported in 2008 (Jayapalan et al., 2008). However, 
the data retrieved from this previous study (Jayapalan et al., 2008) still need to be 
validated. In contrast, there has been no report thus far for ACTN3 R/X gene polymorphism 
distribution in the Malaysian population. Besides, it had been necessary to obtain 
information concerning distributions of ACE I/D and ACTN3 R/X gene polymorphisms in 
the general population of Malaysia before establishing their effects on physical 
performance in this population. Since there was ethnic variation in the distributions of 
ACE I/D and ACTN3 R/X gene polymorphisms, it would also be interesting to compare 
the distribution patterns of ACE I/D and ACTN3 R/X gene polymorphisms in the 
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Malaysian population to other population for a comprehensive description concerning the 
ethnic variation on these polymorphisms. 
 
4.2 Aims 
 
The aims of the present study were to (i) establish the distribution patterns of ACE I/D and 
ACTN3 R/X gene polymorphisms in the multi-ethnic Malaysian population, and (ii) 
investigate ethnic variation on these polymorphisms by comparing the distribution of the 
data between Malaysian and Australian populations, as well as between four ethnic groups 
(Malay, Chinese, Indian, and Other Bumiputra) in Malaysia. The distributions of ACE I/D 
and ACTN3 R/X gene polymorphisms were hypothesized to vary between ethnic groups. 
 
4.3 Methods and Participants 
 
4.3.1 Study Design 
 
This population-based study utilized two research designs, which were simple and 
comparative descriptive research designs. Simple descriptive research was employed to 
obtain information relating to the distributions of ACE I/D and ACTN3 R/X gene 
polymorphisms in the Malaysian population. Meanwhile, the comparative descriptive 
research was used to compare the distributions of ACE I/D and ACTN3 R/X gene 
polymorphisms among the populations.  
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4.3.2 Participants 
 
The study group consisted of 180 Asians from Malaysia, and 180 Caucasians from 
Australia, who had provided informed consent to participate in this study. To limit 
variation due to genetic admixture, participants reported with mixed ancestry within three 
generations were excluded from this study. The number of participants for this study was 
based on the sample size calculation using the Power and Sample Size Calculation version 
3.1.2 software (Dupont and Plummer, 1990) [Calculated sample size in each group = 164 
participants; Research sample size = 164 participants + (164*10% (expected drop out)) = 
180 participants]. The power of the study was set at 0.80 with the alpha level of 0.05 and 
the effect size of 0.25. Participants consent and information details forms were presented 
in Appendix C. 
 
4.3.2.1 Malaysian population 
 
One hundred and eighty participants from the Malaysian population were sedentary 
healthy individuals (70 males, 110 females), who reported having a sedentary lifestyle 
(two or fewer days a week of recreational exercise for less than 30 minutes a day for the 
preceding three months (Pate et al., 2008)), aged 20.4 ± 1.6 years. They were drawn from 
four ethnic groups in Malaysia. In order to obtain comprehensive results for the 
distributions of ACE I/D and ACTN3 R/X gene polymorphisms in the Malaysian 
population, the proportion of participants with different ethnic backgrounds had been set 
according to the current distribution ratio in Malaysia (Statistic, 2011). Based on the 
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respective ratio, 99 Malays (55%), 45 Chinese (24.7%), 23 Other Bumiputras (12.9%), 
and 13 Indians (7.4%) were selected as participants for this study. All study participants 
were students from several universities in Malaysia. 
 
4.3.2.2 Australian population 
 
In addition, in comparison to the Malaysian population, 180 sedentary healthy individuals 
of Caucasian origin (62 males, 118 females), who reported having a sedentary lifestyle 
(two or fewer days a week of recreational exercise for less than 30 minutes a day for the 
preceding three months (Pate et al., 2008), aged 23.3 ± 3.6 years had been recruited from 
the Australian population. All the participants were students at the University of Sydney, 
Sydney, Australia. 
 
4.3.3 Deoxyribonucleic Acid (DNA) Sample Collection 
 
After obtaining personal information from the participants, deoxyribonucleic acid (DNA) 
samples from each participant were obtained via buccal swab using a sterile swab 
applicator (Classic Swabs by Copan Flock Technologies, Brescia, Italy). The swabs were 
air dried and placed in sterile 1.5 ml microcentrifuge tubes and stored at -20°C until used 
for DNA isolation. 
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4.3.4 Genotype Determination 
 
4.3.4.1 DNA Extraction 
 
Genomic DNA was isolated from the swab samples using the GeneAll® ExgeneTM Cell 
SV kit following the manufacturer’s protocol (GeneAll Biotechnology Co. Ltd, Seoul, 
South Korea). First, 400 µl of 1X phosphate buffered saline (PBS), 20 µl of Proteinase K 
(20 mg/ml), and 400 µl of blood lysis buffer were added into the tube with the swab. 
Immediately, the solutions were mixed with vigorous vortex. After that, the tube was 
incubated at 56˚C for 10 minutes and followed by a short spin to remove any drop from 
the inside of the lid. Thereafter, 400 µl of absolute ethanol was added to the lysates and 
was mixed well via vortex. The tube was subsequently centrifuged briefly and 700 µl of 
the mixture was carefully transferred to the SV column. The tube was then centrifuged for 
1 minute at 6000 x g above (> 8000 revolutions per minute (rpm)). After discarding the 
supernatant, the SV column was reinserted into the new collection tube. Afterwards, 600 
µl of column wash solution b buffer was added into the tube and was centrifuged for 1 
min at 6,000 x g above (> 8000 rpm). After replacing the collection tube with a new one, 
700 µl of column wash solution t buffer was added and the tube was centrifuged for 1 min 
at 6000 x g above (> 8000 rpm). Again, the pass-through was discarded and the SV column 
was reinserted into the collection tube. The tube was then centrifuged at full speed for 1 
minute to remove the residual wash buffer, and the SV column was then placed in a fresh 
1.5 ml Eppendorf tube. Lastly, 200 µl of elution buffer was added to the tube to increase 
the total DNA yield, and followed by an incubation process for 1 minute at room 
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temperature. The tube was centrifuged at full speed for 1 minute and was stored at -200C 
before applying it to molecular analysis. 
 
4.3.4.2 Molecular Analysis for ACE I/D Gene Polymorphism 
 
Polymerase chain reaction (PCR) was carried out in a final volume of 25 μl consisting of 
2.5 μl of 10X standard reaction buffer (GeneAll Biotechnology Co. Ltd., Seoul, South 
Korea) (25 mm Mg2+, 50 mm Tris-HCl, 50 mm KCl, 0.1 mm EDTA, 1 mm DTT, 0.5 mm 
PMSF, and 50% glycerol), 2.0 μl of dNTP mix (200 μm from each dNTP (dATP, dCTP, 
dGTP, and dTTP)), 0.8 μm of each primer (forward primer: 5’-
CTGGAGACCACTCCCATCCTTTCT-3’: reverse primer: 5’-
CTGGAGACCACTCCCATCCTTTCT-3’), 0.5 units of Taq DNA polymerase, 2.5 μl of  
dimethylsulfoxide, 10.8 μl of sterilize distilled water, and 5 μl of genomic DNA (2-8 
ng/μl). The target fragment bearing the ACE I/D gene polymorphism was amplified under 
the following conditions; 7 minutes at 95°C, followed by 25 cycles of 30 seconds at 95°C, 
30 seconds at 62°C, and 1 minute at 72°C, with a final step of 7 minutes at 72°C. The 
amplified products were electrophoresed on 1.5% agarose gel that was pre-stained with 
ethidium bromide at 70 volts for 1 hour. The presence of 490 base pair (bp) and 190 bp 
bands indicated the ACE insertion (I) and deletion (D) alleles, respectively. The PCR 
products for ACE I/D gene polymorphism were confirmed by sequencing (First BASE 
Laboratories Sdn Bhd, Selangor, Malaysia). 
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4.3.4.3 Molecular Analysis for ACTN3 R/X Gene Polymorphism 
 
PCR was carried out in a final volume of 25 μl consisting of 2.5 μl of 10X standard 
reaction buffer (GeneAll Biotechnology Co. Ltd., Seoul, South Korea) (25 mm Mg2+, 50 
mm Tris-HCl, 50 mm KCl, 0.1 mm EDTA, 1 mm DTT, 0.5 mm PMSF, and 50% glycerol), 
2.0 μl of dNTP mix (200 μm from each dNTP (dATP, dCTP, dGTP, and dTTP)), 0.2 μm 
of each primer (forward primer: 5’-CTGTTGCCTGTGGTAAGTGGG-3’: reverse 
primer: 5’-TGGTCACAGTATGCAGGAGGG-3’), 0.5 units of Taq DNA polymerase, 
2.5 μl of  dimethylsulfoxide, 12.3 μl of sterilize distilled water, and 5 μl of genomic DNA 
(2-8 ng/μl). The target fragment bearing the ACTN3 R/X gene polymorphism was 
amplified under the following conditions; 2 minutes at 95°C, followed by 26 cycles of 30 
seconds at 95°C, 30 seconds at 61.6°C, and 30 seconds at 72°C, with a final step of 5 
minutes at 72°C. The amplified products were electrophoresed on 1.5% agarose gel that 
was pre-stained with ethidium bromide at 70 volts for 1 hour. The presence of 291 bp 
band indicated the successful amplification of ACTN3 gene. The PCR product was then 
confirmed by DNA sequencing (First BASE Laboratories Sdn Bhd, Selangor, Malaysia). 
In order to obtain the genotype of the ACTN3 R/X gene polymorphism, the amplified PCR 
product was digested with DdeI restriction enzyme (New England Biolabs, Beverly, MA, 
USA) in a final volume of 10 μl consisting of 1.0 μl of 10X NEBuffer3 (New England 
Biolabs, Beverly, MA, USA), 1 U of DdeI restriction enzyme (New England Biolabs, 
Beverly, MA, USA), and 8.5 μl of amplified PCR product. The reaction mix was incubated 
at 37°C for 45 minutes and the digestion product was electrophoresed on 2.5% agarose 
gel that was pre-stained with ethidium bromide at 70 volts for 1 hour. The presence of 205 
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bp and 86 bp bands indicated R allele, while the presence of 108 bp, 97 bp, and 86 bp 
bands indicated X allele.  
 
4.4 Statistical Analysis 
 
The descriptive data are presented as mean ± standard deviation (SD). Allele frequencies 
of ACE I/D and ACTN3 R/X gene polymorphisms were determined by direct counting. 
The Hardy-Weinberg equilibrium (HWE) test was used for genotyping quality control to 
describe that the genotype distribution of a population is large, self-contained, and 
randomly mating (Xu et al., 2002). Simple HWE calculator (http://www.koonec.com/wp-
content/uploads/k-blog/HWE.xls.) was used to confirm that the observed ACE I/D and 
ACTN3 R/X genotype frequencies were in HWE for all groups ((i) Malaysian population 
(Malay, Chinese, Indian, and Other Bumiputra) and (ii) Australian population 
(Caucasian)). The chi-square (X2) test was used to examine the difference in allele and 
genotype frequencies of the ACE I/D and ACTN3 R/X gene polymorphisms between the 
ethnic groups ((i) Malay vs. Chinese vs. Indian vs. Other Bumiputra, and (ii) Malaysian 
vs. Australian). All statistical evaluations were performed by using the IBM SPSS 
statistical version 20.0 (Armonk, New York, USA), with the level of significance set at p 
< 0.050. 
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4.5 Results 
 
4.5.1 Hardy-Weinberg Equilibrium Test 
 
The distribution of ACE I/D and ACTN3 R/X genotypes for all groups had been in 
agreement with Hardy-Weinberg equilibrium (p > 0.05) (Appendix D).  
 
4.5.2 The Distribution of ACE I/D Gene Polymorphism 
 
4.5.2.1 Multi-Ethnic Groups in Malaysia 
 
The distribution of ACE I/D genotype in the multi-ethnic population in Malaysia is 
presented in Figure 4.1. The Malay group had ACE I/D genotype frequencies of 0.40, 
0.51, and 0.09, for II, ID, and DD genotypes respectively. Meanwhile, in the Chinese 
group, the frequencies of II, ID, and DD genotypes were 0.29, 0.49, and 0.22, respectively. 
The frequencies of II, ID, and DD genotypes for Indian and Other Bumiputra groups were 
0.08, 0.77, and 0.15, as well as 0.09, 0.65, and 0.26, respectively. The statistical analysis 
showed that there was a significant difference in the distribution of ACE I/D genotype 
polymorphism between the ethnic groups (X2 = 16.828, df = 6, p = 0.010). The Malay 
group differed significantly in ACE I/D genotype frequency when compared with the 
Other Bumiputra group (X2 = 10.594, df = 2, p = 0.005), but not to those in the Chinese 
(X2 = 5.174, df = 2, p = 0.075) and Indian (X2 = 5.319, df = 2, p = 0.070) groups. The 
Chinese group did not differ significantly in ACE I/D genotype frequency when compared 
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with the Indian (X2 = 3.542, df = 2, p = 0.170) and Other Bumiputra (X2 = 3.656, df = 2, 
p = 0.161) groups. In addition, the Indian group did not differ significantly in ACE I/D 
genotype frequency when compared with the Other Bumiputra group (X2 = 0.602, df = 2, 
p = 0.740). Among the four ethnic groups, the Malay and Other Bumiputra groups had the 
highest frequencies of II and DD genotypes, respectively. In contrast, the distribution of 
ACE I/D allele was not significantly different between Malay (I = 0.66; D = 0.34), Chinese 
(I = 0.53; D = 0.47), Indian (I = 0.46; D = 0.54), and Others Bumiputra (I = 0.41; D = 
0.59) groups (X2 = 6.882, df = 3, p = 0.076). 
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Figure 4.1 ACE I/D allele and genotype frequencies in the multi-ethnic groups in Malaysia 
 
Note.                              
 *p = 0.005 for genotype frequency in Malay group vs. Other Bumiputra group 
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ACE I/D Genotype ACE I/D Allele
Malay (n=99) 0.40 0.51 0.09 0.66 0.34
Chinese (n=45) 0.29 0.49 0.22 0.53 0.47
Indian (n=13) 0.08 0.77 0.15 0.46 0.54
Other Bumiputra (n=23) 0.09 0.65 0.26 0.41 0.59
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4.5.2.2 Malaysian and Australian Populations 
 
The distributions of ACE I/D genotype in Malaysian and Australian populations are 
presented in Figure 4.2. In the Malaysian population, the frequencies of II, ID, and DD 
genotypes were 0.31, 0.54, and 0.15, respectively. Meanwhile, the frequencies of II, ID, 
and DD genotypes in the Australian population were 0.25, 0.47, and 0.28, respectively. 
Moreover, the statistical analysis showed that there was a significant difference in the 
distributions of ACE I/D genotype between Malaysian and Australian populations (X2 = 
9.516, df = 2, p = 0.009) with the frequencies of the II and ID genotypes higher among 
Malaysians compared to Australians. However, the distribution of ACE I/D allele were 
not significantly different between Malaysian (I = 0.58; D = 0.42) and Australian (I = 
0.48; D = 0.52) populations (X2 = 3.611, df = 1, p = 0.057). 
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Figure 4.2 Frequencies of ACE I/D genotype in Malaysian and Australian populations 
 
Note. 
*p = 0.009 for genotype frequency in Malaysian population vs. Australian population
                     Malaysian population (n=180)               Australian population (n=180) 
  
0.31*
0.54*
0.15* 0.25
0.47
0.28
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4.5.3 The Distribution of ACTN R/X Gene Polymorphism 
 
4.5.3.1 Multi-Ethnic Groups in Malaysia 
 
The ACTN3 R/X allele and genotype distributions of four ethnic groups in Malaysia are 
presented in Figure 4.3. The Malay group had ACTN3 R/X genotype frequencies of 0.23, 
0.56, and 0.21, for RR, RX, and XX genotypes respectively. Meanwhile, in the Chinese 
group, the frequencies of RR, RX, and XX genotypes were 0.29, 0.49, and 0.22, 
respectively. The frequencies of RR, RX, and XX genotypes for Indian and Other 
Bumiputra groups were 0.00, 0.69, and 0.31, as well as 0.17, 0.70, and 0.13, respectively. 
The statistical analysis, however, showed insignificant difference between the ethnic 
groups with regard to ACTN3 R/X genotype frequency (X2 = 6.926, df = 6, p = 0.328). The 
distribution of ACTN3 R/X allele was also not significantly different between Malay (R = 
0.51; X = 0.49), Chinese (R = 0.53; X = 0.47), Indian (R = 0.35; X = 0.65), and Other 
Bumiputra (R = 0.52; X = 0.48) groups (X2 = 0.9383, df = 3, p = 0.816). 
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Figure 4.3 ACTN3 R/X allele and genotype frequencies in the multi-ethnic groups in Malaysia 
 
RR RX XX R X
ACTN3 R/X Genotype ACTN3 R/X Allele
Malay (n=99) 0.23 0.56 0.21 0.51 0.49
Chinese (n=45) 0.29 0.49 0.22 0.53 0.47
Indian (n=13) 0.00 0.69 0.31 0.35 0.65
Other Bumiputra (n=23) 0.17 0.70 0.13 0.52 0.48
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4.5.3.2 Malaysian and Australian Populations 
 
The distributions of ACTN3 R/X genotype in Malaysian and Australian populations are 
shown in Figure 4.4. In the Malaysian population, the frequencies of RR, RX, and XX 
genotypes were 0.22, 0.57, and 0.21, respectively. Meanwhile, the frequencies of RR, RX, 
and XX genotypes in the Australian population were 0.24, 0.57, and 0.19, respectively. 
Nevertheless, there was no significant difference in ACTN3 R/X genotype frequencies 
between Malaysian and Australian populations (X2 = 0.413, df = 2, p = 0.814). In the 
Malaysian population, the frequencies of R and X alleles were 0.51 and 0.49, respectively. 
Meanwhile, the frequencies of R and X alleles in the Australian population were 0.53 and 
0.47, respectively. The statistical analysis also showed that the difference in ACTN3 R/X 
allele frequency was insignificant between these two populations (X2 = 0.1002, df = 1, p 
= 0.752). 
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Figure 4.4 ACTN3 R/X genotype frequencies in Malaysian and Australian populations 
                   Malaysian population (n=180)         Australian population (n=180) 
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4.6 Discussion 
 
This population-based study established the distribution patterns of ACE I/D and ACTN3 
R/X gene polymorphisms in the Malaysian population. In order to determine the exact 
distributions of ACE I/D and ACTN3 R/X gene polymorphisms in the various populations 
in Malaysia, the number of participants with different ethnic groups was based on the 
current distribution ratio of ethnicity in Malaysia (Statistic, 2011), and included Other 
Bumiputra group, which had not been previously studied. This study was also designed to 
investigate ethnic variation in the distributions of ACE I/D and ACTN3 R/X gene 
polymorphisms by comparing the data from two different populations (Malaysians and 
Australians), and also between four ethnic groups in Malaysia. 
 
The main finding of this study was that the distribution of ACE I/D gene 
polymorphism varied by ethnicity, as defined by a significant difference in the distribution 
of this polymorphism between Malaysian and Australian populations, as well as among 
the four ethnic groups in Malaysia. In contrast, the present study found that distribution 
of ACTN3 R/X gene polymorphism did not vary as much by ethnicity as no significant 
difference was observed in the distribution of this polymorphism among the ethnic groups.  
 
As expected, a significant ethnic difference was observed in the distribution of the 
ACE I/D gene polymorphism between Malaysian and Australian populations. The results 
demonstrated that the DD genotype was significantly more frequent in the Australian 
population (0.28) than in the Malaysian population (0.15). The frequency of the DD 
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genotype in the Australian group was similar to a previous report for the Australian 
population (Lester et al., 1999, Lea et al., 2005). Meanwhile, the lower frequency of the 
DD genotype observed in the Malaysian population had been consistent with the findings 
obtained from previous studies conducted among other Asian populations (Saha et al., 
1996, Huang et al., 2004, Movva et al., 2007).  
 
The frequencies of ACE II, ID, and DD genotypes in Malaysian population were 
0.31, 0.54 and 0.15, respectively. The results differed slightly from the previous report for 
the Malaysian population (Jayapalan et al., 2008). In the previous study, the ACE  I/D 
genotype frequencies for the Malaysian population were 0.43, 0.43, and 0.14 for II, ID, 
and DD genotypes, respectively (Jayapalan et al., 2008). The reason for this inconsistent 
finding may be due to the different sample sizes involved in the study. The sample size 
for each ethnic group in the present study was based on the current distribution of these 
groups in Malaysia (Statistic, 2011), which had not been controlled for in the previous 
study (Jayapalan et al., 2008), thereby providing a more representative distribution of the 
ACE I/D gene polymorphism in the Malaysian population. 
 
Within the Malaysian population, there was also a difference in the distribution of 
the ACE I/D gene polymorphism. Both Malay and Chinese groups showed to have higher 
frequency of I allele over the D allele, whereas the D allele appeared to be more prevalent 
than I allele in Indian and Other Bumiputra groups. The present result differed from the 
previous Malaysian study carried out by Jayapalan et al. (2008) in terms of allele and 
genotype frequencies though the similar trend of ethnic variation was observed. I allele 
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frequency was higher in the Malay group (0.66), followed by the Chinese (0.53), Indian 
(0.46), and the lowest in the Other Bumiputra group (0.41). The distribution pattern of 
ACE I/D gene polymorphism for the Malay group in the present study was remarkably 
similar with those in Japanese (Matsubara et al., 2002) and Taiwanese (Chuang et al., 
1997) populations. The similar pattern between the Malay group and these populations 
matched with the Taiwan model, which hypothesised that the Malay group in the 
Malaysian population originated from the Austronesian group from Taiwan that have been 
thought to have migrated to the Malaysia Peninsular roughly 3,000 years ago (Comas et 
al., 1998). On the other hand, the distribution patterns of ACE I/D gene polymorphism for 
Chinese and Indian groups were slightly similar with the previous reports from 
populations in China (Saha et al., 1996) and India (Movva et al., 2007), respectively. This 
is of no surprise as Chinese in Malaysia mostly originated from Southern China while the 
Indians in Malaysia were mostly immigrants from Southern India (Gan et al., 2013). 
Nevertheless, there has been no any report on the frequency of ACE I/D gene 
polymorphism in the Other Bumiputra group, hence, this study had provided the first data 
set of this ethnic group. The frequency of the I allele in the Other Bumiputra group seemed 
to be among the lowest reported for Asian population, and was similar to that in Caucasian 
population (Ferrieres et al., 1999, Cam et al., 2005).  
 
Apart from that, Batzer et al. (1994) suggested that the ACE I/D gene 
polymorphism is of African origin and the current ethnic variation on this polymorphism 
was due to the migration of modern humans out of Africa. During the migration of human, 
the frequencies of ACE I/D allele and genotype changed due to evolutionary factors, such 
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as natural selection and gene flow (Batzer et al., 1994). The ACE I/D gene polymorphism 
was used as markers in numerous population structure analyses as it has been considered 
to be a highly stable polymorphism, where there is no mechanism for deletion of this 
newly inserted element (Stoneking et al., 1997). The D allele is known as the ancestral 
form of this polymorphism, while the I allele is the most recent version of this 
polymorphism (Stoneking et al., 1997). The higher frequency of the D allele in a certain 
ethnic group is, therefore, indicative of the ancestral ethnic origin for this polymorphism 
(Stoneking et al., 1997). The frequencies of D allele observed in the Malaysian (0.42) and 
Australian (0.52) populations in the present study was relatively lower compared to 
previously reported of the black population (0.73) by Batzer et al. (1994), which appear 
to be consistent with this theory. Therefore, the finding of the present study supported the 
theory that the ACE I/D gene polymorphism is of African origin and the current ethnic 
variation on this polymorphism was due to the migration of modern humans out of Africa. 
 
With regard to the present data obtained for ACE I/D gene polymorphism, 
ethnicity factor plays a significant role for the distribution of ACE I/D gene polymorphism, 
as previously suggested by Barley et al. (1994). These data indicate that the effect of ACE 
I/D gene polymorphism on human physical performance, as previously reported for the 
Caucasian population could be different in the Malaysian population.  
 
In addition, with regard to ACTN3 R/X gene polymorphism, this is the first study 
reporting its distribution in the Malaysian population. The distributions of ACTN3 RR, RX, 
and XX genotypes were 0.22, 0.57, and 0.21, respectively. Meanwhile, the allele 
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distributions were 0.51 and 0.49 respectively, for R and X alleles. The allele frequency of 
R allele in the Malaysian population was closely similar to those reported for Indian  
population (Goel and Mittal, 2007). Moreover, demarcation data analysis of the Malaysian 
population based on ethnicity showed that the frequency of R allele in the Malay was 0.51, 
which was comparable with the findings obtained from Indian  population (Goel and 
Mittal, 2007). The similar pattern between Malay group and Indian population had been 
concurrent with the finding retrieved from Comas et al. (1998), who reported that the 
Malay group in Malaysia are descendants of the Proto-Malays, who had admixed with 
Siamese, Javanese, Sumatran, Indian, Thai, Arab, and Chinese traders. On the other hand, 
the present results obtained for the Chinese and the Other Bumiputra groups were 
markedly similar to the previous report for the Asian population (Clarkson et al., 2005a). 
Meanwhile, the findings for the Indian group matched with the report by Kothari et al. 
(2011) for the Indian population.  
 
When the data for the Malaysian population were compared to the Australian 
population, insignificant difference was observed for the genotype and the allele distri-
butions of ACTN3 R/X gene polymorphism between these two populations. These findings 
are consistent with a previous study carried out by Goel and Mittal (2007), who 
demonstrated that the frequencies of both alleles and genotypes of ACTN3 R/X gene 
polymorphism in the Asian population had been similar to those of the Caucasian 
population. Within the Malaysian population, the statistical analysis also indicated 
insignificant difference in the distribution of this polymorphism between the four ethnic 
groups in Malaysia. A similar distribution between the Malaysian and the Australian 
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populations, as well as between the four ethnic groups in Malaysia, indicated that these 
studied populations may share similar positive selection of ACTN3 R/X gene 
polymorphism, as opposed in the previous study (MacArthur et al., 2007). In fact, it had 
been revealed that the effect of ACTN3 R/X gene polymorphism on human physical 
performance previously reported for the Caucasian population may also appear in the 
Malaysian population. 
 
Despite the positive findings in the present study, the small sample size in certain 
ethnic groups is of particular relevance for genetic studies that often require sample size 
may have caused some of the analyses for ACTN3 R/X gene polymorphism to lose 
statistical power. Future studies with larger sample size may render more significant 
results.  
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4.7 Conclusion 
 
In conclusion, this study demonstrated that the distribution of ACE I/D gene 
polymorphism varies by ethnicity, as defined by a significant difference in the distribution 
of this polymorphism between Malaysian and Australian populations, as well as between 
Malay and Other Bumiputra ethnic groups in Malaysia. Conversely, the distribution of 
ACTN3 R/X gene polymorphism did not vary by ethnicity. This study suggests that the 
effect of ACE I/D gene polymorphism on human physical performance may also differ by 
ethnicity, whilst the effects of ACTN3 R/X gene polymorphism on human physical 
performance may be similar across different human populations. The data from this study 
should, therefore, serve as a basis for the assessment of the effects of ACE I/D and ACTN3 
R/X gene polymorphisms on human physical performance in the Malaysian population. 
Therefore, further study is warranted for the assessment of the effects ACE I/D and ACTN3 
R/X gene polymorphisms on human physical performance within the Malaysian 
population.  
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CHAPTER 5 
 
THE EFFECTS OF ACE I/D AND ACTN3 R/X GENE POLYMORPHISMS ON 
HUMAN PHYSICAL PERFORMANCE IN THE MULTI-ETHNIC MALAYSIAN 
POPULATION 
 
5.1 Introduction 
 
Human physical performance is a complex human trait influenced by both environmental 
and genetic factors (Yu and Trent, 2010). Compelling evidence from twin studies reveals 
that genetic factors are more influential than environmental factors in determining human 
physical performance (Chatterjee and Das, 1995, Calvo et al., 2002, Maridaki, 2006, 
Alonso et al., 2014). Over the past several decades, several genetic variants have been 
identified to be related to human physical performance (Rankinen et al., 2001, Rankinen 
et al., 2002, Rankinen et al., 2004, Wolfarth et al., 2005, Rankinen et al., 2006, Bray et 
al., 2009, Loos et al., 2015) and among these, two genetic variants that have been most 
widely studied for human physical performance are angiotensin I-converting enzyme 
(ACE) I/D and alpha-actinin-3 (ACTN3) R/X gene polymorphisms (Ma et al., 2013).  
 
ACE I/D gene polymorphism is responsible for the level of circulating and tissue 
ACE protein (Rigat et al., 1990), which is the main component of the renin-angiotensin 
system (RAS) (Sayed-Tabatabaei et al., 2006). ACE protein converts angiotensin I (ANG 
I) to angiotensin II (ANG II), which is a potent vasoconstrictor, and degrade bradykinin, 
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which is a potent vasodilator (Coates, 2003). I allele of the ACE I/D gene polymorphism 
produces less ACE protein compared to the D allele of this polymorphism (Rigat et al., 
1990). The lower production of ACE protein decreases the conversion of ANG I to ANG 
II resulting in increased vasodilation and an increased delivery of oxygenated blood to the 
working muscles (Jones and Woods, 2003, Sayed-Tabatabaei et al., 2006). On the 
contrary, greater production of ACE protein increases the production of ANG II, which 
also acts as a muscle growth factor, resulting in increased muscle strength (Jones and 
Woods, 2003, Sayed-Tabatabaei et al., 2006). Given these different physiological 
characteristics, possession of the ACE I and D alleles may confer advantages for 
endurance and strength/power events, respectively. 
 
ACTN3 R/X gene polymorphism codes for ACTN3 protein (North et al., 1999) 
which is one of the components of the Z disk of fast-twitch skeletal muscle fibre (Mills et 
al., 2001). While R allele of ACTN3 R/X gene polymorphism produces ACTN3 protein, X 
allele prevents the production of ACTN3 protein (North et al., 1999). The presence of 
ACTN3 protein gives static and stable function in maintaining the ordered myofibrillar 
array with greater coordination to aid  generation of high muscle power and velocity 
during movements (Mills et al., 2001). Meanwhile, the lack of ACTN3 protein has 
resulted in alterations of skeletal muscle metabolism, explicit to aerobic metabolism 
(MacArthur et al., 2007). On the basis of the physiological function, possession of the 
ACTN3 R and X alleles may grant beneficial effects for strength/power and endurance 
activities, respectively. 
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The effects of possession of the ACE  I and ACTN3 X alleles on endurance 
performance have been investigated in several case-control studies, with both alleles 
observed to be more prevalent among endurance-oriented athletes compared to other 
athletes or controls (Myerson et al., 1999, Nazarov et al., 2001, Tsianos et al., 2004b, 
Mayne, 2006, Ahmetov et al., 2008b, Min et al., 2009, Eynon et al., 2009b, Shang et al., 
2010). In accordance with the findings from case-control studies, reports of several cross-
sectional studies demonstrated that individuals with ACE I and ACTN3 X alleles exhibited 
higher endurance performance-related phenotype scores than those with ACE D and 
ACTN3 R alleles (Hagberg et al., 2002, Zhang et al., 2003, Heled, 2004, Lucia et al., 2007, 
Voroshin and Astratenkova, 2008, Goh et al., 2009, Ahmetov et al., 2011).  
 
With regard to the effect of possession of the ACE D and ACTN3 R alleles on 
strength/power performance, several case-control studies reported that these two alleles 
are more frequently found in strength/power-oriented athletes compared to other athletes 
or controls (Nazarov et al., 2001, Yang et al., 2003, Niemi and Majamaa, 2005, Mayne, 
2006, Costa et al., 2009b, Eynon et al., 2009b, Kothari et al., 2011, Kikuchi et al., 2012). 
Additionally, several cross-sectional studies showed that carriers of the ACE D and 
ACTN3 R alleles present greater levels of strength/power performance-related phenotype 
than ACE I and ACTN3 X alleles carriers (Clarkson et al., 2005a, Williams et al., 2005, 
Moran et al., 2006b, Vincent et al., 2007, Charbonneau, 2007, Giaccaglia et al., 2008, 
Ichinoseki-Sekine et al., 2010, Shang et al., 2012, Ahmetov et al., 2013, Erskine et al., 
2014).  
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The effects of ACE I/D and ACTN3 R/X gene polymorphisms on human physical 
performance, however, remain ambiguous as some studies failed to replicate the results 
of others (Hagberg et al., 1999, Zhaoa et al., 2003, Kasikcioglu et al., 2004, Clarkson et 
al., 2005a, Cam et al., 2007, Tobina et al., 2010, Ichinoseki-Sekine et al., 2010). For 
instance, studies involving Caucasian athletes revealed that individuals with ACE II 
genotype had higher maximal oxygen consumption (VO2max) than other genotype 
carriers (Hagberg et al., 1999, Kasikcioglu et al., 2004). On the other hand, a study by 
Zhaoa et al. (2003) among an Asian population found that VO2max value was higher in 
ACE DD genotype carriers compared to those with other ACE I/D genotypes. 
Furthermore, Cam et al. (2007) demonstrated that Caucasian athletes with ACE II 
genotype presented better endurance performance than other genotype carriers while in a 
study involving Japanese runners, the endurance performance was significantly higher in 
those with ACE DD genotype (Tobina et al., 2010). In a study among an Asian population, 
individuals with ACTN3 R allele exhibited a greater strength/power performance 
following resistance training than those with ACTN3 X allele (Ichinoseki-Sekine et al., 
2010). Nevertheless, a study by Clarkson et al. (2005a) among Caucasian samples 
reported that individuals with ACTN3 X allele scored higher in strength/power 
performance following resistance training when compared to ACTN3 R allele carriers. 
These findings demonstrate that the influences of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance remain controversial and more 
importantly, suggest the potential ethnic variation in the effects of these polymorphisms 
on human physical performance. 
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The effects of ACE I/D and ACTN3 R/X gene polymorphisms on human physical 
performance across different ethnic groups have yet to be largely examined. To date, the 
study by Ma et al. (2013) reported insufficient data among Asian populations. The 
findings from the first study of this research project showed that the distribution of ACE 
I/D gene polymorphism varied between the Malaysian and Australian populations. 
Therefore, there is a possibility that the effect of ACE I/D gene polymorphism on human 
physical performance in the Malaysian population would be different from Caucasian 
population. On the other hand, in the first study, the distribution of ACTN3 R/X gene 
polymorphism was similar between Malaysian and Australian populations, which indicate 
that the ACTN3 R/X gene polymorphism may confer similar effects on human physical 
performance between these two populations. 
 
5.2 Aims 
 
This study was designed to examine the effects of ACE I/D and ACTN3 R/X gene 
polymorphisms on athletic status and human physical performance in the Malaysian 
population. This study also determined if the effects of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance differ by ethnicity. Possession of the I 
allele of ACE I/D and X allele of ACTN3 R/X gene polymorphisms were hypothesized to 
affect endurance performance. Meanwhile, possession of the D allele of ACE I/D and R 
allele of ACTN3 R/X gene polymorphisms were hypothesized to affect strength/power 
performance. It was also hypothesized that the effects of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance will differ between ethnic groups. 
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5.3 Methods and Participants 
 
5.3.1 Study Design 
 
This study employed two different approaches to demonstrate the relevance of ACE I/D 
and ACTN3 R/X gene polymorphisms on human physical performance. One of the 
approaches was through case-control study in which the allele and genotype frequencies 
of ACE I/D and ACTN3 R/X gene polymorphisms were compared between: (i) the whole 
cohort of athletes and controls in the Malaysian population, (ii) multi-ethnic groups of 
athletes and controls in the Malaysian population, (iii) endurance athletes, strength/power 
athletes, intermittent athletes, and controls in the Malaysian population, and (iv) Malay 
intermittent athletes and Australian intermittent athletes. The second approach was 
through cross-sectional study, in which endurance and strength/power performances were 
compared to different genotype groups of Malaysian athletes. The study protocols on 
Malaysian and Australian samples were approved by the Human Research Ethics 
Committee in Universiti Sains Malaysia (Appendix A) and the Human Research Ethics 
Committee in University of Sydney, respectively (Appendix B). 
 
5.3.2 Participants 
 
The participants were drawn from two different populations; a population of Asian 
(n=360) and Caucasian (n=33) living in Malaysia and Australia, respectively. Participants 
who reported having mixed ancestry within three generations were excluded from this 
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study. The number of participants for this study was based on the sample size calculation 
using Power and Sample Size Calculation version 3.1.2 software (Dupont and Plummer, 
1990). The power of the study was set at 0.80 with 95% of confidence interval and the 
effect size of 0.25. Participants consent and information details forms were presented in 
Appendix C. 
 
5.3.2.1 Malaysian Population 
 
The study participants for Malaysian population comprised of 180 university athletes (148 
male, 32 female) aged 20.5 ± 1.9 (mean ± SD) years and 180 sedentary healthy individuals 
(70 male, 110 female) aged 20.4 ± 1.6 years. All participants were students from several 
universities in Malaysia. The proportion of participants with different ethnic backgrounds 
had been set according to the current distribution ratio in Malaysia (Statistic, 2011). Based 
on the respective ratio and to ensure there was no ethnicity skew and to overcome any 
potential problems of population stratification, both athletes and control groups have same 
number of samples for each ethnic group with 99 Malays (55%), 45 Chinese (24.7%), 23 
Other Bumiputras (12.9%), and 13 Indians (7.4%) in each group. All sedentary individuals 
reported of having sedentary lifestyle (two or fewer days a week of recreational exercise 
for less than 30 minutes a day for the preceding three months (Pate et al., 2008)). The 
athletes were trained for at least one year and represent the university in national sporting 
competition. Within the cohort of athletes, 34 participants (25 male, 9 female) aged 19.8 
± 1.9 years were classified as endurance athletes, 41 participants (25 male, 16 female) 
aged 19.7 ± 1.8 years as strength/power athletes, and 105 participants (99 male, 6 female) 
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aged 21.0 ± 1.8 years as intermittent athletes according to the type of exercise metabolism 
that predominates in the discipline they practice, time of competitive exercise performance 
and intensity of exertion in each sport using the classification described by Maciejewska-
Karlowska et al. (2013) (Appendix E). Thirty three Malay intermittent athletes (all males) 
aged 20.8 ± 1.7 years in the intermittent group were randomly selected for well-matched 
comparison-group study to Australian population.  
 
5.3.2.2 Australian Population 
 
In addition, 33 intermittent athletes (all males) aged 20.7 ± 4.0 years, who were of 
Caucasian origin and trained for at least one year and represent the university in national 
sporting competition, had been recruited from the Australian population. All the 
participants in the Australian population were students at the University of Sydney, 
Sydney, Australia.  
 
5.3.3 Anthropometric Measurements  
 
Anthropometric measurements were collected from participants in the Malaysian 
population. Participant’s body height was measured using a portable stadiometer (Seca 
213, Seca Corporation, USA). Meanwhile, participant’s body weight, body mass index, 
and body fat, were measured using an Omron KARADA Scan Body Composition & Scale 
(HBF-362, Omron Corporation, Japan).  
 
114 
 
5.3.4 Deoxyribonucleic Acid (DNA) Sample Collection  
 
Deoxyribonucleic acid (DNA) sample from each participant was obtained via buccal swab 
using a sterile swab applicator (Classic Swabs by Copan Flock Technologies, Brescia, 
Italy). The swabs were air dried and placed in sterile 1.5 ml microcentrifuge tubes and 
stored at -20°C until used for DNA isolation. 
 
5.3.5 Genotype Determination 
 
5.3.5.1 DNA Extraction 
 
Genomic DNA was isolated from the swab samples using the GeneAll® ExgeneTM Cell 
SV kit following the manufacturer’s protocol (GeneAll Biotechnology Co. Ltd., Seoul, 
South Korea). First, 400 µl of 1X phosphate buffered saline (PBS), 20 µl of Proteinase K 
(20 mg/ml), and 400 µl of blood lysis buffer were added into the tube with the swab. 
Immediately, the solutions were mixed with vigorous vortex. After that, the tube was 
incubated at 56˚C for 10 minutes and followed by a short spin to remove any drop from 
the inside of the lid. Thereafter, 400 µl of absolute ethanol was added to the lysates and 
was mixed well via vortex. The tube was subsequently centrifuged briefly and 700 µl of 
the mixture was carefully transferred to the SV column. The tube was then centrifuged for 
1 minute at 6000 x g above (> 8000 revolutions per minute (rpm)). After discarding the 
supernatant, the SV column was reinserted into the new collection tube. Afterwards, 600 
µl of column wash solution b buffer was added into the tube and was centrifuged for 1 
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min at 6,000 x g above (> 8000 rpm). After replacing the collection tube with a new one, 
700 µl of column wash solution t buffer was added and the tube was centrifuged for 1 min 
at 6000 x g above (> 8000 rpm). Again, the pass-through was discarded and the SV column 
was reinserted into the collection tube. The tube was then centrifuged at full speed for 1 
minute to remove the residual wash buffer, and the SV column was then placed in a fresh 
1.5 ml Eppendorf tube. Lastly, 200 µl of elution buffer was added to the tube to increase 
the total DNA yield, and followed by an incubation process for 1 minute at room 
temperature. The tube was centrifuged at full speed for 1 minute and was stored at -200C 
before applying it to molecular analysis. 
 
5.3.5.2 Molecular Analysis for ACE I/D Gene Polymorphism 
 
Polymerase chain reaction (PCR) was carried out in a final volume of 25 μl consisting of 
2.5 μl of 10X standard reaction buffer (GeneAll Biotechnology Co. Ltd., Seoul, South 
Korea) (25 mm Mg2+, 50 mm Tris-HCl, 50 mm KCl, 0.1 mm EDTA, 1 mm DTT, 0.5 mm 
PMSF, and 50% glycerol), 2.0 μl of dNTP mix (200 μm from each dNTP (dATP, dCTP, 
dGTP, and dTTP)), 0.8 μm of each primer (forward primer: 5’-
CTGGAGACCACTCCCATCCTTTCT-3’: reverse primer: 5’-
CTGGAGACCACTCCCATCCTTTCT-3’), 0.5 units of Taq DNA polymerase, 2.5 μl of  
dimethylsulfoxide, 10.8 μl of sterilize distilled water, and 5 μl of genomic DNA (2-8 
ng/μl). The target fragment bearing the ACE I/D gene polymorphism was amplified under 
the following conditions; 7 minutes at 95°C, followed by 25 cycles of 30 seconds at 95°C, 
30 seconds at 62°C, and 1 minute at 72°C, with a final step of 7 minutes at 72°C. The 
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amplified products were electrophoresed on 1.5% agarose gel that was pre-stained with 
ethidium bromide at 70 volts for 1 hour. The presence of 490 base pair (bp) and 190 bp 
bands indicated the ACE insertion (I) and deletion (D) alleles, respectively. The PCR 
products for ACE I/D gene polymorphism were confirmed by sequencing (First BASE 
Laboratories Sdn Bhd, Selangor, Malaysia). 
 
5.3.5.3 Molecular Analysis for ACTN3 R/X Gene Polymorphism 
 
PCR was carried out in a final volume of 25 μl consisting of 2.5 μl of 10X standard 
reaction buffer (GeneAll Biotechnology Co. Ltd., Seoul, South Korea) (25 mm Mg2+, 50 
mm Tris-HCl, 50 mm KCl, 0.1 mm EDTA, 1 mm DTT, 0.5 mm PMSF, and 50% glycerol), 
2.0 μl of dNTP mix (200 μm from each dNTP (dATP, dCTP, dGTP, and dTTP)), 0.2 μm 
of each primer (forward primer: 5’-CTGTTGCCTGTGGTAAGTGGG-3’: reverse 
primer: 5’-TGGTCACAGTATGCAGGAGGG-3’), 0.5 units of Taq DNA polymerase, 
2.5 μl of  dimethylsulfoxide, 12.3 μl of sterilize distilled water, and 5 μl of genomic DNA 
(2-8 ng/μl). The target fragment bearing the ACTN3 R/X gene polymorphism was 
amplified under the following conditions; 2 minutes at 95°C, followed by 26 cycles of 30 
seconds at 95°C, 30 seconds at 61.6°C, and 30 seconds at 72°C, with a final step of 5 
minutes at 72°C. The amplified products were electrophoresed on 1.5% agarose gel that 
was pre-stained with ethidium bromide at 70 volts for 1 hour. The presence of 291 bp 
band indicated the successful amplification of ACTN3 gene. The PCR product was then 
confirmed by DNA sequencing (First BASE Laboratories Sdn Bhd, Selangor, Malaysia). 
In order to obtain the genotype of the ACTN3 R/X gene polymorphism, the amplified PCR 
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product was digested with DdeI restriction enzyme (New England Biolabs, Beverly, MA, 
USA) in a final volume of 10 μl consisting of 1.0 μl of 10X NEBuffer3 (New England 
Biolabs, Beverly, MA, USA), 1 U of of DdeI restriction enzyme (New England Biolabs, 
Beverly, MA, USA), and 8.5 μl of amplified PCR product. The reaction mix was incubated 
at 37°C for 45 minutes and the digestion product was electrophoresed on 2.5% agarose 
gel that was pre-stained with ethidium bromide at 70 volts for 1 hour. The presence of 205 
bp and 86 bp bands is an indication for R allele while the presence of 108 bp, 97 bp, and 
86 bp bands is an indication for X allele.  
 
5.3.6 Physical Tests 
 
Subsequent to DNA sampling, three physical tests (Yo-Yo intermittent recovery level 2, 
handgrip and leg strength tests) were administered to the Malaysian varsity athletes in 
order to determine their endurance and strength/power performances. The selection of the 
type of physical test used in this study was governed by the reason that the selected 
physical tests were valid and reliable for testing endurance and strength/power 
performances of the athletes. In addition, a study by Karakoc et al. (2012) found that Yo-
Yo intermittent recovery level 2 is more suitable for testing endurance performances of 
the athletes over the other tests such as Yo-Yo endurance test (continuous) (YET). 
Meanwhile, the handgrip and leg strength tests are often used in physical fitness measures 
because of its ease of administration (Coldwells et al., 1994, Amaral et al., 2012). The 
validity and reliability of the each of the physical tests mentioned above have been 
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previously reviewed (handgrip strength (Anumula et al., 2014), leg strength (Coldwells et 
al., 1994), and Yo-Yo intermittent recovery level 2 (Krustrup et al., 2003) tests).  
 
5.3.6.1 Yo-Yo Intermittent Recovery Level 2 Test 
 
Before the test began, participants were fitted with a Polar transmitter belt (T61, Polar 
Electro Oy, Finland) onto their chest. In this test, the athletes started out shuttling from 
one end of the marked course to the other at a relatively slow pace and then quickly ramped 
up their speed according to the pace set by the recorded beeps. In each bout of intense 
running, they performed 10 seconds of active recovery and then returned to the start/finish 
line to await the cue for the next stage. Athletes were verbally encouraged during the test. 
A warning was given when they did not complete a successful out and back shuttle within 
the allocated time. Their maximum heart rate achieved immediately after running was 
recorded. The last speed level and number of shuttles reached before they received a 
second warning or voluntarily withdrew from the test was recorded as the score for the 
test. The endurance capacity of the athlete was computed by converting the score to the 
total distance covered using standard norm for Yo-Yo intermittent recovery level 2 test. 
In addition, to ensure that the athletes had given their maximum efforts during test, their 
heart rate achieved after running must be within 10 beats per minute (bpm) of their age-
predicted maximum heart rate (Krustrup et al., 2003) (Athlete that did not achieve age-
predicted maximum heart rate were excluded from the study). The procedure of the Yo-
Yo intermittent recovery level 2 was consistent to the earlier method published by 
Bangsbo et al. (2008).  
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5.3.6.2 Handgrip Strength Test 
 
The handgrip test was performed on a hand dynamometer (Takei A5401, Takei Scientific 
Instruments Co. Ltd., Japan) to determine an athlete’s isometric handgrip strength. A 
standard procedure of measuring handgrip strength (kg) using a hand 
dynamometer followed the procedure described by Tomchuk (2011). The dynamometer 
was calibrated according to manufacturer’s instruction, by hanging calibration weights 
across the handle of the dynamometer that fixed on a wooden support. The athletes held 
the dynamometer in the dominant hand (self-reported by the athletes), with the arm at 
right angles and the elbow by the side of the body. The handle of the dynamometer was 
adjusted if required. Prior to the start of the test, the dial on the dynamometer was reset to 
zero. When ready, the athletes squeezed the dynamometer with maximum isometric effort, 
which was maintained for about 5 seconds. Athletes were verbally encouraged during the 
test. The athlete performed the test three times with 10 to 20 seconds rest interval, and the 
average score was used for data analysis.  
 
5.3.6.3 Leg Strength Test 
 
Isometric leg strength (kg) was measured using a back and leg dynamometer (Takei 
A5402, Takei Scientific Instruments Co. Ltd., Japan). The procedure for this test 
followed the procedure described by Ashok (2008). The dynamometer was calibrated 
according to manufacturer’s instruction by using calibration weights. Prior to the start of 
the test, the dial on the dynamometer was reset to zero. The athletes stood upright with 
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both feet on the base of the dynamometer. The chain length was adjusted until the athlete’s 
knees were bent around 110 degrees. In this position, the athletes pulled the handle bar as 
hard as possible for 5 seconds, with the athletes were verbally encouraged during the test. 
The maximum reading indicated on the dynamometer was recorded. Each athlete 
performed the test three times with a pause of about 10 to 20 seconds between each trial 
and the average score was analysed for isometric leg strength.  
 
5.4 Statistical Analysis 
 
The descriptive data are presented as mean ± standard deviation (SD). The independent t-
test was used to compare the means of two independent samples. Allele frequencies of 
ACE I/D and ACTN3 R/X gene polymorphisms were determined by direct counting. The 
Hardy-Weinberg equilibrium (HWE) test was used for genotyping quality control to 
describe that the genotype distribution of a population is large, self-contained, and 
randomly mating (Xu et al., 2002). As HWE may be violated in athletes without being 
caused by genotyping errors (Wittke-Thompson et al., 2005, Attia et al., 2009), the HWE 
test was tested for the control group in the Malaysian population. Simple HWE calculator 
(http://www.koonec.com/wp-content/uploads/k-blog/HWE.xls.) was used to confirm that 
the observed ACE I/D and ACTN3 R/X genotype frequencies were in HWE. The 
multivariate analysis was used to examine the association between ethnicity and studied 
polymorphisms factors on performance measured in this study (the Yo-Yo intermittent 
recovery level 2 performance, handgrip and leg strength). The chi-square (X2) test was 
used to examine the difference in the ACE I/D and ACTN3 R/X allele and genotype 
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frequencies between the groups: (i) the whole cohort of athletes and controls in the 
Malaysian population, (ii) multi-ethnic groups of athletes and controls in the Malaysian 
population, (iii) endurance athletes, strength/power athletes, intermittent athletes, and 
controls in the Malaysian population, and (iv) Malay intermittent athletes and Australian 
intermittent athletes. The mean of the anthropometric data among the athlete group and 
the mean of the Yo-Yo intermittent recovery level 2, handgrip strength and leg strength 
scores among the genotype groups were analysed using one-way analysis of 
variance (ANOVA) and followed by Bonferroni’s post-hoc test when appropriate. All 
statistical evaluations were performed using the IBM SPSS statistical version 20.0, 
(Armonk, New York, USA), with the level of significance set at p < 0.050. 
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5.5 Results 
 
5.5.1 Physical Characteristics of Participants  
 
5.5.1.1 The Whole Cohort of Athletes and Controls in the Malaysian Population 
 
Table 5.1 shows the descriptive statistics for the physical characteristics of the whole 
cohort of athletes and controls in the Malaysian population. There were significant 
differences in all variables between these two groups, with controls having lower mean 
values for height (t(358) = 8.649, p < 0.001), body weight (t(358) = 7.882, p < 0.001), and 
body mass index (t(358) = 4.098, p < 0.001) compared to athletes. Conversely, the mean 
value of body fat was higher in controls than in athletes (t(358) = -4.244, p < 0.001).  
 
Table 5.1 Physical characteristics of athletes and controls in the Malaysian 
population 
Variables Athletes (n=180) Controls (n=180) p value 
Height (cm)     168.8 ± 9.1*      160.7 ± 8.9 < 0.001 
Body Weight (kg)       67.5 ± 13.6*   56.3 ± 12.4 < 0.001 
Body Mass Index (kg/m2) 23.6 ± 4.0* 21.8 ± 3.8 < 0.001 
Body Fat (%) 18.6 ± 6.3* 21.5 ± 7.7 < 0.001 
Note. 
Data shown as mean ± SD 
*Significantly different compared to controls (p < 0.001) 
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5.5.1.2 Endurance, Strength/Power, and Intermittent Athletes in the Malaysian 
Population 
 
Physical characteristics of endurance, strength/power and intermittent athletes in the 
Malaysian population were presented in Table 5.2. All athletes were similar in body mass 
index (F(2, 177) = 2.894, p = 0.058) and body fat (F(2, 177) = 0.635, p = 0.531). There 
were significant differences in height (F(2, 177) = 9,492, p < 0.001) and body weight (F(2, 
177) = 6.027, p = 0.003) between the athlete groups. Post hoc tests using the Bonferroni 
correction revealed that the mean values of height and body weight were significantly 
lower in the strength/power group when compared to the intermittent group (Height: p < 
0.001, Body weight: p = 0.001), though it was not significantly different with the values 
among endurance group (Height: p = 0.056, Body weight: p = 0.940).  
 
Table 5.2 Physical characteristics of endurance, strength/power and intermittent 
athletes in the Malaysian population 
Variables Endurance 
(n=34) 
Strength/Power 
(n=41) 
Intermittent 
(n=105) 
p value 
Height (cm) 168.5 ± 9.8    163.7 ± 10.4* 170.8 ± 7.9 < 0.001 
Body Weight (kg)   63.6 ± 
17.0 
     62.5 ± 9.2#   70.0 ± 13.4 0.003 
Body Mass Index (kg/m2) 22.1 ± 4.1      23.2 ± 3.0   24.0 ± 4.3 0.058 
Body Fat (%) 18.6 ± 6.1      19.6 ± 7.3   18.7 ± 6.4 0.531 
Note. 
Data shown as mean ± SD 
*Significantly different compared to intermittent athletes (p < 0.001) 
# Significantly different compared to intermittent athletes (p = 0.001) 
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Yo-Yo intermittent recovery level 2 performance and leg strength value in athletes from 
different sporting disciplines were presented in Table 5.3. Yo-Yo intermittent recovery 
level 2 performance differed significantly among athletes from the three different sporting 
disciplines (F(2, 177) = 4.340, p = 0.014), with the endurance athletes had significantly 
higher performance scores than the strength/power (p = 0.021) and intermittent athletes 
(p = 0.029). Handgrip strength differed significantly among athletes from the three 
different sporting disciplines (F(2, 177) = 3.994, p = 0.020), with the intermittent athletes 
had significantly higher values of handgrip strength than the strength/power athletes (p = 
0.025), but not significantly different compared to endurance athletes (p = 0.336). There 
was no significant difference was observed for the leg strength value among the sporting 
groups (F(2, 177) = 0.538, p = 0.506).  
 
Table 5.3 Yo-Yo intermittent recovery level 2 performance and leg strength value in 
athletes from different sporting disciplines in the Malaysian population 
Variables Endurance 
      (n=34) 
Strength/Power 
(n=41) 
Intermittent 
(n=105) 
p 
value 
Yo-Yo intermittent 
recovery level 2 
performance (m) 
429.4 ± 203.8 
320.8 ± 
197.5* 
  340.8 ± 
148.7** 
0.014 
Handgrip Strength 
(kg) 
  37.7 ± 9.8   36.1 ± 10.2     40.8 ± 9.2# 0.020 
Leg Strength (kg) 105.6 ± 28.2 108.9 ± 41.2   112.3 ± 33.5 0.506 
Note. 
Data shown as mean ± SD 
  *Significantly different compared to endurance athletes (p = 0.021) 
**Significantly different compared to endurance athletes (p = 0.029) 
     #Significantly different compared to strength/power athletes (p = 0.025) 
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5.5.2 The Distribution of ACE I/D Gene Polymorphism 
 
5.5.2.1 Hardy-Weinberg Equilibrium  
 
ACE I/D genotype distribution for the control group in the Malaysian population was in 
agreement with the Hardy-Weinberg equilibrium (p > 0.050) (Appendix D). 
 
5.5.2.2 The Whole Cohort of Athletes and Controls in the Malaysian Population  
 
The allele and genotype frequencies of ACE I/D gene polymorphism in the whole cohort 
of athletes and controls in the Malaysian population are presented in Figure 5.1. The ACE 
I/D allele frequency in the whole cohort of athletes was significantly different from the 
whole cohort of controls (X2 = 18.776, df = 1, p < 0.001) with the athletes had a lower 
frequency of I allele and higher frequency of D allele than controls. There was also a 
significant difference in ACE I/D genotype frequency between athletes and controls (X2 = 
44.070, df = 2, p < 0.001). The athletes had a lower frequency of II and ID genotypes than 
in controls. On the contrary, the frequency of DD genotype was significantly higher in 
athletes than controls.  
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Figure 5.1    ACE I/D allele and genotype frequencies in the whole cohort of athletes     
  and controls in the Malaysian population 
 
Note. 
*p < 0.001 for allele and genotype frequencies in athletes vs. controls 
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5.5.2.3 Multi-Ethnic Groups of Athletes and Controls in the Malaysian Population 
 
The allele and genotype frequencies of ACE I/D gene polymorphism among multi-ethnic 
groups of athletes and controls in the Malaysian population are presented in Figure 5.2. 
Within athlete group, the distribution of ACE I/D genotype was not significantly different 
between the ethnic groups (X2 = 9.532, df = 6, p = 0.146). The distribution of ACE I/D 
allele was also not significantly different between the ethnic groups (X2 = 5.1082, df = 3, 
p = 0.164). Malay athletes differed from Malay controls in their allele (X2 = 26.248, df = 
1, p < 0.001) and genotype (X2 = 49.350, df = 2, p < 0.001) frequencies, with Malay 
athletes had a higher frequency of D allele and DD genotype than in Malay controls. 
Chinese athletes did not differ from Chinese controls in their ACE I/D allele (X2 = 0.400, 
df = 1, p = 0.527) and genotype (X2 = 3.139, df = 2, p = 0.208) distributions. Similarly, 
Indian athletes did not differ from Indian controls in their ACE I/D allele (X2 = 0.65, df = 
1, p = 0.420) and genotype (X2 = 4.444, df = 2, p = 0.108) frequencies. There were also 
insignificant differences in ACE I/D allele (X2 = 0, df = 1, p = 1) and genotype (X2 = 0.012, 
df = 2, p = 0.222) distributions between athletes and controls within Other Bumiputra 
group. 
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Figure 5.2    ACE I/D allele and genotype frequencies in multi-ethnic groups of athletes and controls in the Malaysian population 
 
 Note. 
 *p < 0.001 for allele and genotype frequencies in Malay athletes vs. Malay controls
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5.5.2.4 Endurance Athletes, Strength/Power Athletes, Intermittent Athletes,  
and Controls in the Malaysian Population 
 
Considering the opposing effects of possession of the I and D alleles on particular sporting 
disciplines, the ACE I/D allele and genotype frequencies were compared between 
endurance athletes, strength/power athletes, intermittent athletes, and controls in the 
Malaysian population as shown in Figure 5.3. The ACE I/D allele (X2 = 28.71, df = 3, p < 
0.001) and genotype (X2 = 63.354, df = 6, p < 0.001) frequencies differed significantly 
across the four groups.  
 
The endurance athletes differed significantly in ACE I/D allele and genotype 
frequencies when compared with the strength/power (X2 = 10.671, df = 1, p = 0.001 for 
allele frequency, and X2 = 16.558, df = 2, p < 0.001 for genotype frequency) and 
intermittent athletes (X2 = 5.0097, df = 1, p = 0.025 for allele frequency, and X2 = 9.919, 
df = 2, p = 0.007 for genotype frequency), but not to those in controls (X2 = 0.042, df = 1, 
p = 0.836 for allele frequency, and X2 = 4.808, df = 2, p = 0.090 for genotype frequency).  
 
The strength/power athletes differed significantly in ACE I/D allele and genotype 
frequencies when compared with the controls (X2 = 19.5623, df = 1, p < 0.001 for allele 
frequency, and X2 = 48.132, df = 2, p < 0.001 for genotype frequency), but not to those in 
intermittent athletes (X2 = 3.0566, df = 1, p = 0.08 for allele frequency, and X2 = 5.103, 
df = 2, p = 0.078 for genotype frequency). Meanwhile, the intermittent athletes differed 
significantly in ACE I/D allele and genotype frequencies when compared with the controls 
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(X2 = 14.6438, df = 1, p < 0.001 for allele frequency, and X2 = 35.308, df = 2, p < 0.001 
for genotype frequency). Among the four groups, the endurance athletes had the highest 
frequencies of II genotype, whilst, the strength/power athletes showed the highest 
frequencies of DD genotype.  
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Figure 5.3 ACE I/D allele and genotype frequencies among endurance athletes, strength/power athletes, intermittent athletes, and 
controls in the Malaysian population 
 
Note. 
ap = 0.001 for allele frequency, and p < 0.001 for genotype frequency in endurance athletes vs. strength/power athletes 
bp = 0.025 for allele frequency, and p = 0.007 for genotype frequency in endurance athletes vs. intermittent athletes 
cp < 0.001 for allele and genotype frequencies in strength/power athletes vs. controls  
dp < 0.001 for allele and genotype frequencies in intermittent athletes vs. controls 
II ID DD I D
ACE I/D Genotype ACE I/D Allele
Endurance athletes (n=34) 0.38 0.35 0.27 0.56 0.44
Strength/Power athletes (n=41) 0.05 0.29 0.66 0.20 0.80
Intermittet athletes (n=105) 0.14 0.39 0.47 0.34 0.66
Controls (n=180) 0.31 0.54 0.15 0.58 0.42
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
F
re
q
u
en
cy
 
ab ab ab 
 c c c 
d  d d 
c c 
d d 
ab ab 
 
II ID DD I D 
  
ab 
ab 
ab 
ab 
ab 
c 
c 
c 
c 
c 
d 
d 
d 
d 
d 
132 
 
5.5.2.5 Malay and Caucasian Intermittent Athletes 
 
The genotype frequency of the ACE I/D gene polymorphism among Malay intermittent 
athletes and Caucasian intermittent athletes are shown in Figure 5.4. There was a 
significant difference in genotype frequency between Malay and Caucasian intermittent 
athletes (X2 = 8.471, df = 2, p = 0.014) with the frequency of the DD genotype in Malay 
intermittent athletes significantly higher than in Caucasian intermittent athletes, 
respectively. However, allele frequency of ACE I/D gene polymorphism amongst the 
Malay intermittent athletes (I = 0.46; D = 0.54) was not significantly different from that 
amongst the Caucasian intermittent athletes (I = 0.56; D = 0.44) (X2 = 0.546, df = 1, p = 
0.460).  
 
5.5.3 Interaction between Ethnicity and ACE I/D Gene Polymorphism on 
Endurance and Strength/Power Performances 
 
There was no significant interaction between ethnicity and ACE I/D gene polymorphism 
on Yo-Yo intermittent recovery level 2 performance (F(2, 174) = 0.651, p = 0.523), 
handgrip strength (F(2, 174) = 0.716, p = 0.490) and leg strength (F(2, 174) = 0.414, p = 
0.662).
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                               Malay intermittent athletes (n=33)                             Caucasian intermittent athletes (n=33) 
 
 
Figure 5.4 ACE I/D genotype frequency in Malay and Caucasian intermittent athletes 
Note. 
*p = 0.014 for genotype frequency in Malay intermittent athletes vs. Caucasian intermittent athletes 
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5.5.4 Effects of ACE I/D Gene Polymorphism on Endurance and Strength/Power 
Performances in the Malaysian Population 
 
5.5.4.1 ACE I/D Gene Polymorphism and Endurance Performance in the Malaysian 
Population 
 
The Yo-Yo intermittent recovery level 2 performances among athletes with different ACE 
I/D genotypes are presented in Table 5.4. The performance of Yo-Yo intermittent recovery 
level 2 was similar among athletes with different ACE I/D genotypes (F(2, 177) = 0.006, 
p = 0.994).  
 
5.5.4.2 ACE I/D Gene Polymorphism and Strength/Power Performance (Handgrip 
Strength) in the Malaysian Population 
 
The mean value of handgrip strength among athletes with different ACE I/D genotypes is 
presented in Table 5.4. There was no significant difference in handgrip strength across the 
genotype groups (F(2, 177) = 1.818, p = 0.165). 
 
Table 5.4 Yo-Yo intermittent recovery level 2 performance and handgrip strength 
value in athletes with different ACE I/D genotypes 
Variables   
II genotype 
(n=30) 
ID genotype 
(n=65) 
DD genotype 
(n=85) 
p 
value 
Yo-Yo intermittent recovery 
level 2 performance (m) 
 350.7 ± 203.9 
 354.7 ± 
170.2 
  352.5 ± 170.0 0.994 
Handgrip strength (kg)    36.1 ± 8.5    39.5 ± 9.9     39.9 ± 9.9 0.165 
Note. 
Data shown as mean ± SD 
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5.5.4.3 ACE I/D Gene Polymorphism with Strength/Power Performance (Leg 
Strength) in the Malaysian Population 
 
The mean values of leg strength among athletes with different ACE I/D genotypes are 
shown in Figure 5.5. There is a significant difference in leg strength across the genotype 
groups (F(2, 177) = 3.122, p = 0.047). Post hoc tests using the Bonferroni 
correction revealed that leg strength was significantly higher in the DD genotype group 
(113.8 ± 36.2) when compared to the II genotype group (96.2 ± 28.0) (p = 0.048), though 
it was not significantly different with the values among ID genotype group (112.2 ± 33.5) 
(p = 0.104). 
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Figure 5.5 The mean value of leg strength in athletes with different ACE I/D 
genotypes in the Malaysian population 
 
Note. 
Data shown as mean ± SD 
*Significantly different compared to II genotype (p = 0.048) 
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5.5.5 The Distribution of ACTN R/X Gene Polymorphism 
 
5.5.5.1 Hardy-Weinberg Equilibrium  
 
ACTN3 R/X genotype distribution for the control group in the Malaysian population was 
in agreement with the Hardy-Weinberg equilibrium (p > 0.050) (Appendix D). 
 
5.5.5.2 The Whole Cohort of Athletes and Controls in the Malaysian Population 
 
The allele and genotype frequencies of ACTN3 R/X gene polymorphism in the whole 
cohort of athletes and controls in the Malaysian population are presented in Figure 5.6. 
The frequency of ACTN3 R/X allele frequency in the whole cohort of athletes (R = 0.59; 
X = 0.41) was not significantly different from that the whole cohort of controls (R = 0.51; 
X = 0.49) (X2 = 2.1998, df = 1, p = 0.138). However, there is a significant difference in 
ACTN3 R/X genotype frequency between athletes and controls (X2 = 11.111, df = 2, p = 
0.004) with the athletes had a higher frequency of RR genotype and lower frequencies of 
RX and XX genotypes compared to controls.  
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Figure 5.6 ACTN3 R/X allele and genotype frequencies in the whole cohort of athletes 
and controls in the Malaysian population 
 
Note. 
 *p = 0.004 for genotype frequency in athletes vs. controls 
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5.5.5.3 Multi-Ethnic Groups of Athletes and Controls in the Malaysian Population 
 
The allele and genotype frequencies of ACTN3 R/X gene polymorphism in the multi-ethnic 
groups of athletes and controls in the Malaysian population are presented in Figure 5.7. 
Within athlete group, the distribution of ACTN3 R/X genotype was not significantly 
different between the ethnic groups (X2 = 6.642, df = 6, p = 0.355). The distribution of 
ACTN3 R/X allele was also not significantly different between the ethnic groups (X2 = 
1.541, df = 3, p = 0.672).  
 
Malay athletes differed from Malay controls in their ACTN3 R/X genotype (X2 = 
49.350, df = 2, p < 0.001) frequency with Malay athletes had a higher frequency of RR 
genotype than in Malay controls. However, allele frequency was similar between the 
Malay athletes and their controls (X2 = 2.444, df = 1 p = 0.117). Similarly, Indian athletes 
differed from Indian controls in their ACTN3 R/X genotype (X2 = 6.923, df = 2, p = 0.031) 
frequency with Indian athletes had a higher frequency of RR genotype than in Indian 
controls. Conversely, allele frequency was similar between the Indian athletes and their 
controls (X2 = 0.619, df = 1, p = 0.431). Chinese athletes did not differ from Chinese 
controls in their ACTN3 R/X allele (X2 = 1.147, df = 1, p = 0.284) and genotype (X2 = 
4.145, df = 2, p = 0.126) distributions. There were also insignificant differences in ACTN3 
R/X allele ((X2 = 0.807, df = 1, p = 0.369) and genotype (X2= 4.674, df = 2, p = 0.097) 
distributions between athletes and controls in Other Bumiputra group. 
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Figure 5.7 ACTN3 R/X allele and genotype frequencies in multi-ethnic groups of athletes and controls in the Malaysian population 
 
Note. 
 ap < 0.001 for genotype frequency in Malay athletes vs. Malay controls 
 bp = 0.031 for genotype frequency in Indian athletes vs. Indian controls
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5.5.5.4 Endurance Athletes, Strength/Power Athletes, Intermittent Athletes,  
and Controls in the Malaysian Population 
 
Considering the opposing effects of possession of the R and X alleles on particular sporting 
disciplines, the ACTN3 R/X allele and genotype frequencies were compared between 
endurance athletes, strength/power athletes, intermittent athletes and controls in the 
Malaysian population as shown in Figure 5.8. The ACTN3 R/X allele frequency was 
similar between the four groups (X2 = 5.291, df = 3, p = 0.152). However, the genotype 
frequencies differed significantly across the groups (X2 = 15.004, df = 6, p = 0.020).  
 
The endurance athletes did not differ significantly in ACTN3 R/X genotype 
frequency when compared with the controls (X2 = 5.504, df = 2, p = 0.064), the 
strength/power (X2 = 0.490, df = 2, p = 0.783) and intermittent (X2 = 0.903, df = 2, p = 
0.637) athletes. The strength/power athletes differed significantly in ACTN3 R/X genotype 
frequency when compared with the controls (X2 = 10.074, df = 2, p = 0.006), but not to 
those in intermittent athletes (X2 = 3.298, df = 2, p = 0.192). Meanwhile, the intermittent 
athletes did not differ significantly in ACTN3 R/X genotype frequency when compared 
with the controls (X2 = 5.781, df = 2, p = 0.056). Among the four groups, the 
strength/power and intermittent athletes had the highest frequencies of RR and XX 
genotypes, respectively.  
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Figure 5.8 ACTN3 R/X allele and genotype frequencies among endurance athletes, strength/power athletes, intermittent athletes, and 
controls in the Malaysian population 
Note. 
*p = 0.006 for genotype frequency in strength/power athletes vs. controls 
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5.5.5.5 Malay and Caucasian Intermittent Athletes 
 
The genotype frequency of the ACTN3 R/X gene polymorphism among Malay intermittent 
athletes and Caucasian intermittent athletes are shown in Figure 5.9. There was a 
significant difference in genotype frequency between Malay and Caucasian intermittent 
athletes (X2 = 9.906, df = 2, p = 0.007) with the frequency of RR and XX genotypes in 
Malay intermittent athletes higher than in Caucasian intermittent athletes. However, allele 
frequency of ACTN3 R/X gene polymorphism amongst the Malay intermittent athletes (R 
= 0.48; X = 0.52) was not significantly different from that amongst the Caucasian 
intermittent athletes (R = 0.56; X = 0.44) (X2 = 0.243, df = 1, p = 0.622).  
 
5.5.6 Interaction between Ethnicity and ACTN3 R/X Gene Polymorphism on 
Strength/Power and Endurance Performances 
 
There was no significant interaction between ethnicity and ACTN3 R/X gene 
polymorphism on handgrip strength (F(2, 174) = 1.153, p = 0.334), leg strength (F(2, 174) 
= 1.308, p = 0.256), and Yo-Yo intermittent recovery level 2 performance (F(2, 174) = 
1.003, p = 0.425). 
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Figure 5.9 ACTN3 R/X genotype frequencies in Malay and Caucasian intermittent athletes 
 
 
Note. 
                                    *p = 0.007 for genotype frequency in Malay intermittent athletes vs. Caucasian intermittent athletes 
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5.5.7 Effects of ACTN3 R/X Gene Polymorphism on Strength/Power and 
Endurance Performances in the Malaysian Population 
 
5.5.7.1ACTN3 R/X Gene Polymorphism and Strength/Power Performance 
(Handgrip Strength) in the Malaysian Population 
 
The mean value of handgrip strength among athletes with different ACTN3 R/X 
genotypes is presented in Figure 5.10. There is a significant difference in handgrip 
strength across the genotype groups (F(2, 177) = 3.647, p = 0.028). Using a Bonferroni 
post hoc test, the handgrip strength recorded by the athletes with RR genotype (41.6 ± 
8.4) is significantly higher than those with the RX genotype (37.4 ± 10.2) (p = 0.031), 
but not significantly different from athletes with the XX genotype (38.1 ± 10.2) (p = 
0.228). 
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Figure 5.10 The mean value of handgrip strength in athletes with different ACTN3 
R/X genotypes in the Malaysian population 
 
Note. 
Data shown as mean ± SD 
*Significantly different compared to RX genotype (p = 0.031) 
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5.5.7.2 ACTN3 R/X Gene Polymorphism and Strength/Power Performance (Leg 
Strength) in the Malaysian Population 
 
The mean value of leg strength among athletes with different ACTN3 R/X genotypes 
is presented in Figure 5.11. There is a significant difference in leg strength across the 
genotype groups (F(2, 177) = 7.979, p < 0.001). Athletes with RR genotype (123.0 ± 
29.8) have a significantly higher leg strength than those with the RX genotype (102.6 
± 35.5) (p = 0.001) and XX genotype (102.6 ± 34.1) (p = 0.010). 
 
5.5.7.3 ACTN3 R/X Gene Polymorphism and Endurance Performance in the 
Malaysian Population 
 
The performance of Yo-Yo intermittent recovery level 2 was similar among athletes 
with RR genotype (377.7 ± 208.1), RX genotype (342.4 ± 138.9), and XX genotype 
(328.7 ± 174.8) (F(2, 177) = 1.663, p = 0.385). 
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Figure 5.11 The mean value of leg strength in athletes with different ACTN3 R/X 
genotypes in the Malaysian population  
 
Note. 
Data shown as mean ± SD 
  *Significantly different compared to RX genotype (p = 0.001) 
**Significantly different compared to XX genotype (p = 0.010) 
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5.6 Discussion 
 
The effects of ACE I/D and ACTN3 R/X gene polymorphisms on human physical 
performance remain controversial with some studies showing positive effect 
(Ahmetov et al., 2008b, Cieszczyk et al., 2009, Pimenta et al., 2011, Cieszczyk et al., 
2011, Eidera et al., 2013), with other studies showing negative effect (Ash et al., 2011, 
Holdys et al., 2011, Wang et al., 2013, Ahmetov et al., 2013). This inconclusive 
finding also appears when examined across the Caucasian (Hagberg et al., 1999, 
Kasikcioglu et al., 2004, Clarkson et al., 2005a, Cam et al., 2007), and Asian (Zhaoa 
et al., 2003, Tobina et al., 2010, Ichinoseki-Sekine et al., 2010) populations. These 
findings suggest that the ACE I/D and ACTN3 R/X gene polymorphisms may confer 
different effects in a specific population. However, the lack of reports in Asian 
population compared to the Caucasian population, as previously highlighted by Ma et 
al. (2013), warrants further investigation on the effects of ACE I/D and ACTN3 R/X 
gene polymorphisms on human physical performance in Asian population. 
 
This study was therefore designed to fill the gap in the literature and thus 
examine the effects of ACE I/D and ACTN3 R/X gene polymorphisms on human 
physical performance within Malaysian population and determine whether their effects 
differ by ethnicity. To the best of author's knowledge, there have been limited studies 
that have examined the effects of ACE I/D and ACTN3 R/X gene polymorphisms on 
human physical performance within multi-ethnic Malaysian population. The main 
finding of this study is that ACE I/D and ACTN3 R/X alleles and genotype frequencies 
did not vary much between the multi-ethnic groups of Malaysian athletes. These small 
variations did not have any influence on the human physical performance between 
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these ethnic groups. Also, the present study identified that possession of the ACE D 
allele and ACTN3 R allele were associated with increased strength/power performance 
within the Malaysian population. Meanwhile, possession of the ACE I allele and 
ACTN3 X allele did not appear to confer an advantage on endurance performance in 
the Malaysian population.  
 
The athletes in the present study were drawn from different ethnic groups in 
Malaysia, thus it is probable that different composition of ACE I/D and ACTN3 R/X 
genes in different ethnic groups could be a factor that influence the performance of the 
athletes, which has been previously suggested by Zilberman-Schapira et al. (2012). 
Findings of the present study observed a similar distribution of ACE I/D and ACTN3 
R/X gene polymorphisms between multi-ethnic groups of Malaysian athletes. The 
present finding for ACE I/D gene polymorphisms had been contradicted with the 
findings obtained from the first study of this research project that the distribution of 
ACE I/D gene polymorphism varied between multi-ethnic groups in Malaysian. In 
addition, a multivariate analysis was performed on the present data to determine the 
interaction between the ethnic origin (Malay, Chinese, Indian and Other Bumiputra) 
and the ACE I/D and ACTN3 R/X gene polymorphisms on the endurance and 
strength/power performances. The analysed data showed that the ACE I/D and ACTN3 
R/X gene polymorphisms did not interact with ethnicity to impact endurance and 
strength/power performances in the Malaysian population. Results of this study are 
consistent with previous research by Goh et al. (2009), who studied the impact of Asian 
ethnicity (Singaporean) on the effect of ACE I/D gene polymorphism on the aerobic 
capacity. Thus, the finding of the current study suggested that ACE I/D and ACTN3 
R/X gene polymorphisms may have universal effect on human physical performance.  
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Previous research of the ACE I/D gene polymorphism in athletes demonstrated 
that the frequency of ACE I allele was significantly higher among endurance athletes 
than strength/power and intermittent athletes (Myerson et al., 1999, Nazarov et al., 
2001, Tsianos et al., 2004b, Mayne, 2006, Min et al., 2009), suggesting that the 
presence of ACE I allele is required for endurance performance. In line with these 
studies, the present study observed the over-representation of the ACE I allele and ACE 
II genotype in the endurance group compared to the strength/power and intermittent 
groups, supporting the potential effect of possession of the ACE I allele on endurance 
performance.  
 
Although the presence of ACE I allele was compatible with endurance athlete 
status in Malaysian population, the result of Yo-Yo intermittent recovery level 2 test 
demonstrated that the presence of ACE I allele is not the predictor of endurance 
performance in this population. The Yo-Yo intermittent recovery level 2 performance 
was found to be similar across the three ACE I/D genotype groups. The finding of this 
study contradicts that of earlier studies among Asian (Goh et al., 2009) and Caucasian 
(Cam et al., 2007, Voroshin and Astratenkova, 2008) samples, suggesting that 
individuals with ACE II genotype have better endurance performance compared to 
those with other ACE I/D genotypes.  
 
The lack of an effect of possession of the ACE I allele on the Yo-Yo 
intermittent recovery level 2 performance observed in this study is consistent with 
previous results involving Caucasian samples (Rankinen et al., 2000c, Sonna et al., 
2001). The reason for the lack of effect of possession of the ACE I allele observed in 
the present study remains unclear. Sonna and colleagues (2001) suggested that the 
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previous association reported for possession of the ACE I allele and endurance 
performance could be due to linkage with another gene in close proximity to the ACE 
locus, such as the human growth hormone gene. This is supported with evidence from 
previous studies on human growth hormone gene which showed that the increases in 
growth hormone production during exercise lead to increases in carbohydrate, fat, and 
protein metabolism (De Palo et al., 2001, Godfrey et al., 2003) and stimulate sweat 
secretion (Jorgensen et al., 2003), thereby influencing endurance performance. The 
finding of the present study suggests that possession of the ACE I allele may not the 
absolute criteria for success in endurance performance. 
 
Furthermore, the present study identified an over-representation of the ACE  D 
allele among strength/power athletes compared to the other athlete groups, which is 
consistent with the previous observations in other Asian (Kikuchi et al., 2012) and 
Caucasian (Nazarov et al., 2001, Mayne, 2006, Costa et al., 2009b) samples. In 
contrast to the finding observed for ACE I allele, the potentially favourable effect of 
possession of the ACE D allele on strength/power athletic status in Malaysian athletes 
is supported by the finding on leg strength. According to the present result, athletes 
with the ACE DD genotype exhibited greater leg strength than those with the ACE II 
and the ACE ID genotypes. This result is in line with previous studies that reported 
positive effects of possession of the ACE D allele on muscular strength parameters, 
such as isometric and isokinetic quadriceps muscle strength (Williams et al., 2005), 
and knee extensor strength (Giaccaglia et al., 2008). All of these positive findings 
indicate that possession of the ACE D allele might have an advantageous effect on 
short duration and high-intensity activities. A positive effect of possession of the ACE 
D allele on muscular strength observed in the present study supports the possible 
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mechanism for the effect of possession of the ACE D allele on muscular strength 
through the production of ANG II in the skeletal muscle (Charbonneau et al., 2008). 
A greater local ANG II production in the skeletal muscle has been reported to increase 
protein synthesis and cell hypertrophy (Jones and Woods, 2003), thereby inducing 
muscle contraction for maximal power (Rattigan et al., 1996). 
 
The ACTN3 protein plays an important role in maintaining the ordered 
myofibrillar array for greater coordination to generate high muscle power and velocity 
during movements (Mills et al., 2001). Based on the physiological role of ACTN3 
protein during muscle contraction, the present study hypothesised that athletes who 
have one or two copies of ACTN3 R allele (codes for ACTN3 protein) would 
predispose to strength/power sports and have greater muscular strength compared to 
athletes with ACTN3 X allele. As expected, the present study found a higher frequency 
ACTN3 RR genotype in the strength/power athletes compared to endurance and 
intermittent athletes. A higher frequency of ACTN3 RR genotype in strength/power 
athletes is in line with the previous finding among Asian (Kothari et al., 2011) and 
Caucasian (Yang et al., 2003, Eynon et al., 2009b) athletes.  
 
The present study also found that athletes with ACTN3 RR genotype had greater 
hand and leg strength than athletes with other genotypes. This finding is consistent 
with the findings of earlier studies involving Caucasian (Clarkson et al., 2005a, 
Vincent et al., 2007, Erskine et al., 2014) and Asian populations (Shang et al., 2012), 
which demonstrated that the ACTN3 RR genotype carriers have greater strength/power 
capacity than other genotype carriers. These results confirm an advantageous effect of 
the presence of ACTN3 protein on muscle strength. This finding supports the previous 
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notion by Thomis et al. (1998) and Vincent et al. (2007), who reported that the 
likelihood of presenting the best performance in muscle strength depends on the 
genetic profile of the individual. 
 
While the production of ACTN3 protein is coded by ACTN3 R allele, the 
incomplete sequence in the ACTN3 X allele prevents the production of this protein 
(North et al., 1999). The lack of ACTN3 protein has been reported to shift skeletal 
muscle metabolism to aerobic metabolism (MacArthur et al., 2007). Therefore, the 
present study hypothesized that the ACTN3 X allele is more frequent among athletes 
involved in endurance sports and athletes with ACTN3 X allele may have greater 
endurance capacity compared to those with ACTN3 R allele. The present data 
demonstrate a higher frequency of ACTN3 XX genotype among intermittent athletes 
than endurance and strength/power athletes. This result is not in agreement with the 
previous reports in the Caucasian population, which demonstrated a higher frequency 
of ACTN3 XX genotype in endurance athletes compared to strength/power and 
intermittent athletes (Eynon et al., 2009b, Ahmetov et al., 2011). This finding is 
contrary to those observed in the Chinese population (Shang et al., 2010). The 
reliability of a higher frequency of ACTN3 X allele in intermittent athletes could be 
explained by the fact that intermittent sport involves aerobic-anaerobic demand. 
Hence, an intermittent athlete requires both aerobic and anaerobic capacity. Therefore, 
the presence of ACTN3 X allele in intermittent athletes may confer a beneficial effect 
for aerobic activity. 
 
In the present study, the endurance performance as measured by Yo-Yo 
intermittent recovery level 2 test was similar between the ACTN3 R/X genotype. This 
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finding is not equivalent to the previous study by Lucia et al. (2007). According to the 
study by Lucia et al. (2007), the carriers of the ACTN3 XX genotype had a higher 
endurance performance compared to carriers of ACTN3 RR and ACTN3 RX genotype. 
The contradictory finding between the present study and the study by Lucia et al. 
(2007) may be attributed to the difference in the study sample criteria. Lucia et al. 
(2007) had studied the effect of possession of the ACTN3 XX genotype on endurance 
performance among untrained people, whilst the present study focused on a group of 
athletes. Therefore, further studies involving both untrained and trained individuals 
may be needed to formulate a conclusive finding on the effect of possession of the 
ACTN3 X allele on endurance performance. Based on the present data, a deficiency of 
ACTN3 protein may not be critical to endurance performance in the Malaysian athletic 
population.  
 
In light of the above-mentioned finding, the present study is the first to show a 
significant difference in the distribution of ACE I/D and ACTN3 R/X gene 
polymorphisms between Malay intermittent athletes in the Malaysian population and 
Caucasian intermittent athletes in the Australian population. For well-matched 
comparison, the groups from these two populations contain adequate sample size of 
intermittent male athletes representing university level sporting competition. With 
respect to the ACE I/D gene polymorphism, there are significant variations in genotype 
frequencies in different ethnic groups with ACE DD genotype higher in those of Malay 
descent. Based on this data, the ACE DD genotype appeared to influence the 
performance of intermittent athletes in Malaysian population whilst this genotype is 
not extremely crucial for Australian athletes.  
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With respect to the ACTN3 R/X gene polymorphism, the genotype frequencies 
significantly differed between Malay and Caucasian intermittent athletes with ACTN3 
XX genotype higher in those of Malay ethnicity compared to Caucasian athletes. In a 
previous study by Pimenta et al. (2011), athletes with ACTN3 XX genotype were 
reported to have higher concentrations of post-training cortisol when compared to RR 
and RX carriers. The high concentration of cortisol in athletes with XX genotype after 
training indicates to the increased level of muscle damage predicted from the increase 
of CK activity (Pimenta et al., 2011). Therefore, those athletes with XX genotype are 
speculated to have a high risk of muscle damage that may limit their potential to be 
excellent in competition (Pimenta et al., 2011). Based on this information, it is possible 
that the overrepresentation of athletes with XX genotype in Malay group may limits 
the potential to achieve successful results in intermittent competitions such as soccer 
and hockey when compared to Caucasian athletes. There is no clear explanation for 
the existence of the differences in the frequency of ACE I/D and ACTN3 R/X gene 
polymorphisms between Malay and Caucasian intermittent athlete populations, but it 
could not exclude that this difference could also be due to the different athlete 
development programs between these two cultures that may be influencing this shift.  
 
The present study is presented with several limitations. The first limitation was 
related to the number of athletes used in this study as when the athletes were divided 
into three groups based on their sporting disciplines, the sample size decreased 
considerably. As in all such studies, extension to, and replication with a larger sample 
size is warranted. The studied groups in the Malaysian population were comprised of 
both females and males. Therefore, it remains unknown if the effects of the selected 
polymorphisms may differ by gender. As the aims of the present study was not related 
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to training effect, there is no data available on the training status of the athletes. 
Therefore, it is likely that performance measured in the present study due to the 
training effect which could mask gene-related effects on physical performance. The 
present study did not measure the physical performance of controls in the Malaysian 
population to reduce variability of the results. In addition, due to time constraints, there 
is no available data for the physical performance of Australian athletes. However, 
replicate study should be performed in future studies to validate the present findings.  
 
Despite the above-mentioned limitation, confidence in the validity of the 
present findings is increased by the fact that each athlete group demonstrate different 
endurance and strength/power performances that are reliable with their physical 
characteristics. The population comparison between Malaysian athletes and Australian 
athletes were matched on sample size, gender, age, and sports discipline. Athlete and 
control groups in the Malaysian population were ethnically-matched to limit and 
control the effect of ethnicity. The genetic assessment was accurate and unbiased as 
the genotype distributions of the studied polymorphisms in the control group were in 
Hardy-Weinberg equilibrium. 
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5.7 Conclusion 
 
In summary, this study demonstrates that the distributions of ACE I/D and ACTN3 R/X 
gene polymorphisms and their effects on the physical performance do not vary much 
between different ethnic groups of Malaysian athletes. This study confirmed the 
positive effects of possession of the D allele of ACE I/D and R allele of ACTN3 R/X 
gene polymorphisms on strength/power performance within Asian ethnicity as has 
been widely investigated among the Caucasian population. It is further concluded that 
possession of the I allele of ACE I/D and X allele of ACTN3 R/X gene polymorphisms 
are not the predictor for endurance performance within the Malaysian population. 
There is a different pattern in the distribution of ACE I/D and ACTN3 R/X gene 
polymorphisms amongst Malays and Caucasian intermittent athletes that warrants 
further investigation on the athlete development programs between the two 
populations that may be influencing this variation. These preliminary data illustrate 
the importance of understanding the genetic makeup of Malaysian athletes and the 
effect of genetic factors on human physical performance. 
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CHAPTER 6 
 
THE INFLUENCE OF ACE I/D GENE POLYMORPHISM ON 
CARDIOVASCULAR AND MUSCULAR ADAPTATIONS TO 8 WEEKS OF 
ISOMETRIC HANDGRIP TRAINING IN A NORMOTENSIVE 
POPULATION IN MALAYSIA 
 
6.1 Introduction 
 
Managing blood pressure is important in preventing hypertension, which is a major 
risk factor for heart attacks and strokes (Chobanian et al., 2003). It has been shown 
that lowering resting blood pressure can significantly reduce the risk of coronary 
disease by 21%, stroke by 37%, total cardiovascular mortality by 25%, and all-cause 
mortality rates by 13% (He and Whelton, 1999). With that, exercise has been suggested 
as the best and the most affordable way for managing blood pressure (Fagard, 2006). 
 
Moderate-intensity aerobic exercise (about 40% to 50% of maximal oxygen 
consumption (VO2max)) undertaken three to five times per week for 30 to 60 minutes 
per session is effective in reducing resting blood pressure in both normotensive and 
hypertensive individuals (Pescatello and Kulikowich, 2001, Cornelissen and Fagard, 
2005a, Baynard et al., 2008, Goldberg et al., 2012). In a recent meta-analysis 
concerning exercise training for blood pressure, endurance exercise training was 
reported to reduce resting systolic and diastolic blood pressure by about 3.5 mmHg 
and 2.5 mmHg, respectively (Cornelissen and Smart, 2013). 
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Recently, in addition to aerobic exercise, resistance exercise training, which 
has not been previously recommended for blood pressure management in hypertensive 
patients (Palatini et al., 1989), has been shown to lower resting blood pressure in 
normotensive and hypertensive individuals (Wiley et al., 1992, Wood et al., 2001, 
Vincent et al., 2003, Collier et al., 2008). The reductions of 3 to 4 mmHg in resting 
systolic and diastolic blood pressure were observed following four weeks of resistance 
exercise training (Collier et al., 2008). Meanwhile, in another meta-analysis study 
conducted by Cornelissen and Smart (2013), the largest reductions in resting blood 
pressure had been reported following the isometric resistance exercise training 
(systolic: −10.9 mmHg, diastolic: −6.2 mmHg) compared to after endurance (systolic: 
−3.5 mmHg, diastolic: −3.7 mmHg) and dynamic resistance exercise training (systolic: 
−1.8 mmHg, diastolic: −2.5mmHg). Moreover, several earlier studies suggested that 
the isometric exercise training protocol consisting of four sets of 2-minute handgrip 
(McGowan et al., 2007, Millar et al., 2008) or leg contractions (Howden et al., 2002) 
at 30 % to 50 % of maximal voluntary contraction (MVC) (Wiley et al., 1992, Ray and 
Carrasco, 2000) with 1 to 4 minutes of rest period between each contraction (Wiley et 
al., 1992, McGowan et al., 2007) conducted three to five times per week for 4 to 10 
weeks (Devereux et al., 2010, Badrov et al., 2013) to be more effective in lowering 
resting blood pressure than endurance and dynamic resistance exercise training. 
Relative to exercise trained-muscle, hand grip isometric exercise training (Wiley et al., 
1992, Badrov et al., 2013) has been found to reduce resting blood pressure more than 
leg isometric exercise training (Baross et al., 2012). One possible explanation for this 
difference may have to do with greater increase in arterial pressure for hand grip than 
leg muscle contraction, that will stimulate the baroreceptors which in turn leads to 
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greater capacity for reduction in blood pressure following IHG training than leg 
isometric exercise training (Strange, 1999). 
 
 While the benefit of isometric exercise training for blood pressure management 
has been well documented, it has remained unclear on how factors that can influence 
blood pressure, such as gender and genetics, may influence efficiency of this isometric 
exercise program. Several twin studies previously reported that blood pressure is 
controlled by genetic factors (van den Bree et al., 1996, Hottenga et al., 2005). Given 
the fact that blood pressure has a genetic basis, research efforts have been directed 
towards identifying the candidate genes involved in blood pressure regulation (Sober 
et al., 2009, Arora and Newton-Cheh, 2010). Among the proposed candidate genes for 
blood pressure, the angiotensin I-converting enzyme (ACE) gene, has attracted much 
attention due to its role in the renin-angiotensin system (RAS); a physiological system 
that regulates blood pressure (Hagberg et al., 2000, Marteau et al., 2005, Dhanachandra 
Singh et al., 2014). 
 
Within the ACE gene, the ACE I/D gene polymorphism showed a strong link 
with the level of ACE in the RAS (Tiret et al., 1992) and accounted for 47% of the 
total phenotypic variance of ACE (Rigat et al., 1990). On top of that, an initial report 
by Rigat et al. (1990) observed that ACE levels were progressively higher among 
individuals with II, ID, and DD genotypes of the ACE I/D gene polymorphism, 
respectively. Individuals with II genotype had been reported to have lower resting 
blood pressure than those with ID and DD genotypes (Wong et al., 2012). This is 
attributed to a lower ACE level in individuals with II genotype that decreases the 
formation of ANG II (a potent vasoconstrictor) and increases the production of 
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bradykinin (a potent vasodilator), leading to lower resting blood pressure (Coates, 
2003).  
 
 The influences of the ACE I/D gene polymorphism on blood pressure in 
response to exercise training have been investigated in several studies, but the results 
have been inconsistent (Montgomery et al., 1997, Hagberg et al., 1999, Rankinen et 
al., 2000a, Zhang et al., 2002, Dengel et al., 2002, Kim, 2009, Mota et al., 2013). Some 
studies reported that the ACE I/D gene polymorphism did not influence blood pressure 
response to endurance (Montgomery et al., 1997, Rankinen et al., 2000a, Dengel et al., 
2002) and dynamic resistance (Mota et al., 2013) exercise training. On the other hand, 
Hagberg et al. (1999) reported a greater drop in resting blood pressure among  
hypertensive men with II and ID genotypes compared to those with DD genotype after 
9 months of endurance exercise training at 75 to 85 % of maximal oxygen 
consumption. Furthermore, a similar finding was also observed by Zhang et al. (2002), 
who investigated the impact of the ACE I/D gene polymorphism on blood pressure 
response to 10 weeks exercise therapy on a bicycle ergometer among 64 Japanese with 
mild to moderate essential hypertension. In contrast to the results obtained by Hagberg 
et al. (1999) and Zhang et al. (2002), Kim (2009) discovered that adult women with 
DD genotype had greater reduction in blood pressure (diastolic) than those with II and 
ID genotypes, following a 12-week combined aerobic and resistance exercise training. 
The reasons for these inconsistent results are unclear, but it may be due to the 
differences in sample sizes and insufficient exercise intensities for eliciting substantial 
changes in resting blood pressure. For instance, a study by Kim (2009) involved mixed 
aerobic and resistance exercise training compared with only aerobic training 
(endurance training) in study by Hagberg et al. (1999).  
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Despite the inconsistencies of some findings, to our knowledge, no study has 
investigated the effect of isometric exercise training on blood pressure response among 
individuals with different genotypes of the ACE I/D gene polymorphism. This 
investigation is important in determining if ACE I/D gene polymorphism has an 
influence on blood pressure in response to exercise training, which could help to 
identify individuals who would be more likely to benefit from this exercise program. 
 
6.2 Aim 
 
The aim of this study was to examine the effect of ACE I/D gene polymorphism on 
cardiovascular and muscular adaptations following an 8-week isometric handgrip 
training on cardiovascular and muscular adaptations among normotensive men. It was 
hypothesized that the ACE I/D gene polymorphism would influence the cardiovascular 
and muscular adaptations to an 8-week isometric handgrip training. 
 
6.3 Methods and Participants 
 
6.3.1 Study Design 
 
This study employed a single-blind, repeated measures study design. Since the ACE 
I/D gene polymorphism was reported to be associated with an enhanced cardiovascular 
(Hagberg et al., 1999, Zhang et al., 2002, Kim, 2009) and muscular (Giaccaglia et al., 
2008) responses to training, all participants underwent identical cardiovascular and 
muscular assessments before training (pre-training), after the initial training session 
(mid-training), and after 8 weeks of training (post-training). They performed isometric 
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handgrip (IHG) exercise three days per week for 8 weeks. All assessments and IHG 
training were conducted in a quiet temperature-controlled room (20 to 25ºC). A 
flowchart of the study design is presented in Figure 6.1.  
 
6.3.2 Participants 
 
At the initial phase of this study, a total of 50 healthy, normotensive, untrained males 
aged 30.3 ± 5.1 years old, who had been reported to having Malay ancestry within 
three generations and sedentary lifestyle (two or fewer days a week of recreational 
exercise for less than 30 minutes a day for the preceding three months (Pate et al., 
2008)) were screened for ACE I/D gene polymorphism. Thirty of these initial 
participants, who comprised of 10 participants with each II, ID, and DD genotypes of 
ACE I/D gene polymorphism were then selected for isometric handgrip training. The 
number of participants for this study was based on the sample size calculation by using 
the Power and Sample Size Calculation version 3.1.2 software (Dupont and Plummer, 
1990) [Calculated sample size = 27 participants; Research sample size = 27 
participants + (27*10% (expected drop out)) = 30 participants]. The statistical power 
of the study was set at 0.80 with 95% of confidence interval and the effect size of 0.25.  
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Figure 6.1 Flow chart of the study design 
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6.3.3 Familiarization Session 
 
The participants were briefed of the testing protocols and familiarized with the 
instruments, as well as the procedures involved in the MVC test. After they had signed 
and completed the consent form, they were interviewed about their personal information, 
including gender, age, ethnicity, and health status. Participants consent and information 
details forms were presented in Appendix C. 
 
6.3.4 Preliminary Assessments 
 
During this session, anthropometric data of the participants, such as body weight, body 
height, body mass index, and body fat, were collected. Participant’s body height was 
measured using a portable stadiometer (Seca 213, Seca Corporation, USA). Meanwhile, 
participant’s body weight, body mass index, and body fat, were measured using an Omron 
KARADA Scan Body Composition & Scale (HBF-362, Omron Corporation, Japan). 
Immediately following this, deoxyribonucleic acid (DNA) sample from each participant 
was collected by using buccal swab with a sterile swab applicator (Classic Swabs by 
Copan Flock Technologies, Brescia, Italy). The swabs were air dried and placed in sterile 
1.5 ml microcentrifuge tubes and stored at -20°C until used for DNA isolation. 
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6.3.5 ACE I/D Genotyping Determination 
 
Genomic DNA was isolated from the swab samples by using the GeneAll® ExgeneTM Cell 
SV kit following the manufacturer’s protocol (GeneAll Biotechnology Co. Ltd., Seoul, 
South Korea). Polymerase chain reaction (PCR) was carried out in a final volume of 25 
μl consisting of 2.5 μl of 10X standard reaction buffer (GeneAll Biotechnology Co. Ltd., 
Seoul, South Korea) (25 mm Mg2+, 50 mm Tris-HCl, 50 mm KCl, 0.1 mm EDTA, 1 mm 
DTT, 0.5 mm PMSF, and 50% glycerol), 2.0 μl of dNTP mix (200 μm from each dNTP 
(dATP, dCTP, dGTP, and dTTP)), 0.8 μm of each primer (forward primer: 5’-
CTGGAGACCACTCCCATCCTTTCT-3’: reverse primer: 5’-
CTGGAGACCACTCCCATCCTTTCT-3’), 0.5 units of Taq DNA polymerase, 2.5 μl of  
dimethylsulfoxide, 10.8 μl of sterilize distilled water, and 5 μl of genomic DNA (2-8 
ng/μl). The target fragment bearing the ACE I/D gene polymorphism was amplified under 
the following conditions; 7 minutes at 95°C, followed by 25 cycles of 30 seconds at 95°C, 
30 seconds at 62°C, and 1 minute at 72°C, with a final step of 7 minutes at 72°C. The 
amplified products were electrophoresed on 1.5% agarose gel that was pre-stained with 
ethidium bromide at 70 volts for 1 hour. The presence of 490 base pair (bp) and 190 bp 
bands indicated the ACE insertion (I) and deletion (D) alleles, respectively. The PCR 
products for ACE I/D gene polymorphism were confirmed by sequencing (First BASE 
Laboratories Sdn Bhd, Selangor, Malaysia). 
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6.3.6 Cardiovascular and Muscular Assessments 
 
Prior to measurement of the study variables, the participants were asked to refrain from 
performing vigorous exercise and consuming caffeinated beverages within 24 hours 
before the assessments. A hand dynamometer (Takei A5401, Takei Scientific Instruments 
Co. Ltd., Japan) was used to measure the muscular variable, whilst the cardiovascular 
variables were assessed by using a non-invasive automated brachial oscillometry (Omron 
HEM907XL, Omron Healthcare, Inc., United States). 
 
Cardiovascular (systolic blood pressure (SBP), diastolic blood pressure (DBP), 
mean arterial pressure (MAP), pulse pressure (PP), and heart rate (HR)), and muscular 
(handgrip strength (HGS)) variables were measured on three consecutive days (at the same 
time (± 2 hours)) immediately prior to commencing training. During each visit, after 10 
minutes of seated rest, all variables were measured on the dominant arm hand (self-
reported by the participant) in the sitting position for four successive times with 2-minute 
rest intervals. The first of the four measurements of all variables in each visit was 
discarded (due to the white coat effect), while the remaining three measurements were 
averaged over the three visits to represent the pre-training value (Millar et al., 2008).  
 
One hour after the initial training session (mid-training), the cardiovascular and 
the muscular variables were assessed based on the procedure described above to examine 
the acute effects of IHG exercise (Hecksteden et al., 2013). For this assessment, the first 
and the second measurements were discarded, while the last two measurements were 
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averaged to represent the mid-training value, as previously described in a study by 
Hecksteden et al. (2013). 
 
In three consecutive days after 8 weeks of training (post-training), the 
cardiovascular and the muscular variables were again assessed based on the procedure 
described above. The measurements of cardiovascular and muscular variables were 
averaged in the same way as described for pre-training value to represent the post-training 
value (Millar et al., 2008). 
 
6.3.7 Isometric Handgrip Training 
 
The isometric handgrip (IHG) training protocol used in this study was based on the 
training protocol described by McGowan et al. (2007). Before every training session, the 
left and the right MVC values of the participants were assessed with two attempts on each 
side (contraction duration less than 2 seconds), separated by 30 seconds of rest. If the 
variance from the two recordings was less than 5%, the highest value was taken as the 
participant’s MVC for that side. If the recordings differed by more than 5%, further 
attempts were made at 1-minute interval until a stable maximal value was obtained. All 
participants were trained using unilateral, alternate IHG exercise, three days per week for 
eight weeks (at the same time (± 2 hours)). In each session, the participants performed the 
IHG exercise while sitting with the working arm extended towards the front. The 
participants performed four trials of 2 minutes of IHG exercise at 30% of their MVC, with 
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a 1-minute rest period between each trial. The IHG exercise was performed using alternate 
hands starting with dominant hand. 
 
6.4 Statistical Analysis 
 
The descriptive data are presented as mean ± standard deviation (SD). Differences in pre- 
and post-training values were calculated as final (mid- or post-training) minus initial (pre-
training) value. Positive and negative results indicated an increase and a decrease with 
IHG training, respectively. The mean of all variables at pre-, mid-, and post-training were 
compared with II, ID, and DD genotype groups via one-way analysis of 
variance (ANOVA), and was followed by Bonferroni’s post-hoc test when appropriate. 
Paired sample t-test was used to compare mid- and post- training data with pre-training 
data of the entire cohort and each genotype group. All statistical evaluations were 
performed by using the IBM SPSS statistical version 20.0 (Armonk, New York, USA), 
with the level of significance set at p < 0.050. 
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6.5 Results 
 
6.5.1 Characteristics of Participants 
 
The physical characteristics of the participants according to ACE I/D genotype are shown 
in Table 6.1. All ACE I/D genotype groups were similar in age (F(2, 27) = 2.834, p = 
0.071), height (F(2, 27) = 0.133, p = 0.876), body weight (F(2, 27) = 0.066, p = 0.961), 
body mass index (F(2, 27) = 0.672, p = 0.519), and body fat (F(2, 27) = 0.937, p = 0.404).  
 
Table 6.1 Physical characteristics of participants according to ACE I/D genotype 
Variables II  
(n=10) 
ID  
(n=10) 
  DD  
(n=10) 
p value 
Age (years)   27.8 ± 6.2   32.9 ± 3.1   30.0 ± 4.5    0.071 
Height (cm) 169.0 ± 6.2 170.4 ± 9.3 169.0 ± 5.4    0.876 
Body Weight (kg)   72.6 ± 10.0   74.7 ± 24.0   72.4 ± 7.4    0.961 
Body Mass Index (kg/m2)   25.4 ± 3.1   27.1 ± 4.4   25.6 ± 3.2    0.519 
Body Fat (%)   23.8 ± 3.5   26.0 ± 4.7   24.1 ± 3.7    0.404 
Note. 
Data shown as mean ± SD 
 
6.5.2 Cardiovascular and Muscular Responses 
 
Table 6.2 demonstrates the cardiovascular and muscular responses following 8 weeks of 
IHG training. SBP (t(29) = 3.753, p = 0.001), MAP (t(29) = 3.008, p = 0.004), PP (t(29) 
= 2.401, p = 0.023), and HR (t(29) = 2.398, p = 0.023), except DBP (t(29) = 1.737, p = 
0.093), were significantly lower following IHG training than at pre-training. Meanwhile, 
HGS significantly increased after IHG training (t(29) = -3.175, p = 0.004). 
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Table 6.2 Cardiovascular and muscular responses to 8 weeks of IHG training 
Variables Pre-training Post-training 
Change (Δ) 
with training 
p value 
SBP (mmHg)        121.3 ± 9.1 117.1 ± 6.6* -4.2 ± 6.1   0.001 
DBP (mmHg) 76.2 ± 7.2   74.7 ± 7.9 -1.4 ± 4.5   0.093 
MAP (mmHg) 91.2 ± 6.9   88.9 ± 6.8* -2.4 ± 4.2   0.004 
PP (mmHg) 45.1 ± 8.2   42.4 ± 6.8* -2.8 ± 6.3   0.023 
HR (bpm) 79.4 ± 7.7   76.8 ± 8.9* -2.6 ± 5.9   0.023 
HGS (kg) 43.5 ± 6.7   46.0 ± 7.5*  2.6 ± 4.4   0.004 
Note. 
 Data shown as mean ± SD 
*Significantly different compared to pre-training value (p < 0.050) 
 
Table 6.3 demonstrates the cardiovascular and the muscular responses following a session 
of IHG exercise. SBP (t(29) = 2.456, p = 0.020) and MAP (t(29) = 2.506, p = 0.018), 
except DBP (t(29) = 2.024, p = 0.052), PP (t(29) = 0.655, p = 0.518), and HR (t(29) = 
0.608, p = 0.548) had been significantly lower following a session of IHG exercise than 
at pre-training. Meanwhile, HGS (t(29) = 0.8, p = 0.430) did not increase significantly 
after IHG exercise.  
 
Table 6.3 Cardiovascular and muscular responses to a session of IHG exercise 
Variables Pre-training Mid-training 
Change (Δ) 
with IHG 
exercise 
p value 
SBP (mmHg)        121.3 ± 9.1    118.1 ± 9.4* -3.2 ± 7.2    0.020 
DBP (mmHg) 76.2 ± 7.2      73.8 ± 8.5 -2.4 ± 6.5    0.052 
MAP mmHg) 91.2 ± 6.9      88.5 ± 8.0* -2.7 ± 5.8    0.018 
PP (mmHg) 45.1 ± 8.2      44.3 ± 8.0 -0.9 ± 7.1     0.518  
HR (bpm) 79.4 ± 7.7      78.5 ± 9.1 -0.9 ± 7.6     0.548 
HGS (kg) 43.5 ± 6.7      43.2 ± 6.9 -0.3 ± 2.3     0.430 
Note.   
Data shown as mean ± SD 
*Significantly different compared to pre-training value (p < 0.050) 
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6.5.3 ACE I/D Gene Polymorphism and Cardiovascular Response 
 
6.5.3.1 Systolic Blood Pressure (SBP) 
 
SBP among ACE I/D genotype groups at pre-, mid-, and post-training are shown in Table 
6.4. SBP at the pre-training differed significantly between the ACE I/D genotype groups 
(F(2, 27) = 4.005, p = 0.030). SBP at pre-training in the II genotype group was 
significantly lower compared with the ID genotype group (p = 0.043). However, no 
significant difference in the SBP at pre-training between II and DD genotype groups (p = 
0.102) was identified. There was also insignificant difference in SBP for mid-training 
(F(2, 27) = 3.157, p = 0.059) and post-training (F(2, 27) = 2.018, p = 0.152) between ACE  
I/D genotype groups. 
 
Table 6.4 Systolic blood pressure at pre-, mid-, and post-training among ACE I/D 
genotype groups 
Time course II (n=10) ID (n=10) DD (n=10) p value 
Pre-training   115.3 ± 7.2* 125.0 ± 9.3 123.6 ± 8.2           0.030 
Mid-training 113.2 ± 7.5 123.1 ± 8.9 117.9 ± 9.8  0.059 
Post-training 113.8 ± 6.3 118.7 ± 4.9 118.8 ± 7.6  0.152 
Note. 
Data shown as mean ± SD 
*Significantly different compared to ID genotype group (p = 0.043) 
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Figure 6.2 shows the changes in SBP following mid- and post-training in ACE I/D 
genotype groups. Following mid-training, SBP significantly decreased in the DD 
genotype group (Δ = -5.7 ± 6.6, t(9) = 2.734, p = 0.023), but not in the ID (Δ = -2.0 ± 8.4, 
t(9) = 0.738, p = 0.479) and II (Δ = -2.1 ± 6.8, t(9) = 0.986, p = 0.350) genotype groups. 
In post-training, SBP decreased significantly in the ID (Δ = -6.3 ± 7.3, t(9) = 2.750, p = 
0.022) and DD (Δ = -4.7 ± 5.2, t(9) = 2.905, p = 0.017) genotype groups. However, SBP 
in the II genotype group was not significantly changed following post-training (Δ = -1.5 
± 5.3, t(9) = 0.909, p = 0.387). 
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Figure 6.2 Changes in systolic blood pressure value to IHG training in ACE I/D 
genotype groups 
 
Note. 
Data shown as mean ± SD 
 *Significant change from pre-training (p = 0.022) 
  #Significant change from pre-training (p = 0.023) 
##Significant change from pre-training (p = 0.017) 
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6.5.3.2 Diastolic Blood Pressure (DBP) 
 
Table 6.5 presents the DBP at pre-, mid-, and post-training among ACE I/D genotype 
groups. There were significant differences in DBP at pre-training (F(2, 27) = 8.798, p = 
0.001), mid-training (F(2, 27) = 6.292, p = 0.006), and post-training (F(2, 27) = 6.328, p 
= 0.006) between the ACE I/D genotype groups. DBP at pre-training in the II genotype 
group was significantly lower compared with the ID (p = 0.001) and DD genotype groups 
(p = 0.018). At mid-training, the II genotype group had a significantly lower DBP than 
the ID genotype group (p = 0.006), but not for the DD genotype group (p = 0.053). 
Meanwhile, DBP at post-training in the II genotype group was significantly lower 
compared to ID (p = 0.007) and DD (p = 0.038) genotype groups.  
 
Table 6.5 Diastolic blood pressure at pre-, mid-, and post-training among ACE I/D 
genotype groups 
Time course II (n=10) ID (n=10) DD (n=10) p value 
Pre-training      70.1 ± 4.6      0.6 ± 5.9*     77.8 ± 6.7** 0.001 
Mid-training      67.3 ± 7.0≠    78.5 ± 5.2     75.6 ± 9.1 0.006 
Post-training      68.6 ± 6.7    78.8 ± 6.7#     76.7 ± 6.9## 0.006 
Note. 
Data shown as mean ± SD 
*Significantly different compared to II genotype group (p = 0.001) 
**Significantly different compared to II genotype group (p = 0.018) 
     ≠Significantly different compared to ID genotype group (p = 0.006) 
 #Significantly different compared to II genotype group (p = 0.007) 
   ##Significantly different compared to II genotype group (p = 0.038) 
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Changes in DBP following mid- and post-training in ACE I/D genotype groups are 
portrayed in Figure 6.3. DBP in all genotype groups did not significantly change following 
mid-training (II = (Δ = -2.8 ± 5.6, t(9) = 1.576, p = 0.149), ID = (Δ = -2.1 ± 3.9, t(9) = 
1.747, p = 0.115), and DD = (Δ = -2.3 ± 9.4, t(9) = 0.759, p = 0.467)). DBP in all genotype 
groups was also not significantly changed following post-training (II = (Δ = -1.4 ± 3.7, 
t(9) = 1.231, p = 0.250), ID = (Δ = -1.8 ± 5.7, t(9) = 0.971, p = 0.357), and DD = (Δ = -
1.1 ± 4.4, t(9) = 0.801, p = 0.444)). 
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Figure 6.3 Changes in diastolic blood pressure value to IHG training in ACE I/D 
genotype groups 
 
Note. 
Data shown as mean ± SD 
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6.5.3.3 Mean Arterial Pressure (MAP) 
 
MAP at pre-, mid-, and post-training among ACE I/D genotype groups are shown in Table 
6.6. MAP at pre-training (F(2, 27) = 9.747, p = 0.001), mid-training (F(2, 27) = 6.395, p 
= 0.005), and post-training (F(2, 27) = 6.006, p = 0.007) were significantly different 
between the ACE I/D genotype groups. At pre-training, MAP in the II genotype group was 
significantly lower than ID (p = 0.001) and DD (p = 0.009) genotype groups. At mid-
training, II genotype group had a significantly lower MAP than the ID genotype group (p 
= 0.005), but not for the DD genotype group (p = 0.085). Meanwhile, MAP at post-training 
in the II genotype group was significantly lower compared to the ID (p = 0.010) and DD 
(p = 0.035) genotype groups. 
 
Table 6.6 Mean arterial pressure at pre-, mid-, and post-training among ACE I/D 
genotype groups 
Time course II (n=10) ID (n=10) DD (n=10) p value 
Pre-training 85.2 ± 4.5 95.4 ± 5.8*    93.1 ± 6.0**   0.001 
Mid-training  82.6 ± 6.4≠ 93.3 ± 4.5    89.7 ± 8.8   0.005 
Post-training 83.7 ± 5.3 92.1 ± 5.3#    90.7 ± 6.7##   0.007 
Note. 
Data shown as mean ± SD 
   *Significantly different compared to II genotype group (p = 0.001) 
 **Significantly different compared to II genotype group (p = 0.009) 
      ≠Significantly different compared to ID genotype group (p = 0.005) 
 #Significantly different compared to II genotype group (p = 0.010) 
   ##Significantly different compared to II genotype group (p = 0.035) 
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Changes in MAP following mid- and post-training in ACE I/D genotype groups are 
displayed in Figure 6.4. MAP in all genotype groups did not significantly change with 
mid-training (II = (Δ = -2.6 ± 5.0, t(9) = 1.599, p = 0.144), ID = (Δ = -2.1 ± 4.9, t(9) = 
1.347, p = 0.211), and DD = (Δ = -3.4 ± 7.7, t(9) = 1.387, p = 0.199)). MAP in all genotype 
groups was also not significantly changed with post-training (II = (Δ = -1.5 ± 3.5, t(9) = 
1.309, p = 0.223), ID = (Δ = -3.3 ± 5.3, t(9) = 1.953, p = 0.083), and DD = (Δ = -2.3 ± 3.7, 
t(9) = 1.987, p = 0.078)). 
 
 
 
182 
 
 
 
Figure 6.4 Changes in mean arterial pressure value to IHG training in ACE I/D 
genotype groups 
 
Note. 
 Data shown as mean ± SD 
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6.5.3.4 Pulse Pressure (PP) 
 
Table 6.7 presents PP at pre-, mid-, and post-training among ACE I/D genotype groups. 
PP at pre-training (F(2, 27) = 0.064, p = 0.938), mid-training (F(2, 27) = 0.488, p = 0.619), 
and post-training (F(2, 27) = 1.574, p = 0.226) were not significantly different between 
the ACE I/D genotype groups.  
 
Table 6.7 Pulse pressure at pre-, mid-, and post-training among ACE I/D genotype 
groups 
Time course II (n=10) ID (n=10) DD (n=10) p value 
Pre-training 45.2 ± 7.3 44.4 ± 9.2 45.8 ± 8.7 0.938 
Mid-training 45.9 ± 7.0   44.6 ± 10.3 42.4 ± 6.6 0.619 
Post-training 45.2 ± 8.2 39.9 ± 6.4 42.1 ± 5.1 0.226 
Note. 
Data shown as mean ± SD 
 
Changes in PP following mid- and post-training in ACE I/D genotype groups are displayed 
in Figure 6.5. PP in all genotype groups did not significantly change with mid-training (II 
= (Δ = 0.7 ± 6.9, t(9) = -0.303, p = 0.769), ID = (Δ = 0.2 ± 6.5, t(9) = -0.092, p = 0.928), 
and DD = (Δ = -3.4 ± 7.9, t(9) = 1.364, p = 0.206)). PP in all genotype groups was also 
not significantly changed with post-training (II = (Δ = -0.1 ± 5.2, t(9) = 0.054, p = 0.958), 
ID = (Δ = -4.6 ± 7.2, t(9) = 2.009, p = 0.075), and DD = (Δ = -3.6 ± 6.0, t(9) = 1.899, p = 
0.090)). 
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Figure 6.5 Changes in pulse pressure value to IHG training in ACE I/D genotype 
groups 
 
Note. 
Data shown as mean ± SD 
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6.5.3.5 Heart Rate (HR) 
 
Table 6.8 presents HR at pre-, mid-, and post-training among ACE I/D genotype groups. 
HR at pre-training (F(2, 27) = 0.083, p = 0.920), mid-training (F(2, 27) = 0.891, p = 0.422), 
and post-training (F(2, 27) = 0.407, p = 0.669) were not significantly different between 
the ACE I/D genotype groups.  
 
Table 6.8 Heart rate at pre-, mid-, and post-training among ACE I/D genotype 
groups 
Time course II (n=10)   ID (n=10) DD (n=10) p value 
Pre-training 78.6 ± 6.5 79.8 ± 9.5 79.8 ± 7.7 0.920 
Mid-training 77.0 ± 8.7   77.0 ± 10.2 81.7 ± 8.3 0.422 
Post-training 78.9 ± 8.1 76.1 ± 9.3 75.5 ± 9.8 0.669 
Note.  
Data shown as mean ± SD 
 
Changes in HR following mid- and post-training in ACE I/D genotype groups are 
presented in Figure 6.6. HR in all genotype groups did not significantly change with mid-
training (II = (Δ = -1.6 ± 6.8, t(9) = 0.726, p = 0.486), ID = (Δ = -2.9 ± 9.1, t(9) = 1.009, p 
= 0.339), and DD = (Δ = 1.9 ± 6.8, t(9) = -0.884, p = 0.400)). HR decreased significantly 
following post-training in ID (Δ = -3.8 ± 3.5, t(9) = 3.392, p = 0.008) and DD (Δ = -4.3 ± 
4.2, t(9) = 3.246, p = 0.010) genotype groups. However, HR in II genotype group did not 
significantly change following post-training (Δ = 0.4 ± 8.1, t(9) = -0.144, p = 0.889). 
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Figure 6.6 Changes in heart rate value to IHG training in ACE I/D genotype groups 
 
Note. 
Data shown as mean ± SD 
*Significant change from pre-training (p = 0.008) 
# Significant change from pre-training (p = 0.010) 
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6.5.4 ACE I/D Gene Polymorphism and Muscular Response 
 
6.5.4.1 Handgrip Strength (HGS) 
 
HGS at pre-, mid-, and post-training among ACE I/D genotype groups are shown in Table 
6.9. HGS at pre-training (F(2, 27) = 1.827, p = 0.180), mid-training (F(2, 27) = 2.306, p = 
0.119), and post-training (F(2, 27) = 0.870, p = 0.431) were not significantly different 
between the ACE I/D genotype groups.  
 
Table 6.9 Handgrip strength at pre-, mid-, and post-training among ACE I/D 
genotype groups 
Time course II (n=10) ID (n=10) DD (n=10) p value 
Pre-training 43.4 ± 4.9 46.3 ± 8.0 40.8 ± 6.3 0.180 
Mid-training 43.3 ± 5.7 46.3 ± 7.9 39.9 ± 6.0 0.119 
Post-training 47.6 ± 4.6 47.1 ± 9.5 43.5 ± 7.8 0.431 
Note. 
Data shown as mean ± SD  
 
Changes in HGS following mid- and post-training in ACE I/D genotype groups are 
presented in Figure 6.7. HGS in all genotype groups did not significantly change with 
mid-training (II = (Δ = -0.1 ± 2.1, t(9) = 0.149, p = 0.885), ID = (Δ = -0.1 ± 1.4, t(9) = 
0.136, p = 0.895), and DD = (Δ = -0.8 ± 3.1, t(9) = 0.844, p = 0.420)). HGS increased 
significantly following post-training in the II genotype group (Δ = 4.2 ± 4.1, t(9) = -3.212, 
p = 0.011). Nevertheless, HGS in ID (Δ = 0.8 ± 2.8, t(9) = -0.851, p = 0.417) and DD (Δ 
= 2.7 ± 5.6, t(9) = -1.542, p = 0.158) genotype groups did not significantly change with 
IHG training. 
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Figure 6.7 Changes in handgrip strength value to IHG training in ACE I/D genotype 
groups 
 
Note. 
Data shown as mean ± SD 
*Significant change from pre-training (p = 0.011) 
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6.6 Discussion 
 
This study examined if the ACE I/D gene polymorphism could influence cardiovascular 
and muscular responses to 8-weeks of IHG training among normotensive men in 
Malaysia. The main finding of this study was that the ACE I/D gene polymorphism 
influences cardiovascular and muscular adaptations to an 8-week IHG training in a 
normotensive population with the possession of ACE D and ACE I allele had an effect in 
reducing resting blood pressure and improved muscular strength, respectively, following 
the training. 
 
Findings obtained from the current study showed that cardiovascular and muscular 
responses to IHG training varied between normotensive individuals with different ACE 
I/D genotypes. Consistent with the results retrieved from Kim (2009), this study revealed 
that normotensive men with DD and ID genotypes tended to have decreased resting SBP 
and HR with IHG training more than those with II genotype. Nevertheless, this finding 
was not comparable to the findings obtained from some previous studies (Hagberg et al., 
1999, Zhang et al., 2002) that demonstrated individuals with II genotype had lower resting 
blood pressure than other genotypes after exercise. This inconsistency may be due to the 
differences in the mode of exercise performed. For example, a study by Kim (2009) 
involved mixed aerobic and resistance exercise training compared with only aerobic 
training (endurance training) in study by Hagberg et al. (1999). Several studies have 
demonstrated that the physiological adaptation for aerobic training was greater among 
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individuals with II genotype, and those with DD genotype responded better to resistance 
training (Cam et al., 2005, Defoor et al., 2006, Cam et al., 2007). 
 
With regard to ACE activity, individuals with DD genotype had higher ACE  
activity compared to those with II genotype (Rigat et al., 1990). A higher level of ACE in 
circulating and skeletal muscle renin-angiotensin system (RAS) would increase the 
production of angiotensin II (ANG II) (Jones and Woods, 2003, Sayed-Tabatabaei et al., 
2006). Nevertheless, ANG II has different effects on circulating and skeletal muscle RAS 
(Jones and Woods, 2003). In circulating RAS, ANG II binds to several receptors that 
construct the blood vessels to increase blood pressure (Sayed-Tabatabaei et al., 2006). 
However, ANG II in skeletal muscle RAS stimulates the production of angiotensin (ANG) 
(1-7) peptide; a potent vasodilator that causes a decrease in blood pressure (Jones and 
Woods, 2003). As this study employed an IHG training that particularly involved the 
contraction of skeletal muscle, the reduction in SBP and HR in individuals with DD 
genotype might be interpreted due to high production of ANG (1-7) during exercise. 
Nonetheless, the present study did not measure the components of skeletal muscle RAS, 
which warrants for future studies to confirm this possible mechanism. 
 
The greater reduction in SBP and HR among DD genotype carrier could also be 
due to their higher baseline blood pressure values. This present result was consistent with 
the finding obtained by Millar et al. (2007), who demonstrated that normotensive 
individuals with higher baseline values of resting SBP and HR had a more pronounced 
reduction in these parameters after IHG training than those with lower baseline values. 
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This finding was also consistent with Wiley’s et al. (1992), who observed a larger 
reduction in resting blood pressure in hypertensive patients following isometric exercise 
training compared with normotensive individuals. Collectively, these findings support the 
idea generated by Badrov et al. (2013), who had previously suggested that individuals 
with higher baseline blood pressure values might have greater capacity for reduction in 
blood pressure following IHG training compared to those with lower baseline blood 
pressure value. This speculation is supported by the fact that those with higher resting 
blood pressure, such as hypertensive patients, present greater sympathetic activity at rest 
(Schlaich et al., 2004) that could lead to greater hemodynamic responsiveness to 
sympathetic activation (Kaushik et al., 2004).  
 
In the present study, the ACE I/D gene polymorphism was observed to influence 
muscular response to IHG training. The II genotype carriers exhibited a significantly 
greater increase in muscle strength after IHG training than ID and DD genotype carriers. 
This finding appears to contradict previous studies, which demonstrated that individuals 
with DD genotype obtained higher gains in muscle strength after exercise training than 
other genotype groups (Folland et al., 2000, Giaccaglia et al., 2008). The possible 
interpretation of the present data is that the lower ACE activity in participants with ACE 
II genotype may raise the production of bradykinin in skeletal muscle that increases local 
concentrations of nitric oxide, which in turn, raises mitochondrial efficiency, and thus, 
contractile function in skeletal muscle (Zhao et al., 1999). Moreover, previous study has 
shown that a high level of bradykinin in II genotype carriers resulted in improved tissue 
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oxygenation and a lesser rise in lactate that could lead to greater muscle efficiency 
(Kanazawa et al., 2002).   
 
The findings obtained from the current study reaffirm previous reports of a 
reduction in resting BP after an 8-week IHG training among normotensive individuals 
(McGowan et al., 2007, Millar et al., 2008, Badrov et al., 2013). Similar to previous 
studies, this study found that an 8-week IHG training significantly decreased resting SBP, 
MAP, and PP by 4.2 mmHg, 2.4 mmHg, and 2.8 mmHg, respectively, (McGowan et al., 
2007, Millar et al., 2008, Badrov et al., 2013). However, insignificant difference was 
observed in resting DBP after the IHG training program, which was similar to those 
reported previously among normotensive women (Badrov et al., 2013). However, the 
explanation for the lack of change in DBP following an 8-week IHG training has remained 
unclear. It may likely be due to the fact that DBP has a smaller range of values than SBP 
that limits the maximal change in DBP value (Pikilidou et al., 2013).  
 
Concomitant with the reduction in resting BP, resting HR was also observed to be 
significantly lower after an 8-week IHG training. The decrease in resting HR in the present 
study was similar to the earlier finding by Singh et al. (2014). In fact, previous studies 
have suggested that the decrease in resting blood pressure and HR may be due to a 
reduction in sympathetic nerve activity during IHG exercise (Wiley et al., 1992, Mueller, 
2007). When blood pressure is elevated during IHG exercise, the baroreceptors are 
stretched, resulting in a reflex-mediated increase in parasympathetic nerve activity, and a 
decrease in sympathetic nerve activity (Wiley et al., 1992). Consequently, it caused the 
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decline in the heart rate, while the diameter of blood vessels increased; leading to a drop 
in the blood pressure (Wiley et al., 1992).  
 
Besides resting blood pressure and HR, the present study also showed that the 8-
week IHG training improved muscle strength. The increase in muscle strength observed 
in this study had been consistent with those found in previous studies that demonstrated 
IHG exercise at 30% of MVC improved muscle strength (Howden et al., 2002, Mortimer 
and McKune, 2011). Considering all the changes in resting BP and HR, as well as muscle 
strength following IHG training, this training mode may be prescribed as part of lifestyle 
modification in maintaining a desirable blood pressure level, improving health quality of 
life, and reducing the risk of several diseases.  
 
Comparable with the findings on cardiovascular response to IHG training, there 
was a significant reduction in cardiovascular variables immediately following a session of 
IHG exercise. Resting SBP and MAP were observed to significantly reduce by 3.2 mmHG 
and 2.7 mmHG, respectively, in response to IHG exercise. These findings indicated that 
IHG exercise may provide substantial benefits for hypertensive patients to lower their 
resting BP and HR for certain periods. 
 
Although the present study has yielded some preliminary findings, there are some 
limitations that should be considered. First, the sample size in each genotype group may 
have been too small, and further larger studies are required to confirm these results. 
Second, the present study did not include a non-exercising control group to reduce 
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variability of the results as the present study was primarily designed to investigate the 
effects of ACE I/D gene polymorphism on IHG training adaptation where data were 
compared between genotype groups.  
 
Despite these limitations, the current results remain valid and applicable as the 
participants in each were relatively homogeneous in terms gender, physical 
characteristics, and health status. The intervention was standardized participants with the 
same trained investigator conducted the training intervention. The participants underwent 
familiarization procedures to reduce the apprehension-induced variability of the baseline 
measurements. The present study was conducted as single-blind study where the genotype 
of the participants was withheld from the participants.  
 
6.7 Conclusion 
 
In conclusion, the present study demonstrated the influence of ACE I/D gene 
polymorphism on cardiovascular and muscular adaptations to an 8-week IHG training in 
a normotensive population. Hence, future studies on hypertensive patients are warranted 
to confirm the effects of ACE I/D gene polymorphism on cardiovascular and muscular 
responses to an 8-week IHG training. 
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CHAPTER 7 
 
GENERAL CONCLUSION AND FUTURE DIRECTIONS 
 
7.1 General Conclusion 
 
The series of experiments presented in this thesis aimed to investigate the distribution of 
angiotensin I-converting enzyme (ACE) I/D and alpha-actinin-3 (ACTN3) R/X gene 
polymorphisms among an Asian population in Malaysia and its effect on human physical 
performance. The novelty of this entire research project was to demonstrate if ACE I/D 
and ACTN3 R/X gene polymorphisms influence physical performance and health in an 
Asian population in Malaysia which has received little previous attention compared to 
Caucasian populations. Specifically, this project addressed whether the distribution of 
ACE I/D and ACTN3 R/X gene polymorphisms is different in the Asian population in 
Malaysia as compared to the Caucasian population. Further investigation was carried out 
to determine if human physical performance is affected by the ACE I/D and ACTN3 R/X 
gene polymorphisms within the Asian population in Malaysia as has been widely reported 
among the Caucasian population. 
 
Based on the findings retrieved from the three presented studies, this thesis 
concludes that the ACE I/D and ACTN3 R/X gene polymorphisms play an important role 
in human physical performance and health within the Malaysian population. The specific 
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conclusions derived from the series of experiments presented in this thesis are depicted in 
the following:-  
 
1. The distribution of ACE I/D gene polymorphism within the Malaysian population 
was different to the Australian population. The distribution of ACE I/D gene 
polymorphism also varied significantly between four ethnic groups in the 
Malaysian population. This finding highlighted that the current understanding on 
how ACE I/D gene polymorphism may influence human physical performance 
may be different in different ethnic population. Conversely, the distribution of 
ACTN3 R/X gene polymorphism did not differ between Malaysian and Australian 
populations as well as between four ethnic groups in the Malaysian population. 
This finding suggests that the ACTN3 R/X gene polymorphism may confer similar 
effects across different ethnic population. 
 
2. Possession of the D allele of ACE I/D and R allele of ACTN3 R/X gene 
polymorphisms had a positive effect on strength/power performance in Malaysian 
population. This data confirmed the positive effects of possession of the D allele 
of ACE I/D and R allele of ACTN3 R/X gene polymorphisms on strength/power 
performance within the Asian ethnicity, as previously suggested for the Caucasian 
population (Clarkson et al., 2005b, Williams et al., 2005, Moran et al., 2006b, 
Vincent et al., 2007, Charbonneau, 2007, Giaccaglia et al., 2008, Ahmetov et al., 
2013, Erskine et al., 2014). This finding highlights the importance of genetic 
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screening for athletes to ensure that they are suited to play a particular sport based 
on their genetic profile and for coaches to use when planning training programs. 
 
On the other hand, possession of the I allele of ACE I/D and X allele of 
ACTN3 R/X gene polymorphisms did not influence endurance performance in the 
Malaysian population. This finding suggests that possession of the I allele of ACE 
I/D and X allele of ACTN3 R/X gene polymorphisms may not the absolute criteria 
for success as far as endurance performance is concerned. 
 
The distribution of ACE I/D and ACTN3 R/X gene polymorphisms do not 
vary much between different ethnic groups of Malaysian athletes and did not have 
much influence on the physical performance between these ethnic groups. This 
finding indicated that ACE I/D and ACTN3 R/X gene polymorphisms may confer 
similar effects on human physical performance across different ethnic group in 
Malaysia. 
 
3. The ACE I/D gene polymorphism influences cardiovascular and muscular 
adaptations to an 8-week isometric handgrip (IHG) training in a normotensive 
population. This study demonstrated that the normotensive men with DD and ID 
genotypes tended to have a decreased resting SBP and HR with IHG training more 
than those men with II genotype. On the contrary, the II genotype carriers 
exhibited a significantly greater increase in muscle strength after IHG training than 
those with ID and DD genotype carriers. This data may serve as a basis in 
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identifying individuals who would be more likely to benefit from the 8-week IHG 
training program. 
 
7.2 Strengths and Limitations 
 
Although this entire research project has reached its aims, there were some unavoidable 
limitations. Unforeseen difficulty in obtaining a large enough number of participants in 
each study may limit the generalizability of the current findings. As the second study are 
based on relatively mixed samples comprised of both genders, it is not clear whether the 
effects of ACE I/D and ACTN3 R/X gene polymorphisms on human physical performance 
within the Malaysian population is related to specific gender.  
 
Another shortcoming of the research is that the analyses of physical performance 
in the second study were restricted to the Malaysian athletes with no data available for the 
Malaysian controls in order to improve power by reducing variability. In addition, due to 
time constraint, there is no data available on the physical performance of Australian 
athletes. However, this is not considered to have any important impact on the main results 
of this study and further research could replicate the analyses of physical performance 
amongst the Australian athletes and Malaysian controls to further confirm the current 
finding. Another limitation of the research is the third study did not include a non-
exercising control group to reduce variability of the results as the third study was primarily 
designed to investigate the effects of ACE I/D gene polymorphism on IHG training 
adaptation where data were compared between genotype groups. Nevertheless, future 
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studies involving non-exercising control group are warranted to confirm the present 
findings. 
 
Despite the unavoidable limitations in the present research, a number of design 
features of this research lend support for the validity of the present findings. This research 
project followed recent recommendations on genomic research and exercise, that studies 
should use all the experimental approaches (case-control, cross-sectional and intervention 
studies) to demonstrate the relevance of ACE I/D and ACTN3 R/X gene polymorphisms to 
human physical performance and health within the Malaysian population (Guilherme et 
al., 2014). In the first and second study, the proportion of participants with different ethnic 
backgrounds in the Malaysian population had been set according to the current distribution 
ratio in Malaysia (Statistic, 2011), providing a more representative findings for the 
Malaysian population. In addition, participants within athlete and control groups in the 
Malaysian population were ethnically-matched to limit and control the potential effect of 
ethnicity. Malaysian and Australian populations were well-matched on age, gender, 
sample size and sporting discipline. Given that genotype distributions of studied 
polymorphisms were in Hardy-Weinberg equilibrium in the control group, the genetic 
assessment was accurate and unbiased. In the third study, the participants were relatively 
homogeneous in terms of age, sex, physical characteristic and health status with the 
intervention was standardized across the participants. 
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7.3 Future Directions 
 
The current understanding on the influence of ACE I/D and ACTN3 R/X gene 
polymorphisms on human physical performance and health remained controversial with 
inclusive findings especially when examined across different ethnicity. The series of 
experiments presented in this thesis has provided new insight regarding ethnicity and the 
ACE I/D and ACTN3 R/X gene polymorphisms effect on human physical performance and 
health. While several conclusions were drawn in this thesis, further studies are warranted 
in order to further confirm the effect of genetic across different ethnicities. Based on the 
current findings, further studies which address the following research question should be 
considered; 
 
1. Are there any genetic variant interaction between the ACE I/D and ACTN3 R/X 
gene polymorphisms in influencing human physical performance? 
 
2. Do the effects of ACE I/D and ACTN3 R/X gene polymorphisms on human 
physical performance differ by gender? 
 
3. What is the potential mechanism underlying the effects of ACE I/D and ACTN3 
R/X gene polymorphisms on human physical performance and health?  
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4. Do the effects of ACE I/D and ACTN3 R/X gene polymorphisms on human 
physical performance observed within the Malaysian population be of significance 
in other Asian populations? 
 
5. Does the difference in the athlete development program between Malaysian and 
Australian population influence the distribution pattern of the ACE I/D and ACTN3 
R/X gene polymorphisms in athletic population of these two populations? 
 
6. Does the ACE I/D gene polymorphism drive similar cardiovascular and muscular 
changes in hypertensive patients following an 8-week IHG training program as 
those observed in normotensive participants in the current thesis?
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Research Title: Genetics Influence on Sport Performance: An analysis on 
Malaysian Varsity Athletes 
 
Researcher’s Name:  Dr. Ahmad Munir Bin Che Muhamed 
 
To become a part this study, you or your legal representative must sign this page. By signing 
this page, I am confirming the following: 
 
  I  have read a l l  o f  the  in form at ion  in  th is  Sub jec t  I n form at ion  and  
Consent  Form  inc lud ing  any in form at ion  regard ing  the  r isk  in  t h is  
s tudy and  I  have had t im e to  th ink  about  i t .  
  A l l  o f  m y ques t ions  have  been answered  t o  m y sa t is fac t ion .  
  I  vo lun tar i l y  agree to  be  par t  o f  th is  research s tudy,  t o  f o l l ow the  
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  I  have rece ived a  copy o f  th is  Sub jec t  I n form at ion  and Consent  
Form  to  keep fo r  m yse l f .  
 
 
 
 
Subject Name (Print or type)        Subject Initials and Number 
 
 
 
Subject I.C No. (New)          Subject I.C No. (Old) 
 
 
 
 
Signature of Subject or Legal Representative       Date (dd/MM/yy) 
                                                                                   (Add time if applicable) 
 
 
Name of Individual  
Conducting Consent Discussion (Print or Type) 
 
 
Signature of Individual            Date (dd/MM/yy) 
Conducting Consent Discussion   
 
 
 
Name & Signature of Witness                   Date (dd/MM/yy) 
 
 
 
Note:  i) All subject who are involved in this study will not be covered by insurance. 
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To become a part this study, you or your legal representative must sign this page. By signing 
this page, I am confirming the following: 
 
  I  have read a l l  o f  the  in form at ion  in  th is  Sub jec t  I n form at ion  and  
Consent  Form  inc lud ing  any in form at ion  regard ing  the  r isk  in  t h is  
s tudy and  I  have had t im e to  th in k  about  i t .  
  A l l  o f  m y ques t ions  have  been answered  to  m y sa t is fac t ion .  
  I  vo lun tar i l y  agree to  be  par t  o f  th is  research s tudy,  t o  f o l l ow the  
s tudy procedures ,  and to  prov ide  necessary in form at ion  to  the  
researcher ,  o r  o ther  s ta f f  m em bers ,  as  reques ted.  
  I  m ay f ree l y choose to  s top  be ing a  par t  o f  th is  s tudy a t  anyt im e.  
  I  have rece ived a  copy o f  th is  Sub jec t  I n form at ion  and Consent  
Form  to  keep fo r  m yse l f .  
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Subject I.C No. (New)          Subject I.C No. (Old) 
 
 
 
Signature of Subject or Legal Representative       Date (dd/MM/yy) 
                                                                                   (Add time if applicable) 
 
Name of Individual  
conducting Consent Discussion (Print or Type) 
 
 
 
Signature of Individual                     Date (dd/MM/yy) 
Conducting Consent Discussion   
 
 
 
Name & Signature of Witness                   Date (dd/MM/yy) 
  
 
 
 
Note:  i) All subject who are involved in this study will not be covered by insurance. 
ii) Excess samples from this research will not be used for other reasons and will be destroyed with the 
consent from the Research Ethics Committee (Human), USM. 
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Research Title: Genetics Influence on Sport Performance: An analysis on 
Malaysian Varsity Athletes 
Researcher’s Name:  Dr. Ahmad Munir Bin Che Muhamed 
 
To become a part this study, you or your legal representative must sign this page.  
By signing this page, I am confirming the following: 
 
 I  unders tood tha t  my nam e wi l l  no t  appear  on  the  m ater ia ls  
pub l ished and there  have been e f fo r ts  to  m ake sure  tha t  t he  
pr ivacy o f  m y nam e is  kept  conf ident ia l  a l though the  
conf ident ia l i t y  is  no t  com ple te l y  guaranteed  due to  unexpec ted  
c i rcum stances .  
 
 I have read the materials or general description of what the material contains and 
reviewed all photographs and figures in which I am included that could be 
published.  
 
  I have been offered the opportunity to read the manuscript and to see all materials in 
which I am included, but have waived my right to do so.  
 
  A l l  the  pub l ished m ater ia ls  w i l l  be  shared am ong the  sc ien t i s ts  
and journa l is t  wor ldwide.  
 
  The m ater ia ls  wi l l  a lso  be used in  loca l  pub l ica t ions ,  book  
pub l ica t ions  and accessed b y m any loca l  and  in ternat iona l  
researchers  wor ldwide.  
 
  I  hereby agree and  a l low the  m ater ia l s  to  be  used  in  o ther  
pub l ica t ions  requ i red  by o ther  pub l ishers  w i th  these cond i t ions :  
 
  The m ater ia ls  w i l l  no t  be  used as  adver t i sem ent  purposes  or  as  
packag ing m ater ia ls .  
 
  The m ater ia ls  wi l l  no t  be  used out  o f  contex  –  i .e . :  Sam ple  
p ic tu res  w i l l  no t  be  used in  an  ar t ic le  wh ich  is  unre la ted  sub jec t  to  
the  p ic tu re .  
 
 
Subject Name (Print or type)     Subject Initials or Number 
 
 
Subject I.C No.   Subject’s Signature  Date (dd/MM/yy) 
 
 
Name and Signature of Individual     Date (dd/MM/yy) 
Conducting Consent Discussion  
 
Note:  i) All subject who are involved in this study will not be covered by insurance. 
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PARTICIPANT CONSENT FORM 
 
 
I, ...........................................................................................[PRINT NAME], give 
consent to my participation in the research project 
 
TITLE: Genetic Influence on Athletes Performance: An analysis on Malaysian and 
Australian Athletes 
 
In giving my consent I acknowledge that: 
 
1. The procedures required for the project and the time involved have been explained 
to me, including any inconvenience, risk, discomfort or side effect and any questions 
I have about the project have been answered to my satisfaction. 
 
 
2. I have read the Participant Information Statement and have been given the 
opportunity to discuss the information and my involvement in the project with the 
researcher/s. 
 
 
3. I understand that being in this study is completely voluntary – I am not under any 
obligation to consent. 
 
 
4. I understand that my involvement is strictly confidential. I understand that any 
research data gathered from the results of the study may be published however no 
information about me will be used in any way that is identifiable. 
 
 
  
 
 
5. I understand that I can withdraw from the study at any time, without affecting my 
relationship with the researcher(s) or the University of Sydney now or in the future. 
 
6. I consent to:  
 
 Cheek Swabs for DNA sampling YES    NO  
 
 Personal Detail Questionnaire YES    NO   
 
 My coach providing you a record of my playing history and performance  
      YES    NO  
 
 
 
 ............................. ................................................... 
Signature  
 
 
 
 ............................ .................................................... 
Please PRINT name 
 
 
.................................................................................. 
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I, ...........................................................................................[PRINT NAME], give 
consent to my participation in the research project 
 
TITLE: Establishing an estimation of frequencies of genotypes related to sport 
performance in a non-elite reference population 
In giving my consent I acknowledge that: 
 
1. The procedures required for the project and the time involved have been 
explained to me, including any inconvenience, risk, discomfort or side effect and 
any questions I have about the project have been answered to my satisfaction. 
2. I have read the Participant Information Statement and have been given the 
opportunity to discuss the information and my involvement in the project with the 
researcher/s. 
3. I understand that being in this study is completely voluntary – I am not under any 
obligation to consent. 
4. I understand that my involvement is strictly confidential. I understand that any 
research data gathered from the results of the study may be published however 
no information about me will be used in any way that is identifiable. 
5. I understand that I can withdraw from the study at any time, without affecting my 
relationship with the researcher(s) or the University of Sydney now or in the 
future. 
6. I consent to:  
 Cheek Swabs for DNA sampling  YES  NO  
 Personal Detail Questionnaire   YES  NO  
 ............................. ................................................... 
Signature  
 ............................ .................................................... 
Please PRINT name 
.................................................................................. 
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Research Subject Information and Consent Form 
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Research Title: _______________________________________________ 
 
Researcher’s Name:  _______________________________________________ 
 
I voluntarily consent to take part in this research study. I have fully discussed and understood 
the purpose, procedures and possible risks of this study. This study has been explained to me in 
a language that I understand. I have been given enough time to ask any questions that I have 
about the study, and all my questions have been answered to my satisfaction.  
                                       
Name of Subject (>12 years),     Signature              Date  
   
________________________   ______________________ _______________________ 
                                         
 
Name of Parent or Legally        Signature              Date  
Accepted Representative  
   
________________________   ______________________ ________________________ 
 
 
Translator Information 
The study has been explained to the participant / legally acceptable representative in [specify 
the language used) language by [name of translator]. 
 
Witness Statement 
I, the undersigned, certify to the best of my knowledge that the participant signing this informed 
consent form had the study fully explained in a language understood by him / her and clearly 
understands the nature, risks and benefits of his / her participation in the study.  
   
                                         
Name of Witness Signature        Date  
   
_______________________ ______________________ 
   
Investigator Statement  
I, the undersigned, certify that I explained the study to the participant and to the best of my 
knowledge the participant signing this informed consent form clearly understands the nature, 
risks and benefits of her participation in the study.  
   
                                         
Name of Investigator /   Signature       Date    Time Start Time End 
Person administering consent  
   
   
____________________________     _____________________  __________     ________ 
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Research Subject’s Material Publication Consent Form 
Signature Page 
 
 
Research Title: ________________________________________________ 
 
Researcher’s Name:  ______________________________________________ 
 
To become a part this study, you or your legal representative must sign this page.  
 
By signing this page, I am confirming the following: 
 
 I  unders tood tha t  my nam e wi l l  no t  appear  on  the  m ater ia ls  
pub l ished and there  have been e f fo r ts  to  m ake sure  tha t  t he  
pr ivacy o f  m y nam e is  kept  conf ident ia l  a l though the  
conf ident ia l i t y  is  no t  com ple te l y guaranteed  due to  unexpec ted  
c i rcum stances .  
 
 I have read the materials or general description of what the material contains and 
reviewed all photographs and figures in which I am included that could be 
published.  
 
  I have been offered the opportunity to read the manuscript and to see all materials in 
which I am included, but have waived my right to do so.  
 
  A l l  t he  pub l ished  mater ia ls  w i l l  be  shared am ong the  m edica l  
p rac t i t i oners ,  sc ien t is ts  and journa l is t  wor ld  wide.  
 
  The m ater ia ls  wi l l  a lso  be  used in  loca l  pub l ica t ions ,  book  
pub l ica t ions  and accessed b y m any loca l  and in ternat iona l  doc to rs  
wor ld  w ide.  
 
  I  hereby agree and  a l low the  m ater ia l s  to  be  used  in  o ther  
pub l ica t ions  requ i red  by o ther  pub l ishers  w i th  these cond i t ions :  
 
  The m ater ia ls  wi l l  no t  be  used as  adver t isem ent  purposes  nor  as  
packag ing m ater ia ls .  
 
  The m ater ia ls  wi l l  no t  be  used out  o f  contex  –  i .e . :  Sam ple  
p ic tu res  w i l l  no t  be  used in  an  ar t ic le  wh ich  is  unre la ted  sub jec t  to  
the  p ic tu re .  
 
 
Research Subject Name (Print or type)        Research Subject Initials or Number 
 
Research Subject I.C No.   Research Subject’s Signature Date (dd/MM/yy) 
 
 
Name and Signature of Individual    Date (dd/MM/yy) 
Conducting Consent Discussion 
 
 
The influence of ACE I/D gene polymorphism on blood 
pressure response following isometric exercise training 
Hazwani Binti Ahmad Yusof @ Hanafi 
 
  
 
PARTICIPANT INFORMATION DETAILS 
BUTIRAN MAKLUMAT PESERTA 
Life Style Science Cluster, Advanced Medical & Dental Institute, Universiti Sains Malaysia  
THE EFFECTS OF ANGIOTENSIN I-CONVERTING ENZYME (ACE) I/D AND ALPHA-
ACTININ-3 (ACTN3) R/X GENE POLYMORPHISMS ON HUMAN PHYSICAL PERFORMANCE 
AND HEALTH WITHIN THE MALAYSIAN POPULATION 
KESAN POLIMORFISME GEN ANGIOTENSIN I-CONVERTING ENZYME (ACE) I/D DAN 
ALPHA-ACTININ-3 (ACTN3) R/X KE ATAS PRESTASI FIZIKAL DAN KESIHATAN MANUSIA 
DI KALANGAN POPULASI MALAYSIA 
 
A. Personal Details 
Maklumat Peribadi 
 
1. Participant’s I.D NO:____________________________________________________ 
No. ID peserta 
 
2. Name of Participant:__________________________________________________ 
Nama peserta 
 
3. I.D. NO:______________________________________________________________  
No. kad pengenalan 
 
4. Gender: _______________________________5. Race:________________________ 
Jantina                                                                     Bangsa 
 
6.   Current Address:______________________________________________________ 
      Alamat terkini     
                                  _______________________________________________________ 
   
7.   Permanent Address:____________________________________________________ 
      Alamat tetap          
                                        ___________________________________________________ 
             
8.   Email Address:_________________________9.  Phone No:____________________ 
      Alamat email                                                             No. Telefon 
 
10. Career:_______________________________11.  Marital Status:_________________ 
      Kerjaya                                                                     Status perkahwinan 
 
12. Education Level:_______________________________________________________ 
            Tahap pengajian 
 
 
 
 
 
 
 
 
 
 
 
  
 
B. Medical and Health Information 
     Maklumat Perubatan dan Kesihatan 
 
1. Have you ever had any of the following disease: 
Adakah anda pernah menghidapi mana-mana penyakit seperti 
berikut: 
Yes 
Ya 
No 
Tidak 
I.  Heart Disease/ Penyakit Jantung   
II.  Hypertension/ Tekanan Darah Tinggi   
III.  Heart Attack/ Serangan Jantung   
IV.  Stroke/ Angin Ahmar   
V.  Asthma/ Asma   
VI.  Diabetes/ Kencing Manis   
VII.  Kidney Diseases/ Penyakit Ginjal   
VIII.  Liver Diseases/ Penyakit Hati   
IX.  Anemia/ Anemia   
X.  Spinal injury/ Kecederaan Tulang Belakang   
2. Do you engage in a diet program? 
Adakah anda mengikuti program diet? 
  
3. Do you smoke? 
Adakah anda merokok? 
  
 
*Thick (/) as appropriate 
  Sila tanda (/) mana-mana yang berkenaan 
 
4.   What types of exercise do you do (in the past 3 months)?_____________________ 
      Apakah jenis senaman yang anda lakukan (dalam 3 bulan yang lalu)? 
 
5.   How frequent do you exercise do (in the past 3 months)?_____________________ 
Berapa kerap kamu bersenam (dalam 3 bulan yang lalu)? 
 
6.   Duration of exercise for each session (in minutes) do (in the past 3 months):_____ 
Tempoh masa senaman bagi setiap sesi (dalam minit) (dalam 3 bulan yang lalu) 
 
 7.   Are you an athlete? If yes, please answer the questions below:________________ 
       Adakah anda seorang atlet?Jika Ya, sila jawab soalan di bawah: 
 
7.1  Sports involvement:_________________________________________________ 
       Bidang sukan yang diceburi 
 
7.2 Current Level of competition:_________________________________________ 
      Tahap pertandingan sekarang 
 
7.3 Years playing at current level:_________________________________________ 
      Tahun bermain pada tahap sekarang 
     
 
 
 
 
 
 
 
A. Data Demografik 
 
Nama: ___________________________ 
 
No. KP: ____________________________ 
 
Umur: _________ Agama:_______ 
 
Jantina:  Lelaki   Perempuan 
 
No. Tel: ___________________________ 
Alamat: 
___________________________________ 
 
___________________________________ 
 
 
Etnik: 
 
 Melayu  Cina   India
  
  
 Orang asli; Suku kaum. 
Nyatakan:_____________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. Kriteria Inklusi 
 
 Ya Tidak 
1. Ketiga-tiga generasi 
mempunyai darah keturunan 
suku yang sama 
  
2. Tiada perkahwinan 
campuran dengan 
suku/bangsa lain untuk 
ketiga-tiga generasi 
  
3. Mengetahui sejarah keluarga 
dengan jelas untuk ketiga-
tiga generasi 
  
4. Bertutur menggunakan dialek 
suku anda untuk urusan 
harian 
  
 
C. Sejarah penyakit jangkitan 
 
 Ya Tidak 
1. Malaria   
2. TB   
3. Denggi   
4. Lain-lain. Nyatakan: 
…………………   
 
C. Analisis Filogeni dan Filogeografi di Semenanjung Malaysia. 
Susur-galur keluarga: 
 
 
 
 
ANDA 
Etnik: 
Penyakit: 
 
AYAH 
Etnik: 
Penyakit: 
IBU 
Etnik: 
Penyakit: 
 
DATUK 
Etnik: 
Penyakit: 
NENEK 
Etnik: 
Penyakit: 
 
DATUK 
Etnik: 
Penyakit: 
NENEK 
Etnik: 
Penyakit: 
 
     
PARTICIPANT INFORMATION DETAILS 
Discipline of Exercise and Sport Science, Faculty of Health Sciences, University of 
Sydney, 75 East Street, Lidcombe, NSW 2141, Australia. 
 
 
Establishing an estimation of frequencies of genotypes related to sport 
performance in a non-elite reference population 
 
1.  Participant I.D NO 
(Filled in by researcher) 
 
 
2.  Name   
 
3.  Gender  
 
4.  Date of Birth  
 
5.  Ethnicity (Country of Birth) 
Participant  
Participant’s Mother  
Participant’s Maternal grandmother  
Participant’s Maternal grandfather  
Participant’s Father  
Participant’s Paternal grandmother  
Participant’s Paternal grandfather  
6.  Current Address  
 
 
7.  Email Address  
 
8.  Contact No  
 
 
Have you ever had any kind of disease? e.g: Hypertension. If yes, please 
write down the name of the disease below. 
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
____________________________________________________________ 
 
 
 
     
 
PARTICIPANT INFORMATION DETAILS 
Discipline of Exercise and Sport Science, Faculty of Health Sciences, University of 
Sydney, 75 East Street, Lidcombe, NSW 2141, Australia. 
 
 
Genetic Influence on Athletes Performance: An analysis on Malaysian and  
              Australian Athletes 
 
B. Personal Details 
 
 Participant I.D NO 
(Filled in by researcher) 
 
1.  Name   
2.  Gender  
3.  Date of Birth  
4.  Ethnicity (Country of Birth) 
5.  Participant  
6.  Participant’s Mother  
7.  Participant’s Maternal grandmother  
8.  Participant’s Maternal grandfather  
9.  Participant’s Father  
10.  Participant’s Paternal grandmother  
11.  Participant’s Paternal grandfather  
12.  Current Address  
 
 
13.  Email Address  
14.  Contact No  
15.  Sport  
16.  Current Level of competition  
17.  Years playing at current level  
 
 
Comments (please list here information specific to your event example – if 
you are in a team sport list your most common positions played, if you are in 
an individual sport what is the distance you run / swim / cycle etc.): 
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
______________________________________________________ 
     
C. Injury History 
 
1. Are you currently injured?      YES 
 NO  
 If yes, Are you able to compete or are on training duties only? 
 
 ______________________________________________________ 
2. In the past 12 months have you been injured?   YES  NO  
If yes, what was the injury and were you able to compete or were 
limited to training duties only? 
 
 ______________________________________________________ 
 
3. Over the past 3 years how often have you been injured to the point of 
missing competition? 
 
 
 
 
4. Over the past 3 years how often have you been injured but were still 
able to compete? 
 
 
 
 
 
Not at all Frequently Sometimes 
Not at all Frequently Sometimes 
     
SUBJECT’S INFORMATION DETAILS 
Lifestyle Science Cluster, Advanced Medical & Dental Institute, USM 
The influence of ACE I/D gene polymorphism on blood pressure response 
following isometric exercise training 
 
D. Personal Details 
 
1.  Subject’s I.D NO 
(Filled in by researcher) 
 
2.  Gender  
3.  Age  
4.  Ethnicity 
5.  Subject  
6.  Subject’s Mother  
7.  Subject’s Maternal 
grandmother 
 
 
8.  Subject’s Maternal 
grandfather 
 
 
9.  Subject’s Father  
10.  Subject’s Paternal 
grandmother 
 
 
11.  Subject’s Paternal 
grandfather 
 
 
12.  Current Address  
 
13.  Email Address  
14.  Contact No  
15.  Career  
   B. Medical and Health Information 
1. Have you ever had any of the following disease: Yes No 
I.  Heart Disease   
II.  Hypertension   
III.  Heart Attack   
IV.  Stroke   
V.  Asthma   
VI.  Diabetes   
VII.  Kidney Diseases   
VIII.  Liver Diseases   
IX.  Anemia   
X.  Spinal injury   
2. Do you smoke?   
*Thick (/) as appropriate 
4.   What types of exercise do you do (in the past 3 months)?_______________ 
5.   How frequent do you exercise?_____________________________________ 
6.   Duration of exercise for each session (in minutes):___________________ 
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APPENDIX D 
HARDY-WEINBERG EQUILIBRIUM TEST 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
Malaysian general population (n=180) 
        Observed HW - Expected     
ACE I/D  n allele I allele D Frequency % Frequency % cell Chi-sq. p-value 
II 56 112 0 56 31.11 60.67 33.70 0.359   
ID 97 97 97 97 53.89 87.66 48.70 0.994   
DD 27 0 54 27 15.00 31.67 17.59 0.688   
Total 180 209 151 180 100.00 180.00 100.00 2.042 0.150 
  360 0.58 0.42 360       (p-value) Chisq w 1 df   
 
Australian general population (n=180) 
        Observed HW - Expected     
ACE I/D   n allele I allele D Frequency % Frequency % cell Chi-sq. p-value 
II 45 90 0 45 25.00 42.05 23.36 0.207   
ID 84 84 84 84 46.67 89.90 49.94 0.387   
DD 51 0 102 51 28.33 48.05 26.69 0.181   
Total 180 174 186 180 100.00 180.00 100.00 0.775 0.380 
  360 0.48 0.52 360       (p-value) Chisq w 1 df   
 
Malay general population (n=99) 
    
Observed 
 
HW - Expected 
   ACE I/D   n allele I allele D Frequency % Frequency % cell Chi-sq. p-value 
II 40 80 0 40 40.40 42.68 43.11 0.168   
ID 50 50 50 50 50.51 44.65 45.10 0.642   
DD 9 0 18 9 9.09 11.68 11.79 0.614   
Total 99 130 68 99 100.00 99.00 100.00 1.423 0.230 
 
198 0.66 0.34 198 
   
(p-value) Chisq w 1 df 
 
     
 
Chinese general population (n=45) 
        Observed HW - Expected     
ACE I/D   n allele I allele D Frequency % Frequency % cell Chi-sq. p-value 
II 13 26 0 13 28.89 12.80 28.44 0.003   
ID 22 22 22 22 48.89 22.40 49.78 0.007   
DD 10 0 20 10 22.22 9.80 21.78 0.004   
Total 45 48 42 45 100.00 45.00 100.00 0.014 0.900 
  90 0.53 0.47 90       (p-value) Chisq w 1 df   
 
Indian general population (n=13) 
        Observed HW - Expected     
ACE I/D   n allele I allele D Frequency % Frequency % cell Chi-sq. p-value 
II 1 2 0 1 7.69 2.77 21.30 1.130   
ID 10 10 10 10 76.92 6.46 49.70 1.938   
DD 2 0 4 2 15.38 3.77 28.99 0.830   
Total 13 12 14 13 100.00 13.00 100.00 3.899 0.050 
  26 0.46 0.54 26       (p-value) Chisq w 1 df   
 
Other Bumiputra general population (n=23) 
        Observed HW - Expected     
ACE I/D   n allele I allele D Frequency % Frequency % cell Chi-sq. p-value 
II 2 4 0 2 8.70 3.92 17.06 0.943   
ID 15 15 15 15 65.22 11.15 48.49 1.328   
DD 6 0 12 6 26.09 7.92 34.45 0.467   
Total 23 19 27 23 100.00 23.00 100.00 2.738 0.100 
  46 0.41 0.59 46       (p-value) Chisq w 1 df   
 
     
 
Malaysian general population (n=180) 
        Observed HW - Expected     
ACTN3 R/X  n allele R allele X Frequency % Frequency % cell Chi-sq. p-value 
RR 40 80 0 40 22.22 46.01 25.56 0.784   
RX 102 102 102 102 56.67 89.99 49.99 1.603   
XX 38 0 76 38 21.11 44.01 24.45 0.820   
Total 180 182 178 180 100.00 180.00 100.00 3.207 0.070 
  360 0.51 0.49 360       (p-value) Chisq w 1 df   
 
Australian general population (n=180) 
        Observed HW - Expected     
ACTN3 R/X  n allele R allele X Frequency % Frequency % cell Chi-sq. p-value 
RR 44 88 0 44 24.44 50.14 27.85 0.752   
RX 102 102 102 102 56.67 89.72 49.85 1.680   
XX 34 0 68 34 18.89 40.14 22.30 0.939   
Total 180 190 170 180 100.00 180.00 100.00 3.371 0.070 
  360 0.53 0.47 360       (p-value) Chisq w 1 df   
 
Malay general population (n=99) 
        Observed HW - Expected     
ACTN3 R/X  n allele R allele X Frequency % Frequency % cell Chi-sq. p-value 
RR 23 46 0 23 23.23 25.76 26.02 0.296   
RX 55 55 55 55 55.56 49.48 49.98 0.616   
XX 21 0 42 21 21.21 23.76 24.00 0.321   
Total 99 101 97 99 100.00 99.00 100.00 1.232 0.270 
  198 0.51 0.49 198       (p-value) Chisq w 1 df   
 
 
     
Chinese general population (n=45) 
        Observed HW - Expected     
ACTN3 R/X  n allele R allele X Frequency % Frequency % cell Chi-sq. p-value 
RR 13 26 0 13 28.89 12.80 28.44 0.003   
RX 22 22 22 22 48.89 22.40 49.78 0.007   
XX 10 0 20 10 22.22 9.80 21.78 0.004   
Total 45 48 42 45 100.00 45.00 100.00 0.014 0.900 
  90 0.53 0.47 90       (p-value) Chisq w 1 df   
 
Indian general population (n=13) 
        Observed HW - Expected     
ACTN3 R/X  n allele R allele X Frequency % Frequency % cell Chi-sq. p-value 
RR 0 0 0 0 0.00 1.56 11.98 1.558   
RX 9 9 9 9 69.23 5.88 45.27 1.649   
XX 4 0 8 4 30.77 5.56 42.75 0.437   
Total 13 9 17 13 100.00 13.00 100.00 3.644 0.060 
  26 0.35 0.65 26       (p-value) Chisq w 1 df   
 
Other Bumiputra general population (n=23) 
        Observed HW - Expected     
ACTN3 R/X  n allele R allele X Frequency % Frequency % cell Chi-sq. p-value 
RR 4 8 0 4 17.39 6.26 27.22 0.816   
RX 16 16 16 16 69.57 11.48 49.91 1.781   
XX 3 0 6 3 13.04 5.26 22.87 0.972   
Total 23 24 22 23 100.00 23.00 100.00 3.569 0.060 
  46 0.52 0.48 46       (p-value) Chisq w 1 df   
 
 
 
     
 
Control group in the Malaysian population (n=180) 
        Observed HW - Expected     
ACE I/D  n allele I allele D Frequency % Frequency % cell Chi-sq. p-value 
II 56 112 0 56 31.11 60.67 33.70 0.359   
ID 97 97 97 97 53.89 87.66 48.70 0.994   
DD 27 0 54 27 15.00 31.67 17.59 0.688   
Total 180 209 151 180 100.00 180.00 100.00 2.042 0.150 
  360 0.58 0.42 360       (p-value) Chisq w 1 df   
 
 
Control group in the Malaysian population (n=180) 
        Observed HW - Expected     
ACTN3 R/X  n allele R allele X Frequency % Frequency % cell Chi-sq. p-value 
RR 40 80 0 40 22.22 46.01 25.56 0.784   
RX 102 102 102 102 56.67 89.99 49.99 1.603   
XX 38 0 76 38 21.11 44.01 24.45 0.820   
Total 180 182 178 180 100.00 180.00 100.00 3.207 0.070 
  360 0.51 0.49 360       (p-value) Chisq w 1 df   
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APPENDIX E 
DETAIL INFORMATION OF ATHLETES
     
 
Endurance athletes (n=34) 
  
  
    No Gender Sports Age Height 
(cm) 
Body 
Weight 
(kg) 
Body Mass 
Index 
(kg/m2) 
Body Fat 
(%) 
Yo-Yo 
intermittent 
recovery level 
2 
performance 
(m) 
Handgrip 
Strength (kg) 
Leg Strength 
(kg) 
1 Female Long distance cycling  17 151.0 45.0 19.7 20.1 320.00 27.8 77.3 
2 Female Long distance cycling  18 154.6 45.8 19.2 16.1 480.00 28.6 77.5 
3 Female Long distance cycling  18 166.5 58.0 20.9 18.2 480.00 28.9 82.5 
4 Female Long distance cycling  18 154.0 47.7 20.1 15.7 560.00 26.4 98.5 
5 Male Long distance cycling  19 172.0 58.5 19.8 17.6 640.00 36.0 109.5 
6 Male Long distance cycling  17 172.0 59.1 20.0 14.5 480.00 34.7 114.3 
7 Male Long distance cycling  21 168.0 65.4 23.2 10.8 880.00 45.3 125.5 
8 Male Long distance cycling  18 171.5 65.7 22.3 16.6 400.00 44.6 137.0 
9 Male Long distance cycling  19 172.0 69.3 23.4 18.0 640.00 47.1 138.7 
10 Male Long distance cycling  20 161.0 60.4 23.3 8.0 880.00 45.8 158.0 
11 Male Long distance swimmer > 400 m 23 166.0 58.9 21.4 13.1 240.00 43.4 98.3 
12 Male Long distance swimmer > 400 m 21 168.6 74.7 26.3 22.6 240.00 36.8 116.0 
13 Male Long distance swimmer > 400 m 23 182.0 80.3 24.2 20.9 240.00 47.1 117.3 
14 Male Long distance swimmer > 400 m 23 168.7 55.8 19.6 11.8 400.00 34.2 122.7 
15 Male Long distance swimmer > 400 m 23 171.5 75.1 25.5 17.3 240.00 48.0 151.0 
16 Female Long distance track and field 20 151.5 44.4 19.3 21.8 200.00 22.1 41.2 
17 Female Long distance track and field 19 149.0 38.7 17.4 25.5 120.00 24.8 48.7 
18 Female Long distance track and field 20 154.0 49.2 20.7 24.0 200.00 21.9 51.3 
19 Female Long distance track and field 20 163.0 77.8 29.3 33.9 200.00 33.0 68.5 
20 Male Long distance track and field 19 165.0 62.7 23.0 20.5 440.00 40.8 87.8 
     
21 Male Long distance track and field 22 169.0 55.8 19.5 11.0 400.00 36.6 92.5 
22 Male Long distance track and field 23 182.1 72.5 21.9 16.5 400.00 46.5 93.5 
23 Female Long distance track and field 22 167.0 62.0 22.2 28.1 200.00 30.9 96.5 
24 Male Long distance track and field 20 168.0 58.3 20.7 24.0 440.00 40.2 98.6 
25 Male Long distance track and field 21 178.0 54.0 17.0 13.8 440.00 42.3 99.0 
26 Male Long distance track and field 20 173.0 61.1 20.4 24.3 440.00 37.7 100.8 
27 Male Long distance track and field 22 180.0 69.9 21.6 19.5 640.00 42.5 105.3 
28 Male Long distance track and field 24 176.5 70.8 22.7 16.4 440.00 48.1 111.8 
29 Male Long distance track and field 20 167.8 56.5 20.0 15.4 880.00 27.8 117.2 
30 Male Long distance track and field 17 173.7 61.1 20.3 12.8 480.00 37.8 122.8 
31 Male Long distance track and field 19 185.0 67.6 19.8 15.7 200.00 25.6 125.3 
32 Male Long distance track and field 19 176.5 96.9 31.1 27.4 480.00 40.2 129.5 
33 Male Long distance track and field 21 165.0 51.6 19.0 10.3 640.00 39.5 131.0 
34 Male Long distance track and field 18 186.7 133.0 38.1 30.9 240.00 70.2 143.3 
    
Mean ± SD 19.8 ± 
1.9 
168.5 ± 
9.8 
63.6 ± 17.0 22.1 ± 4.1 18.6 ± 6.1 429.4 ± 203.8 37.7 ± 9.8 105.6 ± 28.2 
     
Strength/power athletes (n=41) 
  
  
  No Gender Sports Age Height (cm) Body Weight (kg) Body Mass 
Index 
(kg/m2) 
Body 
Fat 
(%) 
Yo-Yo 
intermittent 
recovery level 2 
performance (m) 
Handgrip 
Strength (kg) 
Leg 
Strength 
(kg) 
1 Male Boxing 20 171.0 57.7 19.7 10.7 440.00 39.1 140.3 
2 Male Boxing 18 165.5 63.6 23.2 13.3 640.00 43.5 150.3 
3 Male Boxing 23 178.4 77.7 24.5 22.8 440.00 44.9 203.8 
4 Female Karate 19 166.0 56.5 20.5 21.9 160.00 30.1 109.8 
5 Female Taekwando 20 150.0 42.5 18.9 20.5 120.00 21.3 33.3 
6 Female Taekwando 20 160.0 57.6 22.5 27.1 160.00 29.1 44.5 
7 Female Taekwando 21 141.5 43.7 21.8 30.3 200.00 23.7 52.5 
8 Female Taekwando 21 165.5 51.2 18.7 24.3 120.00 20.0 54.7 
9 Female Taekwando 20 153.0 61.8 26.4 32.3 160.00 24.4 56.3 
10 Female Taekwando 21 156.5 56.8 23.2 28.0 160.00 25.4 61.7 
11 Male Taekwando 20 161.0 83.9 32.4 38.3 80.00 27.4 77.2 
12 Female Taekwando 19 136.0 68.9 28.3 33.5 200.00 25.5 79.3 
13 Female Taekwando 20 154.5 55.9 23.4 24.2 80.00 21.0 81.5 
14 Female Taekwando 23 156.0 53.1 21.8 22.7 320.00 22.7 83.3 
15 Female Taekwando 20 159.0 52.0 20.6 25.8 120.00 30.5 86.7 
16 Male Taekwando 21 165.5 64.7 23.6 17.8 120.00 31.8 87.3 
17 Female Taekwando 20 166.3 63.5 22.9 18.2 200.00 35.4 89.8 
18 Male Taekwando 20 171.6 58.1 19.8 11.1 320.00 38.6 91.5 
19 Male Taekwando 23 178.4 56.1 17.6 12.4 240.00 30.5 94.0 
20 Male Taekwando 23 169.5 71.5 24.9 18.7 120.00 40.5 96.8 
21 Male Taekwando 20 166.5 60.7 21.9 19.0 160.00 34.9 96.8 
22 Male Taekwando 20 173.5 73.3 24.3 15.9 280.00 47.2 104.2 
23 Male Taekwando 21 172.5 66.6 22.4 16.1 240.00 40.3 115.0 
24 Male Taekwando 20 170.0 62.1 21.5 12.1 360.00 36.6 124.0 
25 Male Taekwando 21 174.5 66.1 21.7 14.4 320.00 39.7 127.0 
26 Male Taekwando 18 168.5 75.2 26.5 19.4 280.00 48.0 131.7 
27 Male Taekwando 20 170.0 59.8 20.7 17.6 200.00 41.5 137.5 
28 Male Taekwando 20 168.5 64.4 22.7 15.8 320.00 35.4 143.5 
29 Male Taekwando 23 189.5 80.4 22.4 17.4 240.00 57.1 168.0 
30 Female Weight lifting 17 150.5 55.2 24.4 25.7 520.00 26.6 60.3 
     
31 Female Weight lifting 17 150.4 51.7 22.9 23.6 274.00 24.0 80.8 
32 Female Weight lifting 17 159.4 60.9 23.9 23.6 480.00 33.6 85.4 
33 Female Weight lifting 17 147.4 64.1 29.5 28.9 200.00 29.1 92.5 
34 Male Weight lifting 17 156.2 54.4 22.3 15.0 560.00 48.1 106.9 
35 Male Weight lifting 17 165.2 70.4 25.8 11.6 760.00 47.7 140.5 
36 Male Weight lifting 17 169.2 57.0 19.9 7.8 320.00 39.4 143.5 
37 Male Weight lifting 17 168.4 64.1 22.6 11.2 800.00 40.5 152.8 
38 Male Weight lifting 21 170.0 70.6 24.4 23.0 560.00 44.4 166.0 
39 Male Weight lifting 17 168.2 68.6 24.2 10.3 640.00 51.4 168.3 
40 Male Weight lifting 17 165.5 77.1 28.1 14.9 640.00 50.5 172.5 
41 Male Weight lifting 18 160.8 64.9 25.1 7.8 600.00 56.9 174.5 
    
Mean ± SD 19.7 ± 1.8 163.7 ± 10.4 62.5 ± 9.2 23.2 ± 3.0 19.6 ± 
7.3 
320.8 ± 197.5 36.1 ± 10.2 108.9 ± 41.2 
     
Intermittent athletes (n=105) 
  
  
  No Gender Sports Age Height (cm) Body Weight (kg) Body Mass 
Index 
(kg/m2) 
Body Fat 
(%) 
Yo-Yo 
intermittent 
recovery level 2 
performance (m) 
Handgrip 
Strength (kg) 
Leg 
Strength 
(kg) 
1 Male Badminton 24 167.5 55.8 19.9 23.8 120.00 32.1 77.7 
2 Male Badminton 23 166.0 61.3 22.2 18.2 280.00 48.6 82.5 
3 Male Badminton 24 157.2 55.6 22.5 11.0 200.00 41.3 83.0 
4 Male Badminton 23 176.0 67.8 21.9 17.6 280.00 35.5 97.0 
5 Male Badminton 20 182.5 72.3 21.7 13.6 280.00 50.5 118.3 
6 Male Badminton 20 167.5 65.5 23.3 14.3 280.00 48.3 136.7 
7 Male Basketball 22 169.5 63.9 22.2 14.1 480.00 39.4 63.2 
8 Male Basketball 22 169.0 74.4 26.0 17.1 320.00 23.9 65.2 
9 Male Basketball 22 165.2 67.5 24.8 19.9 320.00 32.4 80.3 
10 Male Basketball 23 176.6 63.5 20.4 18.4 160.00 47.2 123.5 
11 Male Basketball 23 179.1 69.6 21.7 22.5 120.00 33.7 129.2 
12 Male Cricket 21 170.5 82.1 28.2 23.7 160.00 47.9 107.0 
13 Male Cricket 21 162.6 56.5 21.4 16.8 440.00 44.7 116.7 
14 Male Cricket 20 152.2 59.9 25.9 19.7 640.00 41.3 122.7 
15 Male Cricket 19 178.1 72.0 22.7 16.3 440.00 47.5 130.5 
16 Male Cricket 21 167.5 80.3 28.6 23.3 240.00 52.2 135.0 
17 Male Cricket 22 177.6 71.4 22.7 18.0 160.00 46.4 138.8 
18 Male Cricket 20 165.5 66.5 24.3 14.1 440.00 55.7 151.0 
19 Male Cricket 19 172.1 71.9 24.3 17.0 440.00 53.4 154.5 
20 Male Football 19 166.0 68.3 24.8 13.6 482.00 23.6 43.5 
21 Male Football 20 149.0 44.3 20.0 11.8 480.00 26.1 68.5 
     
22 Male Football 21 165.0 55.4 20.3 15.8 600.00 32.6 80.7 
23 Male Football 25 169.3 56.3 19.7 16.7 240.00 31.2 84.0 
24 Male Football 19 167.0 59.4 21.3 8.9 640.00 36.5 85.4 
25 Male Football 19 168.0 64.8 23.0 13.1 400.00 39.8 86.2 
26 Male Football 20 180.0 69.8 21.5 17.9 440.00 37.0 88.3 
27 Male Football 19 171.5 64.5 21.9 13.7 560.00 31.9 91.8 
28 Male Football 21 171.5 69.8 23.7 19.6 440.00 39.2 92.3 
29 Male Football 20 183.5 70.9 21.1 9.8 480.00 46.6 94.0 
30 Male Football 22 172.5 98.1 33.0 30.4 240.00 40.8 96.0 
31 Male Football 21 179.0 70.4 22.0 15.7 240.00 30.3 104.7 
32 Male Football 20 167.5 70.7 25.2 19.7 280.00 39.2 111.8 
33 Male Football 24 170.0 57.3 19.8 13.1 440.00 37.0 115.3 
34 Male Football 24 177.5 70.3 22.3 14.0 640.00 36.3 115.7 
35 Male Football 21 172.0 70.6 23.9 16.4 240.00 41.3 117.0 
36 Male Football 20 172.5 60.3 20.3 9.4 200.00 41.7 120.3 
37 Male Football 21 169.5 64.4 22.4 14.8 280.00 38.7 121.8 
38 Male Football 25 164.0 66.5 24.7 17.7 440.00 43.8 122.5 
39 Male Football 21 170.5 71.2 24.5 18.9 440.00 47.1 124.5 
40 Male Football 21 182.0 71.4 21.6 14.4 320.00 38.5 125.3 
41 Male Football 19 168.0 72.2 25.6 18.6 440.00 46.7 127.8 
42 Male Football 22 172.5 71.4 24.0 18.9 640.00 36.7 130.2 
43 Male Football 20 172.5 63.7 21.4 16.7 440.00 46.0 130.8 
44 Male Football 22 170.0 67.9 23.5 21.7 280.00 36.1 135.7 
45 Male Football 24 161.0 56.0 22.7 15.9 640.00 47.7 145.7 
46 Male Football 19 168.5 65.4 23.0 13.5 640.00 46.5 153.0 
     
47 Male Football 19 174.0 80.1 26.5 22.2 640.00 50.1 160.0 
48 Male Football 21 172.5 72.9 24.5 19.4 400.00 41.8 163.7 
49 Male Futsal 22 177.0 66.5 21.2 13.2 400.00 30.1 58.0 
50 Male Futsal 23 159.5 85.7 33.7 27.9 160.00 22.9 67.5 
51 Male Futsal 20 164.5 51.4 19.0 5.8 400.00 26.1 78.5 
52 Male Futsal 20 177.5 70.6 22.4 16.2 301.00 31.2 84.8 
53 Male Futsal 21 160.5 76.7 29.8 26.8 280.00 22.4 89.0 
54 Male Futsal 23 174.0 62.4 20.6 16.7 240.00 34.1 90.8 
55 Male Futsal 20 172.5 68.1 22.9 14.6 360.00 36.4 99.7 
56 Male Futsal 21 172.5 61.1 20.5 11.9 400.00 26.0 100.7 
57 Male Futsal 24 179.5 64.3 20.0 17.0 560.00 25.8 104.5 
58 Male Futsal 23 167.5 65.0 23.2 18.2 560.00 33.5 105.7 
59 Male Futsal 23 170.0 63.4 21.9 12.9 520.00 37.3 106.2 
60 Male Futsal 20 176.5 68.5 22.0 13.3 440.00 46.4 130.8 
61 Male Futsal 23 175.0 77.2 25.2 23.0 320.00 42.6 133.5 
62 Male Futsal 26 185.5 87.9 25.5 22.6 120.00 45.6 151.5 
63 Male Hockey 21 174.0 64.9 21.4 15.2 360.00 36.5 46.5 
64 Female Hockey 19 161.0 63.9 24.7 29.2 80.00 31.5 71.7 
65 Female Hockey 19 156.5 55.9 22.8 29.4 80.00 48.1 72.0 
66 Female Hockey 19 162.0 108.6 41.4 42.1 80.00 36.7 81.2 
67 Male Hockey 18 168.5 62.4 22.0 17.9 320.00 28.6 91.0 
68 Male Hockey 22 163.0 52.6 19.8 9.9 400.00 44.5 107.5 
69 Male Hockey 20 180.0 78.7 24.3 20.4 320.00 53.7 110.3 
70 Male Hockey 20 184.0 72.5 21.4 19.3 240.00 32.9 113.0 
71 Male Hockey 20 174.0 49.1 16.2 11.5 320.00 52.7 157.2 
     
72 Male Rugby 22 164.5 85.7 31.7 25.6 200.00 43.7 94.7 
73 Male Rugby 20 145.5 62.9 29.7 17.5 280.00 42.4 104.8 
74 Male Rugby 21 169.5 60.5 21.1 13.2 400.00 42.7 114.7 
75 Male Rugby 21 178.5 78.3 24.6 17.4 240.00 58.5 121.5 
76 Male Rugby 25 171.0 91.0 31.1 30.0 200.00 47.5 137.7 
77 Male Rugby 21 177.0 102.8 32.8 33.2 120.00 46.4 142.7 
78 Male Rugby 20 165.0 66.5 24.4 13.8 640.00 48.6 143.3 
79 Male Rugby 22 169.5 103.6 36.1 28.6 200.00 46.1 143.7 
80 Male Rugby 20 173.0 75.9 25.4 18.5 240.00 59.6 146.8 
81 Male Rugby 22 172.5 124.8 41.9 36.2 120.00 47.8 171.5 
82 Male Rugby 22 166.0 83.7 30.4 26.4 240.00 47.0 222.2 
83 Female Sepak takraw 21 160.5 57.8 22.4 24.0 200.00 26.7 36.8 
84 Female Sepak takraw 19 154.0 46.9 19.8 20.9 200.00 25.4 45.7 
85 Male Sepak takraw 18 160.0 53.4 20.9 6.5 440.00 36.8 74.5 
86 Male Sepak takraw 18 178.0 95.7 30.2 22.6 280.00 54.2 79.8 
87 Male Sepak takraw 18 170.5 64.3 22.1 15.1 440.00 35.6 82.7 
88 Male Sepak takraw 19 166.0 57.7 20.9 14.3 240.00 24.9 92.7 
89 Male Sepak takraw 18 172.0 67.7 22.9 22.8 360.00 35.2 98.0 
90 Male Sepak takraw 22 170.0 67.5 23.4 12.4 640.00 52.6 102.7 
91 Male Sepak takraw 21 174.0 76.1 25.1 20.6 240.00 37.5 112.7 
92 Male Sepak takraw 20 170.0 57.5 19.9 11.6 480.00 44.9 113.0 
93 Male Sepak takraw 18 168.0 70.5 25.0 22.1 280.00 41.7 113.2 
94 Male Sepak takraw 23 170.5 55.1 19.0 18.5 240.00 35.0 117.5 
95 Male Sepak takraw 19 175.5 78.6 25.5 17.7 240.00 39.1 119.5 
96 Female Squash 22 161.5 47.5 18.2 25.3 482.00 22.7 64.5 
     
97 Male Volleyball 20 174.0 67.9 22.4 13.4 320.00 49.2 126.0 
98 Male Volleyball 22 180.0 83.6 25.8 23.1 240.00 49.2 126.7 
99 Male Volleyball 20 185.5 81.5 23.7 16.7 200.00 44.4 137.0 
100 Male Volleyball 21 189.0 93.0 26.0 18.8 320.00 44.1 145.3 
101 Male Volleyball 20 170.0 73.6 25.5 19.5 320.00 41.0 153.0 
102 Male Volleyball 22 180.0 95.7 29.5 23.8 200.00 54.9 162.7 
103 Male Volleyball 23 181.5 73.7 22.4 17.0 320.00 58.0 176.7 
104 Male Volleyball 25 178.0 78.3 24.7 18.3 240.00 57.2 177.7 
105 Male Volleyball 19 184.5 71.6 21.0 10.6 280.00 59.6 193.0 
  Mean ± SD 21.0 ± 1.8 170.8 ± 7.9 70.0 ± 13.4 24.0 ± 4.3 18.7 ± 6.4 340.8 ± 148.7 40.8 ± 9.2 112.3 ± 
33.5 
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